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Adhesion through microbial surface components recognizing adhesive matrix 
molecules (MSCRAMM) is an essential step of infection for most pathogenic bacteria. 
Leptospira spp. are pathogenic spirochetes that cause a zonootic disease and express 
several important virulence factors on their surface including immunoglobulin-like 
(Ig-like) proteins, LigA and LigB. In this dissertation, both LigA and LigB were 
discovered as MSCRAMMs to bind to some extracellular matrices such as fibronectin 
(Fn), elastin, tropoelastin, laminin, and collagen. The Fn binding sites are located on 
LigBCen, C-terminal unique Ig-like domains and LigBCtv, C-terminal non-Ig-like 
region. In addition, those Fn-binding fragments can also mediate leptospiral adhesion 
to host cells. 
A high affinity Fn-binding site was identified on LigBCen2, and the domains of 
Fn those contribute to the binding were N-terminal domain (NTD) and gelatin binding 
domain (GBD). Apart from Fn, LigBCen2 can interact with laminin, collagen, and 
fibrinogen. Interestingly, LigBCen2 was also found as a calcium-binding protein, and 
calcium-induced conformational change can assist LigB-NTD interactions. 
Furthermore, LigBCen2 was found to contained a well folded region, 
LigBCen2R containing 12th and partial 11th Ig-like domains, and a disorered region, 
LigBCen2NR. LigBCen2R and LigBCen2NR bind to GBD and NTD, respectively. 
There would be a disordered to ordered transition on LigBCen2NR upon NTD binding. 
In addition to LigBCen2R, most of Ig-like domains on LigA (7’-8th, 10th, 11th, 12th, 
 13th) and LigB (7’-8th, 9th) can bind to GBD. The binding affinity of GBD or MDCK 
cells become greater if the Lig proteins contain more Ig-like domains especilly 
including the terminal Ig-like domain (LigA13 or LigB12). It suggests that Lig-GBD 
interaction is enhanced by multivalency to mediate leptospiral adhesion to host cells. 
Interestingly, Lig proteins with terminal Ig-like domains (LigAVar7’-13 or 
LigBCen7’-12) bind GBD with 40-fold greater affinities than it without terminal Ig-
like domains (LigAVar7’-12 or LigBCen7’-11). The compact structure possessed by 
LigAVar7’-12 or LigBCen7’-11 instead of LigAVar7’-13 or LigBCen7’-12 suggested 
the relevance to their strong binding affinities with GBD and host cells. 
Moreover, the Fn-binding sites of LigBCtv was also identified and located on 
amino acids 1708-1712, LIPAD containing region, and 15th type III modules of Fn 
(15F3) is characterized to be the slow and moderate binding partner of LIPAD 
containing region. LIPAD containing region was proved to be surface exposed and 
possesses a nacent helix and β-strand structure.  
Elastin and tropoelastin were also discovered to interact with Ig-like domains of 
Lig proteins. Interestingly, elastin and tropoelastin can bind to conserved region of Lig, 
which other ECMs don’t bind. Tropoelastin-Lig interaction is attributed to charge-
charge interactions, and ASP341 on 4th Ig-like domain (LigCon4) serves as an 
imporant role for the binding. The binding of Lig proteins to tropoelastin might be 
elicited to inhibit elastogenesis, then, to help the leptospiral entry by preventing tissue 
repair and reorganization. 
Fibrinogen (Fg), a plasma rich protein can be also associated with several Ig-like 
domains of Lig proteins. LigBCen2R including partial 11th and full 12th Ig-like 
domains of LigB, can bind to FgαCC, the C-terminal αC domain of Fg. By binding to 
LigBCen2R, the RGD motif of FgαCC can be blocked and prevent its further 
interaction with integrin αIIbβ3 for platelet adhesion and aggregation. LigBCen2R- 
 FgαCC can also inhibit thrombin-induced fibrin clot formation but not influence the 
binding of plasminogen or tissue plasminogen activator. To sum up, Lig-Fg interaction 
blocking platelet adhesion, aggregation and clot formation might be the one of the 
reasons to lead pulmonary hemorrhage in Leptospira infected patients. 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
 
Leptospirosis in humans and livestock is caused by spirochetes belonging to the genus 
Leptospira and is manifested by various syndromes such as acute or chronic interstitial 
nephritis, pulmonary hemorrhage, myocarditis and hemolytic crisis.  Leptospirosis 
also causes abortions, stillbirths and reproductive failure in cattle, pigs, horses and dogs, 
and there is an increasing prevalence of leptospirosis in humans who have come in 
contact with infected animals.  The involvement of Leptospira in autoimmune disease 
has also been reported in horses and humans (64, 92, 96). Leptospirosis is identified as 
an emerging infectious disease, exemplified by recent large outbreaks in several 
countries, including Nicaragua, Brazil, India, Malaysia, and the United States (69).   In 
1992, Lederberg et al used leptospirosis as an example of an infection that in the past 
caused significant morbidity in military personnel deployed in tropical areas (68).  
 
Biology of Leptospires:  Leptospires are approximately 0.1 by 6 µm to 0.1 by 20 µm 
tightly coiled spirochetes, but occasional cultures may contain much longer cells. The 
helical amplitude and the wavelength are approximately 0.1 to 0.15 µm and 0.5 µm, 
respectively (40). The genus Leptospira comprises of saprophytic and pathogenic 
species and belongs to the phylum of spirochaetes. Saprophytic leptospires, such as L. 
biflexa, are free-living organisms found in water and soil and unlike pathogenic 
Leptospira spp., do not infect human or animal hosts (40). The organisms have pointed 
ends on either side, which are usually bent into a distinctive hook. The periplasmic 
space contains two axial filaments (periplasmic flagella) with polar insertions (111). 
Morphologically all leptospires are indistinguishable in vivo but the structure of 
individual isolates varies with subculture in vitro. Interestingly, the original 
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morphology of leptospires can be restored by passage in hamsters (26). Leptospires 
have a typical double membrane structure in common with other spirochetes, in which 
the cytoplasmic membrane and peptidoglycan cell wall are closely associated and are 
overlain by an outer membrane (46). Leptospiral lipopolysaccharide (LPS) has a 
composition similar to that of other Gram-negative bacteria (127), but has lower 
endotoxic activity (104, 105). Also, leptospiral LPS activates cells through a toll-like 
receptor 2 (TLR2)-dependent mechanism (129).  
    
 
Leptospirosis in human: Leptospirosis caused by Leptospira interrogans is a 
re-emerging zoonosis occurring as large outbreaks throughout the world and US and is 
considered to be the most geographically widespread zoonosis (8, 70, 81, 125). This 
disease affects humans in both urban and rural areas and in temperate and tropical 
climates (9, 125).  However, leptospirosis is a sporadic disease, restricted to risk 
exposure associated with specific occupational groups, such as farmers, miners, abattoir, 
sewer workers (9), athletes (45, 83, 103), military (15, 42) or recreational exposure (47, 
86, 113).  Leptospirosis is a major urban pathogen causing epidemics in South America 
with 10%-15% mortality (9, 66, 98, 102). The transmission of this disease to humans is 
through direct contact with the urine or infected tissues of mammalian reservoirs or 
indirectly through contaminated water, soil, or vegetation (5, 69).  These spirochetes 
usually enter through injured skin and/or intact mucous membranes and then 
disseminate through blood vessels to various organs, such as the kidney, liver and lungs 
(20, 21). The clinical signs of human infection range from subclinical infection to 
jaundice, renal failure, and potentially fatal lung disease (9, 69, 101, 102, 124, 131). 
Although leptospirosis is typically a biphasic illness (anicteric), a fulminant disease can 
also be found in 5–10% of all patients (40, 69). Fatalities typically result from renal, 
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cardiac, or pulmonary failure (21, 69, 75, 101, 102).  In the biphasic illness, the initial 
acute or septicemic phase is characterized by bacteremia that typically lasts about one 
week. Most of the cases present with a febrile illness of sudden onset. Fever, chills, 
headache, severe myalgia, conjunctival suffusion, anorexia, nausea, vomiting, and 
prostration usually characterize acute leptospirosis (21). A substantial proportion of 
people infected by Leptospira may have subclinical disease or very mild symptoms, and 
do not seek medical attention (9, 131). In this leptospiremic phase, leptospires may be 
found in the blood and cerebrospinal fluid (76). The resolution of symptoms may 
coincide with the second or immune phase, when circulating immunoglobulin M (IgM) 
antibodies begin to be produced, accompanied by excretion of spirochetes in the urine 
(21).  However, fever may recur after a remission of 3 to 4 days, producing a biphasic 
illness (21). Weil’s syndrome can develop after the acute phase as the second phase of a 
biphasic illness, or can simply present as a single, progressive illness. It is characterized 
by high fever, intense jaundice, bleeding, renal and lung dysfunction, neurologic 
alterations, and cardiovascular collapse, with a variable clinical course (69, 125, 126). 
 
Leptospirosis in Cattle.  Most serovars of Leptospira that infect cattle cause acute, 
subacute or inapparent leptospirosis.  The most common cause of leptospirosis among 
cattle, especially the dairy cow, is L. borgpetersenii serovar Hardjo. Cattle are the 
maintenance host for serovar Hardjo and shedding from infected animals is responsible 
for the spread of this bacterium in nature. L. borgpetersenii serovar Hardjo (type 
hardjoprajitino) is isolated primarily from cattle in the United Kingdom, while L. 
borgpetersenii serovar Hardjo (type hardjobovis) is common among cattle in the US 
and other parts of the world (50, 118).  After infection, leptospires localize in the 
kidneys (44, 87, 94, 115, 130) and are excreted intermittently in the urine (34). Serovar 
Hardjo causes outbreaks of mastitis (38) and abortion (35, 38) and is found in aborted 
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fetuses and premature calves (28, 38, 43, 54). In addition, hardjo has been isolated from 
normal fetuses (36), the genital tracts of pregnant cattle (39), vaginal discharge after 
calving (37), and the genital tract and urinary tract of >50% of cows (39) and bulls (31) 
in that area. In Australia, both serovars Hardjo and Pomona were demonstrated in 
bovine abortions, but serological evidence suggested that the incidence of hardjobovis 
infection was much higher (25, 62, 108). In the United States, serovar hardjobovis is the 
most commonly isolated serovar in cattle (39), but pomona also occurs. A recent 
serologic survey indicated that 22% and 15% of 1193 Texas slaughterhouse cattle 
serum samples were positive for Pomona and Hardjobovis, respectively (112).  The 
leptospiral vaccine for cattle in use today is an inactivated whole-cell vaccine 
containing L. borgpetersenii serovar Hardjo (type hardjoprajitno), Canicola, Pomona, 
and Icterohaemorrhagiae and L. kirschneri serovar grippotyphosa (52). This vaccine is 
ineffective and provides only short-term immunity. Recently, it has been reported that a 
new L. borgpetersenii serovar Hardjo (hardjobovis) vaccine (SPIROVACTM, Pfizer 
Animal Health) could induce a Th1 immune response and protect against maternal and 
fetal infection in cattle (84, 85).  Since there are a number of reports on the involvement 
of Leptospira in triggering autoimmunity in horses and humans, the administration of 
whole cells as a vaccine needs to be thoroughly studied.  
 
Leptospirosis in horses: The prevalence of leptospiral infection in horses may be greater 
than any other host (117). However horses are considered to be accidental hosts, because 
they are not typically carriers of the disease but are susceptible to leptospiral infection 
only under certain circumstances (like direct exposure to a reservoir host).  The 
bacterium is believed to be transmitted through direct contact with blood, urine or tissues 
of affected animals and may enter the accidental host through the mucous membranes of 
the eyes, nose, and mouth, or an abrasion of the skin (116). The clinical syndromes in 
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horses are uveitis (periodic ophthalmia) (64, 92), corneal opacity (92), abortion (22, 23), 
and renal diseases (19).  Leptospiral infection of horses is a significant problem for the 
equine industry.  In recent years, an increase of systemic leptospiral infection resulting in 
abortions has been reported (59, 60, 65). The number of confirmed leptospiral abortion 
cases increased from 0.6% in 1987 to 5.9% in 1990 (93). Donahue, et al. demonstrated 
that most isolates from aborted fetal tissues are L. interrogans serovar Pomona type 
Kennewicki with occasional isolates of serovar grippotyphosa (22, 23). Hong, et al. 
demonstrated that leptospiral placentitis is one of the most important emerging causes of 
equine abortion (59).  Equine leptospirosis is an emerging infectious disease possibly 
because vaccination with a leptospiral vaccine for cattle has generally been ineffective. 
    
Equine uveitis, a major concern: Equine uveitis is a leading cause of blindness in horses 
and mules in many parts of the world (48).  Post leptospiral uveitis has been confirmed in 
a natural outbreak of leptospirosis on a small farm near Ithaca, NY (97).  Five of the 16 
horses showed fever and recurrent uveitis. A positive correlation between the finding of 
leptospiral serum agglutinins and uveitis has been reported (106).  In addition, 56% of 
112 horses with uveitis and only 9% of 260 horses without uveitis were sero-positive for 
L. interrogans serovar Pomona in western New York (24).  Some of these latter 
seropositive horses subsequently developed signs of uveitis.  Experimental infection 
with L. interrogans serovar Pomona results in a transient, mild systemic disease 
characterized by fever, leptospiremia, and leptospiuria of 120 days duration after 
infection. These findings have also been observed in natural infection with Leptospira.  
In the horse, the inflammatory response is characterized by a large infiltration of 
lymphocytes and plasma cells (30).  The pathogenesis of uveitis remains to be elucidated, 
but clinical and experimental data strongly suggest that it is an immune-mediated disease 
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(64). Parma,et al. have reported that leptospiral-associated uveitis is due to the sharing of 
an antigenic epitope between the equine cornea and Leptospira (74, 91, 92, 122). 
 
Leptospirosis in swine: Leptospirosis in swine is predominantly a chronic, 
asymptomatic disease, which may go unnoticed in a herd for a long time (49, 51).  When 
it manifests itself, it is characterized primarily by the occurrence of abortions, infertility, 
and the birth of premature and weak piglets.  Serovars Pomona and Grippotyphosa are 
recognized as the major contributors of infertility in pigs (27, 53).  However, serogroups 
like Canicola, Hebdomandis, Icterohaemorrhagiae, Autumnalis and Australis have also 
been implicated (27) Acute systemic disease characterized by a haemolytic crisis and 
death is rarely encountered (27).     
 L. interrogans serovar Pomona is the most important cause of porcine leptospirosis 
in the world (27).  This serovar also causes an asymptomatic chronic interstitial nephritis 
which is usually only identified at slaughter. Natural and experimental infections by L. 
interrogans serovar Canicola cause abortions, mummification, stillbirths, neonatal 
mortality and low conception rates.  Serovars of the Australis serogroup are similarly 
associated with infertility, and have been isolated from the genital tracts of sows and 
boars.  Pigs infected with L. interrogans serovar Bratislava, another important serovar 
that causes porcine reproductive failure in Europe and in the US, display clinical signs 
such as stillborn pigs, weak neonatal pigs, and abortions (10, 11, 27, 32, 33).  
  
Leptospirosis in Dogs: In the past, serovars Icterohaemorrhagiae and Canicola were 
responsible for the acute forms of canine leptospirosis (2). However, serovars 
Australis, Pyrogenes, Autumnalis, Pomona and Grippotyphosa can induce typical 
acute leptospirosis, with icterus, acute renal failure, and other clinical signs. (2).  A 
recent outbreak of acute canine lepotspirosis caused by serovars Pomona and 
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Grippotyphosa has been reported 
(http://www.ivis.org/advances/Infect_Dis_Carmichael/mcdonough). Chronic canine 
leptospirosis is less frequently described and is often more difficult to diagnose, 
simply because clinical signs can be observed in vaccinated animals (1).  The present 
vaccine can protect the animal against acute signs but may not prevent infection if the 
dog is exposed to a high infectious challenge or to a highly invasive strain (3). 
However, subacute or chronic disease can also occur following infection by less 
virulent serovars. After delayed treatment of an acute form of leptospirosis, surviving 
bacteria within kidney or liver cells can escape host defenses, which after several 
weeks may lead to subacute or chronic hepatitis or renal failure. Many cases of 
polyuria–polydipsia syndrome of unknown etiology are probably associated with 
chronic leptospirosis in dogs.  Reproductive failure (abortion) can also occur 
following infection (2).  
 
Leptospirosis in sheep and goats: Leptospirosis of sheep manifests as two distinct 
clinical syndromes: an acute and often fatal systemic disease, and genital disease. The 
acute systemic disease in lambs is characterized by icterus, hemoglobinemia, 
hemoglobinuria, fever, and death, and has been associated with infections by the Pomona 
serogroup in particular, but rarely by the Hebdomadis, Ballum and Grippotyphosa 
serogroups (29).  L. borgpetersenii serovar Hardjo infections in sheep cause agalactia, 
abortion, stillbirths, and the birth of weak lambs.  Abortion rates of up to 20% have been 
recorded.  Serovars such as Hebdomadis, Australis and Pomona have been reported to be 
the causative agent in cases of abortion.  Ewes manifesting “agalactia” clinically show 
partial or total loss of milk production, which resolves itself without treatment within 
three to four days.  The syndrome is usually only noticed when lambs with a normal birth 
weight die of malnutrition (80). The Serjoe serogroup has also been isolated from 
  
 
Figure 1. Schematic representation of Leptopsira MSCRAMM including Lig proteins, Len proteins, Lsa21, Lsa27, LipL32, Lp95, 
and TlyC 
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kidneys of infected sheep suffering from subclinical chronic interstitital nephritis (29) .  
Goats are susceptible to infection by L. interrogans serovar Grippotyphosa, which causes 
an acute disease characterized by hemoglobinuria, icterus, anemia, and death in severe 
cases (63).  Serovars Pomona, Sejroe, Icterohaemorrhagiae and Grippotyphosa have 
been associated with death from interstitial nephritis (63).   
  
The virulence potential of leptospiral adhesins: Leptospira spp. are highly adaptive, 
versatile pathogens and are cause of a wide range of clinical diseases in humans and 
animals (69). These spirochetes have the ability to adhere to extracellular matrix 
(ECM) and/or plasma proteins, which is crucial in order for the leptospires to colonize 
and disseminate in the host (4, 7, 14, 55, 57, 71, 72, 109) (Figure. 1). Like other 
pathogenic bacteria, the first step in the infective process is adherence to the host 
matrix (injured ski or mucous membrane). Adherence to host tissues is  mediated by 
bacterial surface adhesins referred to as MSCRAMMs (microbial surface components 
recognising adhesive matrix molecules) (99, 100) or  as SERAMs (secretable 
expanded repertoire adhesive molecules)(13). The first recognized leptospiral adhesin 
genes, ligA and ligB have been cloned and sequenced (77, 88, 89).  Lig proteins, which 
include LigA  and LigB, possess bacterial immunoglobulin-like (Big) domains with 90 
amino acid tandem repeats. LigA is secreted into the extracellular milieu (SERAM), 
and it may not mediate bacterial adhesion (14, 78, 79). The N-terminal sequence of 
630 amino acids are identical, but the C-terminals of LigA and LigB are variable (77, 88, 
89). LigB also encodes a C-terminal, non-repeat domain of 771 amino acid residues (77, 
88). LigA and LigB may serve as a SERAM and MSCRAMM, respectively, that allow 
pathogenic Leptospira to bind to host extracellular matrix components such as 
fibronectin (Fn), fibrinogen, laminin, and collagen (14, 71, 72). Lig proteins may also 
serve as good vaccine candidates and/or as diagnostic antigens (16, 41, 88, 90, 107) and 
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their expression is regulated by osmolarity (78). A high affinity Fn binding region of 
LigB, designated LigBCen2, contains 152 amino acids that include part of an 
immunoglobulin-like domain and a non-repeated region has also been identified (72).   
Barbosa, et al. subsequently identified a Leptospiral surface adhesin (Lsa24) 
that binds to laminin (7).  This protein has been previously reported by Verma, et al. 
as a factor H-binding protein of Leptospira (LfhA) that may be responsible for 
resistance of pathogenic leptospires to complement-mediated killing (123). Stevenson, 
et al. later found that Lsa24 or LfhA belongs to an endostatin-like outer membrane 
protein family that they renamed Len (Leptospiral endostatin-like) proteins that 
contained 6 genes (lenA-F).  LenA and LenB are a single gene while LenC-F contain a 
single gene with an intragenic duplication.  Len proteins bind to fibronectin, laminin, 
and human factor H (109).  Another novel MSCRAMM, Lsa21 has recently reported 
by Atzingen, et al. that also binds to Fn, collagen IV, and laminin (4). LipL32 is a 
surface protein of Leptospira that has been recently found to bind to several ECMs by 
two different groups (55, 57).   However, there is some conflict about their findings 
in that that the group found that LipL32 binds to Fn, but not laminin (56), while the 
other group claims that it binds to laminin and collagen, but not Fn (58). So far, 
several leptospiral MSCRAMMs have been found to have a significant functional 
overlap with the capacity to bind the same host factors (4, 7, 14, 56, 58, 71, 72, 109).   
The reason of such binding plasticity in the pathogenesis of leptospiral infection is not 
well understood.  Each leptospiral adhesin has such a wide range of adhesive 
capability that may allow Leptospira spp. to produce specific adhesins under a broad 
span of environmental conditions and, in particular niches, to allow them to tailor its 
interaction with the host. This seems likely, given that Leptospira spp. causes disease 
in a wide range of hosts, an extensive diversity of tissues (lung, kidney, liver, etc…) 
and causes a wide variety of tissue damage (nephritis, hepatitis, pneumonia, and/or 
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meningitis).  Most leptospiral MSCRAMMs described to date are outer surface 
proteins.  The roles of these adhesins in pathogenesis are still unknown.  However, 
it is clear that Leptospira spp. produce multiple ECM-binding proteins. Although 
many of these proteins may employ distinct mechanisms of ECM-binding, the end 
result is to manipulate ECM’s biology to enhance the microbe’s survival in the host. 
We may find more leptospiral ECM-binding MSCRAMMs as more pathogenic 
Leptospira spp. are sequenced in the near future.  Our knowledge of how these 
leptospiral proteins interact with ECM is still very meager and little is known about 
the importance of these interactions within the disease process after Leptospira spp. 
infection.  
 
The functions of Ca2+ in leptospires. Calcium plays a pivotal role in bacterial 
physiological activities, such as cell cycle, cell division (132), competence 
(121),pathogenesis (110), signal transduction (128), motility and chemotaxis (119, 120). 
Apart from these functions, it is also known that host-pathogen interactions of some 
bacteria are affected by calcium (18, 61). Several types of Ca2+ -binding motifs in 
bacterial proteins have been identified and include the well-known helix-loop-helix or 
EF-hand motif (82), annexin type, C2 domain of protein kinase C (67) or βγ-crystallin 
or Protein S type motif (6, 95, 114), leukotoxin or hemolysin-type calcium-binding 
domain that contains glycine rich repeats (12, 17), and orphan motifs in which oxygen 
atoms provided by several charged glutamate or aspartate residues are used in ligation 
(82). It appears that Lig proteins do not have any of these known Ca2+-binding motifs. 
LigBCen2 shows sequence similarity to the c-type lectin domain of other adhesins 
including invasin of Yersinia pseudotuberculosis and intimin of Escherichia coli (88). 
We have found that LigBcen2 binds to Ca2+ (73) and it would be important to identify 
Ca2+ the binding sites in order to learn about their role in binding to ECMs. 
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Since Lig proteins bind to host ECM, are expressed only in vivo, are regulated by 
environmental cues, and are  good vaccine candidates, I have focused my thesis study 
on the interaction of  Lig proteins and host cells. The purpose of the present study 
was four-fold: 1).  To determinate whether LigA/LigB are ECM or fibrinogen 
binding proteins; 2). To elucidate the role of Ca++ in the binding of LigA/B to 
fibronectin; 3).  To study the conformational changes of LinBcen2 when it binds to 
fibronectin; and 4). To analyze whether LigA/B binds to fibronectin through 
multivalency.      
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CHAPTER 2 
THE C-TERMINAL VARIABLE DOMAIN OF LIGB FROM LEPTOSPIRA 
MEDIATES BINDING TO FIBRONECTIN 
 
Introduction 
Leptospirosis is a zoonotic disease caused by pathogenic spirochetes in the genus 
Leptospira [22]. The disease occurs widely in developing countries and is reemerging in 
the United States [28]. The clinical features are variable and include subclinical 
infection, self-limited anicteric febrile illness, and severe, potentially fatal disease [22]. 
In the severe form of leptospirosis (Weil’s syndrome), the symptoms include an acute 
febrile illness associated with multi-organ damage including liver failure (jaundice), 
renal failure (nephritis), pulmonary hemorrhage and meningitis [10]. If not treated, the 
mortality rate may exceed 15% [48]. Furthermore, Leptospira infection can trigger 
autoimmune diseases in horses and people [35, 40]. Several virulence factors have been 
proposed for Leptospira spp., including the sphingomyelinases, serine proteases, 
zinc-dependent proteases, collagenase [3], LipL32 [58], the novel factor H-binding 
protein LfhA [53], and lipopolysaccharide [55].  
 Pathogenic spirochetes have evolved a variety of strategies to infect host cells such 
as evasion of the innate and adaptive immunity [53]. Attachment to host cells is an 
essential step for colonization by bacterial pathogens. Leptospira has been shown to 
bind to mammalian cells, such as Madin-Darby canine kidney (MDCK) cells [2] via 
extracellular matrix (ECM) [15]. Several adhesion molecules in pathogenic spirochetes 
have been identified including a Fn binding protein (36 kDa protein) [29], a laminin 
binding protein (Lsa24) [1], and Lig proteins [24, 32, 33] from Leptospira spp., 
decorin-binding proteins (Dbp A and B) [36] and Fn-binding proteins (BBK 32 and 47 
 31
kDa) [21, 37] from Borrelia spp. and MSP, Tp0155, Tp0483, Tp0751 from Treponema 
spp. [4, 5, 9]. Lig proteins (Lig A, B and C) possess immunoglobulin-like domains with 
90 amino acid repeats that have been identified in other adhesion molecules, such as the 
intimin of Escherichia coli and the invasin of Yersinia pseudotuberculosis [14, 17]. 
Interestingly, the N-terminal 630 amino acid sequences of LigA and B are identical, but 
the C-terminal amino acid sequences are variable with only 34% homogeneity [32]. ligB 
also encodes a C-terminal, non-repeat domain of 771 amino acid residues [32].  On the 
other hand, the ligA-ligB intergenic regions from L. kirschneri and L. interrogans are 
943 bp and 1347 bp in length respectively, and ligC is not linked to the ligA-ligB locus 
[24]. The expression of LigA and LigB is controlled by a key environmental signal, 
osmolarity, to enhance the binding of Leptospira to host cells [25, 26]. 
It has been shown that the lig genes are present exclusively in pathogenic 
Leptospira spp [24, 32]. LigA and LigB are weakly expressed in low passage, but not in 
high passage cultures of this organism [24, 32]. Importantly, we have shown that LigA 
and LigB expression is upregulated in vivo in the kidneys of Leptospira-infected 
hamsters [33]. Recently, LigA and LigB reportedly bind to extracellular matrix proteins 
including collagens type I and IV, laminin, fibronectin and fibrinogen [6]. These data 
indicate that Lig proteins may play an important role in attachment of pathogenic 
leptospires to host cells.  
Although there are three copies of lig genes (ligA, B and C) in L. interrogans 
serovar Pomona and L. interrogans serovar Copenhageni [30, 32, 33], only ligB is 
present in most pathogenic Leptospira spp. ligA is absent in L. interrogans serovar Lai 
[41], ligC is truncated (a pseudogene) in L. kirschneri serovar Grippotyphosa [24] and 
both ligA and ligC are absent in L. borgpetersenii serovar Harjo [3]. Therefore, we 
focused on LigB in this study and report that the variable region of LigB binds with high 
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affinity to Fn, suggesting that this fragment is crucial for bacterial adhesion to the host 
cells. 
 
Materials and Methods  
Bacterial strains and cell culture   
L. interrogans serovar Pomona (NVSL1427-35-093002) was used in this study [34]. All 
experiments were performed with virulent, low-passage strains obtained by infecting 
golden syrian hamsters as previously described [34]. Leptospires were grown in EMJH 
medium at 30 oC for less than 5 passages and growth was monitored by dark-field 
microscopy. MDCK cells (ATCC CCL34TM) were cultured in Dulbecco minimum 
essential medium (DMEM) containing 10% fetal bovine serum (GIBCO Laboratories, 
Grand Island, NY) and were grown at 37oC in a humidified atmosphere with 5% CO2.  
 
Reagents and antibodies   
Horseradish peroxidase (HRP)-conjugated goat anti-hamster antibody, 
HRP-conjugated goat anti-mouse antibody, and HRP-conjugated goat anti-rabbit 
antibody were purchased from Zymed (San Diego, CA).  Rabbit anti-GST antibody, 
Alexa 594-conjugated goat anti-hamster antibody, Alexa 488-conjugated goat 
anti-hamster antibody and FITC-conjugated goat anti-mouse antibody were purchased 
from Molecular Probe (Eugene, OR). Anti-Fn (MAB1932) and anti-actin mouse 
antibodies (MAB1501) were purchased from Chemicon International (Temecula, CA). 
Human plasma Fn was purchased from GIBCO (City, State).  Anti-L. interrogans 
antibodies were prepared in hamsters as previously described [34].  
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Plasmid construction and protein purification  
Constructs for the expression of glutathione S-transferase (GST), GST fused with the 
conserved region of LigB (LigBCon; amino acids 1-630), and GST fused with the 
central variable region of LigB (LigBCen; amino acids 631-1417) were previously 
generated using the vector pGEX-4T-2 (Amersham Pharmacia Biotech, Piscataway, NJ) 
[32].  GST fused with the C-terminal variable region of LigB (LigBCtv; amino acids 
1418-1889) was generated using the vector pET41A (Novogen, San Diego, CA). 
Relevant fragments of DNA were amplified by PCR using primers based on the ligB 
sequence [32]. Primers were designed to introduce a SalI site at the 5’ end of each 
fragment and a stop codon followed by a NotI site at the 3’ end of each fragment. PCR 
products were digested sequentially with SalI and NotI and then ligated into 
pGEX-4T-2 or pET41A cut with SalI and NotI. In this study, we purified the soluble 
form of GST-LigBCon, GST-LigBCen and GST-LigBCtv from E. coli as previously 
described [33, 34].   
 
Binding assays by ELISA   
To measure the binding of Leptospira to ECM components, 1mg of each ECM 
component (as indicated by Figure. 2.1. A) in 100 μl PBS (pH 7.2) was coated onto 
microtiter plate wells. For the dose-dependent binding experiments, different 
concentrations of Fn (as indicated by Figure. 2.1. B) were coated on microtiter plate 
wells. The plates were incubated at 4oC for 16 h and subsequently blocked with 
blocking buffer (50 μl/well) containing 3.5% BSA in 50mM Tris (pH 7.5)-100mM 
NaCl-1mM MgCl2, MnCl2, and CaCl2 at room temperature (RT) for 2 h. Then, 
Leptospira (107) were added to each well and further incubated at 37oC for 6 h. To 
determine the inhibition of Leptospira binding to MDCK cells by Fn, Leptospira (107) 
were pre-incubated at 37 oC for 1 h with various concentrations of Fn (as indicated in 
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Figure. 2.1.C) prior to the addition of MDCK cells (105) and finally incubated for 6 h at 
37 oC. The percentage of adhesion was determined relative to the attachment of 
untreated Leptospira binding to MDCK cells. For all experiments, the same 
concentration of BSA was used as a negative control. To determine the binding of 
LigBCen or LigBCtv to Fn, 10 nM of GST-LigBCen, GST-LigBCtv or GST (negative 
control) was added to 96 well microtiter plates coated with various concentrations of Fn 
(as indicated in Figure. 2.3. A) or BSA (negative control and data not shown) in 100μl 
PBS for 1 hour at 37 oC.   
To measure the binding inhibition of Leptospira to Fn, various concentrations of 
GST-LigBCen, GST-LigBCtv (as indicated by Figure. 2.3. B) or GST (negative control) 
in 100μl PBS was added to Fn or BSA (negative control and data not shown) (1mg in 
100 μl PBS) coated wells at 37 oC for 1 h, then Leptospira (107) were added to each well 
and incubated at 37 oC for 6 h. To measure the binding of LigBCen or LigBCtv to 
MDCK cells, MDCK cells (105) were incubated with various concentrations (as 
indicated in Figure. 2.4. A.) of GST-LigBCen, GST-LigBCtv or GST (negative control) 
in 100 μl PBS for 1 hour at 37 oC.  To measure the binding inhibition of Leptospira to 
MDCK cells treated with LigBCen or LigBCtv, MDCK cells (105) were pretreated with 
various concentrations (as indicated in Figure. 2.4. B.) of GST-LigBCen, GST-LigBCtv 
or GST (negative control) in 100 μl PBS for 1 hour at 37 oC. Then, Leptospira (107) 
were added to each well and incubated for 6 hours at 37 oC. Following the incubation, 
the plates were washed three times with phosphate-buffered saline (PBS) containing 
0.05% Tween-20 (PBST).  To measure the binding of Leptospira, hamster 
anti-Leptospira (1:200x) and HRP-conjugated goat anti-hamster IgG (1:1,000x) were 
used as primary and secondary antibodies, respectively.  To detect the binding of 
GST-LigBCen, GST-LigBCtv, or GST to Fn or MDCK cells, rabbit anti-GST (1:200x) 
and HRP-conjugated goat anti-rabbit IgG (1:1,000x) were used as primary and 
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secondary antibodies, respectively. After washing the plates thrice with PBST, 100μl of 
TMB (KPL, Gaithersburg, MD) was added to each well and incubated for 5 min. The 
reaction was stopped by adding 100 μl of 0.5% hydrofluoric acid in each well. Each 
plate was read at 630nm by ELISA plate reader (Bioteck EL-312, Winoski, VT). Each 
value represents the mean ± SEM of three trials in triplicate samples. Statistically 
significant (P<0.05) differences are indicated by asterisks.    
 
Binding assays by epifluorescence microscopy (EPM) and confocal laser-scanning 
microscopy (CLSM)   
To measure the binding of Leptospira to Fn by EPM, Leptospira (108) were added to 
each well (eight well culture slides) coated with 1mg Fn or BSA (negative control) in 
100 μl of PBS and incubated at 37 oC for 6 h (Figure. 2.1. D). To measure the binding 
inhibition of Leptospira to MDCK cells by Fn, 108 Leptospira were pre-incubated with 
10 μg of Fn or BSA (negative control) in 100 μl of PBS for 1 hour at 37 oC prior to the 
addition of 106 MDCK cells and incubated 6 h at 37 oC (Figure. 2.1. E). To measure the 
binding inhibition Leptospira to Fn by LigBCen or LigBCtv by EPM.  Fifty nM of 
GST-LigBCen, GST-LigBCtv or GST (negative control) in 100 μl PBS was each added 
to coated Fn or BSA (negative control and data not shown) (1 mg per 100 μl) wells for 1 
h at 37 oC, then, Leptospira (108) were added to each well and incubated for 6 h at 37 oC 
(Figure. 2.3. C). To determine the binding inhibition of Leptospira to MDCK cells by 
LigBCen or LigBCtv by CLSM, MDCK cell (106) was preincubated with 50 nM of 
GST-LigBCen, GST-LigBCtv or GST (negative control) in 100 μl of PBS for 1 h at 37 
oC respectively. Then, Leptospira (108) were added to each well and incubated for 6 h at 
37 oC (Figure. 2.4. C). For the detection of Leptospira binding in Figure. 2.1D. E. and 
Figure. 2.3C, hamster anti-Leptospira antibodies (1:100x) and Alexa 488-conjugated 
goat anti-hamster IgG (1:250x) were used as primary and secondary antibodies, 
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respectively. To determine the attachment of Leptospira and the binding of 
GST-LigBCen, GST-LigBCtv, or GST in Figure. 2.4C., rabbit anti-GST (1:250x) and 
hamster anti-Leptospira antibodies (1:100x) served as primary antibodies, and FITC 
conjugated goat anti-rabbit IgG (1:250x) and Alexa 594-conjugated goat anti-hamster 
IgG (1:250x) were used as secondary antibodies. Fixation and immunofluorescence 
staining were performed as previously described [43] with slight modifications. Briefly, 
Leptopsira and MDCK cells were fixed in 2% praformaldehyde for 60 min at RT. For 
antibody labeling, fixed bacteria were incubated in PBS containing 0.3% BSA for 10 
min at RT. The primary and secondary antibodies in PBS containing 0.3% BSA were 
incubated sequentially for 60min at RT. After incubation with primary and secondary 
antibodies, the glass slides were mounted with coverslips using Prolong Antifade 
(Molecular Probe, Eugene, OR) and viewed with a 60x objective by EPM (Nikon Inc., 
Avon, MA) or CLSM (Olympus, America, Inc., Melville, NY).  An Olympus 
Fluoview 500 confocal laser-scanning imaging system equipped with krypton, argon, 
and He-Ne lasers on an Olympus IX70 inverted microscope with a PLAPO 60X 
objective was used. The settings were identical for all captured images. Images were 
processed using Adobe Photoshop CS2. For counting the attachment of Leptospira to 
the MDCK cells or Fn, three fields were selected to count the number of binding 
organisms.  All studies were repeated three times and the number of leptospria attached 
to MDCK cells were counted by an operator who was blinded to the treatment group.   
 
GST pulldown assay   
The GST pull-down assay was performed as previously described [56]. Purified 
proteins or GST (negative control) were loaded onto 0.5 ml glutathione-Sepharose 
beads (Amersham Biosciences Piscataway, NJ) at 4oC overnight.  The beads were then 
washed three times with the lysis buffer containing 30 mM Tris acetate, 10 mM sodium 
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phosphate, pH 7.4, 0.1% Tween 20, 1mM EDTA, 2 μg/ml leupeptin, 4 μg/ml aprotinin, 
1 μg/ml pepstatin A, and 1 mM phenylmethylsulfonyl fluoride (PMSF). MDCK cells 
(106) were lysed in the lysis buffer and used immediately after lysis. A 500 μl aliquot of 
cell lysate or human plasma Fn (40 μg/ml) was incubated with purified proteins 
immobilized on glutathione-Sepharose beads at 4oC for 3 h. After incubation, the beads 
were separated by centrifugation, washed three times with the lysis buffer, and boiled in 
Laemmli sample loading buffer consisting of 50 mM Tris-HCl (pH6.8), 100 mM 
dithiothreitol, 2% sodium dodecyl sulfate, 0.25 mM PMSF, and 0.1% bromophenol 
blue in 20% glycerol. The eluted proteins were subjected to 6% SDS-PAGE and 
electroblotted onto polyvinylidene difluoride membranes. The membranes were 
incubated in 5% skim milk in PBS/T overnight and then incubated with mouse anti-Fn 
antibody (1:1,000x). The immunocomplexes were detected with an HRP-conjugated 
goat anti-mouse IgG antibody (1:5,000x).  
 
Small interfering RNA (siRNA) inhibition of LigB binding  
siRNA duplexes directed against the sequence 5’-gcagcacaacuuccaauua-3’ of Fn and 
negative siRNA duplex, 5’-auucuaucacuagcgugac- 3’, were selected by a software, 
siDESIGNTM [42] and synthesized by Dharmacon (Lafayette, CO). RNA duplexes were 
introduced into MDCK cells by the method of lipofection [18], and 8 × 105 cells were 
transfected with 0.4 μg negative siRNA and Fn-siRNA. Adhesion assays were 
performed 72 h after lipofection [50]. The knocking down efficiency of endogeneous Fn 
expression was determined as previously described [56] with slight modification. Total 
protein contents of MDCK cells (106) were analyzed using Western immunoblotting as 
described under ‘GST pulldown assays’. The protein bands of actin derived from 
MDCK cells were measured as a control using a mouse anti-actin antibody (1:5,000x). 
The band intensity was measured by densitometry using the Image J software 
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(National Institutes of Health, Bethesda, MD, USA) [52]. LigB binding assay was 
performed 72 h after lipofection. To determine the binding of Lig B fragments to Fn, 
each fragment (50nM) was added to MDCK cells (106) transfected with Fn or negative 
siRNA. To determine the binding of each fragment and the expression of Fn on MDCK 
cells, rabbit anti-GST (1:250x) and mouse anti-Fn (1:250x) served as the primary 
antibodies, and FITC-conjugated goat anti-mouse IgG (1:250x) and Texas 
Red-conjugated goat anti-rabbit IgG (1:250x) were used as secondary antibodies. 
Fixation, immunofluorescence staining, image detection and processing were described 
in the previous sections. All the experiments were performed in triplicate. 
 
Isothermal titration calorimetry   
The experiments were carried out with CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25oC as previously described [46]. In a typical 
experiment, the cell contained 1ml of a solution of proteins, and the syringe contained 
250 μl of a solution of Fn at a concentration that was 20 times higher than the protein 
concentration in the cell. Both solutions were in PBS pH 7.5. The titration was 
performed as follows: 15 to 25 injections of 10 μl (Table 2.1) with a stirring speed of 
250rpm, and the delay time between the injections was 5 min. Data were analyzed 
using Titration BindingWork 3.1 software (Calorimetry Science Corp. Lindon, UT, 
USA) fitting them to an independent binding model. The concentration of Fn and 
LigB used in this study was based on our preliminary titration experiment (data not 
shown). 
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Figure 2.1 The binding of L. interrogans serovar Pomona (NVSL 1427-35-093002) to 
Fn. (A). Binding of Leptopsira to various immobilized ECM components.  Leptospira 
(107) were added to wells coated with each ECM (1mg in 100 μl PBS) including Fn, 
chondroitin-6-sulfate (C6S), chondroitin sulfate A (CSA), chondroitin sulfate B (CSB), 
gelatin A (GA), gelatin B (GB), heparin (HP), keratin (KR), or BSA (negative control). 
(B). Binding of Leptospira (107) to a series concentration of Fn (0, 10, 100 or 1000 µg in 
100 μl PBS).  BSA was coated and used as negative control. (C). Fn inhibits the 
binding of Leptospira to MDCK cells.  Leptospira (107) were treated with a series 
concentration of Fn (0, 0.01, 0.1, 0.2, 1, 2, or 10μg) or BSA (negative control) prior to 
the addition of MDCK cells (105). The percentage of adhesion was determined relative 
to the attachment of untreated Leptospira on MDCK cells. (D). Binding of Leptospira to 
immobilize Fn.  Leptospira (108) were cultured in Fn or BSA (negative control) coated 
(1mg in 100 μl PBS) or un-coated wells (negative control). (E). Fn inhibits the binding 
of Leptospira to MDCK cells.  Leptospira (108) were pre-treated with 10μg of Fn or 
BSA (negative control) prior to the addition of MDCK cells (106). The un-treated 
Leptospira was used as negative control.  The binding of Leptospira to ECMs or Fn or 
the adhesion of Leptospira to MDCK cells was measured by ELISA (A, B, and C) or 
EPM (D and E).  For all experiments, each value represents the mean ± SEM of three 
trials in triplicate samples. Statistically significant (P<0.05) values are indicted by an 
asterisk. The EPM settings were identical for all captured images (D and E). 
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Statistical analysis   
Statistically significant differences between samples was determined using the 
Student’s t-test following logarithmic transformation of the data. Two-tailed P-values 
were determined for each sample, and a P < 0.05 was considered significant. Each data 
point represents the mean ± standard error of the mean (SEM) of a sample tested in 
triplicate. An asterisk indicates the result was statistically significant.  
 
Results  
Attachment of Leptospira to MDCK cells was mediated by fibronectin  
The binding of leptospiral cells to various ECM components was determined using 
ELISA. As shown in Figure. 2.1A, Leptospira strongly bound to Fn, but not to other  
ECM molecules (Figure. 2.1A). Furthermore, the binding of Leptospira to Fn was dose 
dependent (Figure. 2.1B). When Leptospira were pretreated with Fn, binding to MDCK 
cells decreased (Figure. 2.1C). Approxximately 3.5-fold increase in immobilization of 
Leptospira on Fn-coated wells was found compared to the control (Figure. 2.1D). 
Moreover, Fn could also block the attachment of Leptospira by approximately 47% 
when Fn treated Leptospira were added to MDCK cells (Figure. 2.1 E). Thus, Fn can 
mediate the attachment of Leptospira to MDCK cells. 
 
Interaction between LigB and Fn  
To determine whether LigB interacts with Fn, we truncated the LigB protein into three 
parts, LigBCon, LigBCen and LigBCtv, (Figure. 2.2A) due to the difficulty of 
expressing and purifying full length LigB [32]. First, we analyzed the interaction of 
each LigB fragment with Fn using a GST-pull down assay. Our results showed that both 
human plasma Fn and Fn derived from MDCK cell lysates could bind both LigBCen 
and LigBCtv, but not LigBCon (Figure. 2.2B and 2.2C). Since LigBCen and LigBCtv 
  
 
 
 
Table 2.1 Thermodynamic parameters for the interaction of Fn and truncated LigB. 
Macromolecule LigB Residues [Macromolecule] [Fn] ΔH ΔS Kd 
  μM μM kcal mol-1 cal mol-1 
K-1 
μM 
LigBCon 1-630 1.25 25 n/fa n/fa n/fa 
LigBCen 631-1,417 2 40 -2,002.67±14 -6.68 0.011±0.003 
LigBCtv 1,418-1,861 2.82 56.4 -12,140±1557 -40.71 8.55±0.75 
a n/f, non-fittable 
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Figure. 2.2 The interaction between LigB and Fn by GST-pull down assay. (A) A 
schematic diagram showing the structure of LigB and the truncated LigB protein used in 
this study.  (B). Human plasma Fn ( lane 2 to lane 5 ) or cell lysate of MDCK cells 
( lane 7 to lane 10 ) was applied to GST beads preimmobilized by GST, GST-LigBCon, 
GST-LigBCen, or GST-LigBCtv at 4oC for 3 hours. The pull down complex was 
analyzed by immunoblot analysis using Fn antibody. Lane 1 and lane 6 contain 1 μg of 
human plasma Fn and the cell lysate from 1 x 106 MDCK cells, respectively, to serve as 
a positive reference. Lane 2 and lane 7 are GST-LigBCen, lane 3 and lane 8 are 
GST-LigBCtv, lane 4 and lane 9 are GST-LigBCon, and lane 5 and lane 10 are GST.  
The molecular mass of human Fn and canine Fn (MDCK cells) is 261 kDa and 271 kDa, 
respectively, and the relative positions of the standards are given in kDa on the left.  
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Figure 2.3  LigBCen or LigBCtv binds to Fn and inhibits the binding of Leptospira to 
Fn. (A). Binding of LigBCen or LigBCtv to a series concentration of immobilized Fn.  
Ten nM of GST-LigBCen, GST-LigBCtv, or GST (negative control) was added to wells 
coated with a series concentration of Fn (0, 0.27μM, 0.45μM, 2.7μM, 4.5μM, 27μM, or 
45μM) in 100 μl PBS. . The binding of each of these proteins to Fn was measured by 
ELISA. (B). LigBCen or LigBCtv inhibits the binding of Leptospira to immobilized Fn. 
A series concentration (0, 2, 4, 6, or 8 nM) of GST-LigBCen, GST-LigBCtv, or GST 
(negative control) were added to each well coated with Fn (1mg in 100 μl PBS) prior to 
the addition of Leptospira (107). The attachment of Leptopsira to wells was measured 
by ELISA. The percentage of attachment was determined relative to the attachment of 
Leptopsira on untreated Fn. (C). LigBCen or LigBCtv inhibits the binding of Leptospira 
to Fn.  Fifty nM of GST-LigBCen, GST-LigBCtv, or GST (negative control) was 
added to wells coated with Fn (1mg in 100 μl PBS) prior to the addition of Leptospira 
(108). The binding of Leptospira to wells were detected by EPM. In (A) and (B), each 
value represents the mean± SEM of three trials in triplicate samples. Statistically 
significant values (P<0.05) are indicted by *. In (C), The EPM settings were identical 
for all captured images. Images were processed using Adobe Photoshop CS2.  
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Figure. 2.4  Isothermal titration calorimetry (ITC) profile of LigBCtv with Fn as a 
typical ITC profile in this study. A; heat differences obtained from 25 injections. B: 
Integrated curve with experimental point (◆) and the best fit (—). The thermodynamic 
parameters are shown in Table 2.1 
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Figure 2.5  The binding of LigBCen or LigBCtv to MDCK cells reduces leptospiral 
adhesion. (A) Binding of LigBCen or LigBCtv to MDCK cells.  A series concentration 
(0, 2, 4, 6, or 8 nM) of GST-LigBCen, GST-LigBCtv, or GST (negative control) was 
added to MDCK cells (105). The binding of each of these proteins to MDCK cells were 
measured by ELISA. (B) LigBCen or LigBCtv inhibits the binding of Leptopsira to 
MDCK cells.  MDCK cells were incubated with a series concentration (0, 2, 4, 6, or 8 
nM) of GST-LigBCen, GST-LigBCtv, or GST (negative control) prior to the addition of 
Leptopsira (107).  The ashesion of Leptospira to MDCK cells (105) were detected by 
ELISA. The reduced percentage of attachment was determined relative to the 
attachment of Leptopsira on untreated MDCK cells. (C). LigBCen or LigBCtv inhibits 
the binding of Leptopsira to MDCK cells.  MDCK cells (106) were pre-treated with 
50nM of GST-LigBCen, GST-LigBCtv, and GST (negative control) prior to the 
addition of Leptopsira (108). The adhesion of Leptospira or the binding of these proteins 
to MDCK cells were detected by CLSM. In (A) and (B), each value represents the 
mean± SEM of three trials in triplicate samples. Statistically significant values (P<0.05) 
are indicted by *. In (C), the CLSM settings were identical for all the captured images. 
Images were processed using Adobe Photoshop CS2. 
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Figure 2.6  The binding of LigBCen or LigBCtv to Fn siRNA transfected MDCK cells 
was reduced. (A). Detection of the expression of Fn and actin in MDCK cells 72 h after 
transfected by Fn or negative siRNA. Fn and α-actin were detected by immunoblotting 
probed by actin antibody or Fn antibody.  (B) Binding of GST-LigBCen or (C) 
GST-LigBCtv was reduced by the siRNA transfected cells. (D) GST was served as 
negative control.  Fifty nM of GST-LigBCen, GST-LigBCtv, or GST was added to Fn 
or negative siRNA transfected MDCK cells. Expression of Fn and the binding of these 
proteins to MDCK cells were detected by CLSM. The CLSM settings were identical for 
all the captured images. Images were processed using Adobe Photoshop CS2.  
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showed a positive pull down result, the interaction between LigBCen and LigBCtv with 
Fn was further studied using ELISA. We found that both the binding of LigBCen and 
LigBCtv to Fn and the inhibition of the attachment of Leptospira to Fn by LigBCen and 
LigBCtv was dose-dependent (Figure. 2.3A and 2.3B). Moreover, the EPM images 
revealed up to 40% reduction in the attachment of Leptospira to Fn in the presence of 
LigBCen and LigBCtv (Figure. 2.3C). Finally, in order to quantitatively evaluate the 
binding affinity between Fn and LigB fragments, the dissociation constants (Kd) were 
measured by ITC (Table 2.1). Figure. 2.4 shows data of a typical ITC experiment. The 
interaction appears to be exothermic with a favorable enthalpy and unfavorable entropy. 
The calculated Kd values for Fn binding to LigBCen and LigBCtv were 0.01μM and 
8.55μM, respectively (Table 2.1). Binding of LigBCon could not be detected by ITC 
(data not shown). These studies are in agreement with our previous results. Altogether, 
these data indicate that Fn specifically interacts with LigBCen and LigBCtv fragments. 
 
LigBCen and LigBCtv mediate the attachment of Leptospira to MDCK cells  
To determine if LigB is used by Leptospira to adhere to MDCK cells, various 
concentrations of LigBCen or LigBCtv were added to MDCK cells, and binding was 
detected by ELISA and immunofluorescence staining. Our results clearly showed that 
LigBCen and LigBCtv bound to MDCK cells in a dose dependent manner (Figure. 
2.5A). Pretreatment of MDCK cells with LigBCen or LigBCtv reduced the attachment 
of Leptospira by ~32%. The reduction of Leptospira attachment was also 
dose-dependent (Fig. 2.5B and 2.5C). We further elucidated the receptor role of Fn on 
MDCK cells for its possible ligand, LigB, on the surface of Leptospira, by RNA 
interference to decrease endogeneous Fn expression in MDCK cells.  As shown in Fig. 
2.6A, transfection of cells with siRNA duplex specific for canine Fn resulted in ~36% 
reduction in Fn expression, relative to the control cells. The binding of LigBCen and 
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LigBCtv to Fn siRNA-transfected MDCK cells was significantly reduced (Fig. 2.6B, 
2.6C). The data suggest that Fn serves as a receptor for LigB, which mediates 
Leptospira adhesion. 
 
Discussion 
Adhesion to host cells is pivotal for many pathogenic bacteria including 
Leptospira spp.  Since pathogenic Leptospira spp. can infect a variety of tissues 
including liver, kidney and lung, the study of host-pathogen interaction is extremely 
important in leptospirosis. Recently, the leptospiral genome has been sequenced and a 
number of tentative virulence factors have been proposed [3, 30, 41]. However, their 
exact roles in leptospiral pathogenesis remain to be established. To date, several 
leptospiral adhesins have been identified. These include a 36 kDa Fn-binding protein 
[29], a 24 kDa laminin-binding protein [1] and LigA, LigB and LigC proteins [24, 32, 
33]. These molecules may play an important role in the pathogenesis of leptospiral 
infection since they are able to bind to ECMs such as collagens I and IV, laminin and 
fibronectin [6].  
 Pathogenic Leptospira spp. have been previously reported to adhere to 
extracellular matrices [15, 16] including Fn. Fns are dimers of two similar peptides 
linked at their C-termini by two disulfide bonds [8] and serve as a receptor for several 
bacteria, including spirochetes [20, 27, 31, 45, 54] [7, 11, 12, 19, 23, 37, 39, 49]. Our 
results showed that Fn immobilized Leptospira (Fig. 2.1A, B and D). We also found that 
Fn blocked the attachment of Leptospira to MDCK cells if Leptospira were pre-treated 
with Fn (Fig. 2.1C and E). These results confirmed a recent report that Fn could be an 
important molecule by which all pathogenic Leptospira spp. adhere to host cells [6].   
We demonstrated the interaction between LigB and Fn. It was shown that 
the LigBCen and LigBCtv fragments bound to Fn using a GST-pulldown assays (Fig. 
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2.2), ELISA (Fig. 2.3), and ITC measurements (Fig. 2.6). The low Kd values for 
LigBCen indicated that the LigB-Fn interaction is specific. This evidence strongly 
suggests that LigB is a Fn-binding protein (Fbp). A similar study has been reported by 
Choy et al that LigB U1 and LigB U2 (LigBCen equivalent) could strongly bind to Fn, 
while the LigB CTD (LigBCtv equivalent) binds weakly to Fn [6]. However, the Kd 
values of LigBCen and LigBCtv to Fn that we obtained are slightly different to those 
reported by Choy et al [6]. The differences in the obtained Kd values could be 
explained by (i) the protein fragments in this study (LigBCen and LigBCtv) were not 
exactly the same length fragments used by Choy et al (LigBU1, LigBU2, and 
LigBCTD) and (ii) the method we used (ITC) to measure the Kd differs from  that of 
Choy, et al (ELISA). 
 Since pathogenic Leptospira spp. adhere to renal tubular epithelial cells and 
induce severe tubulointerstitial nephritis leading to renal failure [57], it is possible that 
LigB is responsible for the binding of Leptospira to renal tubular epithelium. Our 
results indicated that LigB binds to MDCK cells via LigBCen or LigBCtv fragments 
(Fig. 2.4A, B and C). However, LigBCen could bind to both MDCK cells and Fn with 
greater affinity than could LigBCtv (Fig. 2.3A, Fig. 2.4A and 2.4 B, Table 2.1). The 
microscopic images also showed that not all of the Fn was co-localized with LigB (Fig. 
2.5B and 2.5C). This result suggests that LigB might bind to two or more receptors. 
Our results elucidate how Leptospira attach to MDCK cells, as shown in a previous 
study [51], and indicate why Fn can block leptospiral attachment to MDCK cells, as 
shown in this study (Fig. 2.1D and E).  
 Our results clearly confirm that LigB is one of the MSCRAMM members that 
binds to ECM including Fn. The transmembrane domain of LigB is predicted to reside 
within the conserved region, and only the variable region is exposed on the surface[32, 
33].  These results support our data that Fn-binding domains of LigB are localized in 
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the variable regions. This is not surprising since similar findings have been reported for 
other MSCRAMMs [13, 36, 38]. In Borrelia, the binding motifs in the decorin-binding 
proteins, DbpA and B are located in the central regions, which vary among different 
Borrelia strains (B. burgdorferi, B. garnii, and B. afzeli) [36]. The Fn-binding domain 
of the Fn-binding protein, BBK32 is also variable among different Borrelia strains [38]. 
The repetitive D1, D2 and D3 elements of Staphylococcus aureus Fn-binding protein, 
which bind the N-terminal 29 kDa of Fn, also vary [13].   
Since both LigBCen and LigBCtv bind to Fn but with different affinities, it 
suggests that there is more than one potential Fn-binding domain. In Mycobacterium 
avium, two Fn-binding domains are located on two non-contiguous 24 amino acids of 
the Fn attachment protein-A (FAP-A) [44]. The FnBA of Staphylococcus aureus 
contains three repetitive elements, D1, D2, and D3 and each binds the N-terminal 29 
kDa fragment of Fn [13].  Seven additional Fn-binding elements are located in the 
N-terminal of the D repeats [47]. In Streptococcus dysgalactiae, there are five 
Fn-binding segments within the C-terminus of the Fn binding protein F1/(FnBB) [46, 
47]. Therefore, it is likely that several binding sites might be present in the LigB 
variable region. However, we are unable to identify a similar Fn-binding motif from 
other known Fn-binding proteins.  
  In conclusion, we have shown that LigBCen and LigBCtv bind to Fn and have 
proved that LigB is a member of MSCRAMMs. Since pathogenic Leptospira spp. 
initially attach to mucosal epithelial cells prior to entry into the bloodstream and 
subsequent dissemination to multiple organs such as the kidney, liver, and lung, Lig 
proteins may play a pivotal role in the pathogenesis of leptospirosis. Fn is one of the 
most important ECMs on epithelial cells and serves as a receptor for leptospiral 
adherence [6, 15]. Thus, further studies into the interaction of Lig proteins and ECMs 
are warranted.     
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CHAPTER 3 
A DOMAIN OF THE LEPTOSPIRA LIGB CONTRIBUTES TO HIGH 
AFFINITY BINDING OF FIBRONECTIN 
 
Introduction 
The interaction between bacteria and host cells is the first step in the establishment of a 
productive infection.   Various bacterial adhesion molecules including afimbrial and 
fimbrial adhesins contribute to either extracellular colonization or invasion to the host 
cells [1].  Microbial surface components recognizing adhesive matrix molecules 
(MSCRAMM), defined to bind extracellular matrix (ECM) such as Fn, laminin, elastin, 
or collagen, is one of the strategies that bacterium uses to attach on the host cells [2]. In 
pathogenic  Leptospira spp., it was also known that different ECMs within the host 
were bound by several MSCRAMM including a 36kDa Fn binding protein [3], a  
laminin binding protein (Lsa24) [11] and Lig proteins which bind to several receptors 
(Fn, laminin, collagen and fibrinogen) [4, 5]. 
  Leptospiral immunoglobulin-like proteins, LigA, LigB and LigC possess 12, 13  
and 12  immunoglobulin-like (Ig-like) domains, respectively, and these Ig-like 
domains is similar to some known bacteria adhesion proteins including intimin from 
Escherichia coli and invasin from Yersinia pseudotuberculosis [6-8]. Interestingly, the 
N-terminal 630 amino acids of LigA and LigB are identical, but the C-terminal amino 
acid sequences are only 34% similarity, while LigC is only about 38% identity to that of 
LigA and LigB (serovar Pomona) [14-15].   The expression of ligA and ligB is 
controlled by a key environmental signal, osmolarity to enhance the binding of 
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leptospira to host cells [9, 10].  These data indicated that Lig proteins may be pivotal 
virulence factors of pathogenic Leptospira spp.   
 In a previous study, we have identified two regions, LigBCen and LigBCtv, in the 
C-terminal of LigB which were able to bind to Fn [5]. The aim of the present study was 
to localize the binding site of LigBCen to Fn as fine as possible and we have identified a 
domain containing 152 amino acids of LigB with a strong binding affinity to N-terminal 
domain (NTD), gelatin binding domain (GBD) of Fn, fibrinogen and laminin. 
 
Materials and Methods 
Bacterial strains and Cell Culture   
L. interrogans serovar Pomona (NVSL1427-35-093002) was used as previously 
described [11].  All experiments were performed with virulent, low-passage strains 
obtained by passage to golden syrian hamsters as previously described [16].  
Leptospires were grown in EMJH medium at 30 oC for less than 5 passages and growth 
was monitored by dark-field microscopy.  Madin-Darby canine kidney (MDCK) cells 
(ATCC CCL34TM) were cultured in Dulbecco minimum essential medium (DMEM) 
containing 10% fetal bovine serum (GIBCO Laboratories, Grand Island, NY).  Cells 
were grown at 37oC in a humidified atmosphere with 5% CO2. 
         
Reagents and antibodies   
Horseradish peroxidase (HRP)-conjugated goat anti-hamster antibody and 
HRP-conjugated goat anti-rabbit antibody were ordered from Zymed (San Diego, CA).  
FITC-conjugated goat anti-rabbit antibody, Alexa594-conjugated goat anti-hamster 
antibody, and Rabbit anti-GST antibody were obtained from Molecular Probe (Eugene, 
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OR). Hamster anti-Leptospira was previously prepared in our laboratory [11].   
Human plasma fibronectin was purchased from GIBCO (Carlsbad, CA). N-terminal 
domain (NTD), gelatin binding domain (GBD), and N-terminal domain (70kDa, 
including NTD and GBD) of Fn, fibrinogen (F3879), laminin (L2020), type I (C7774) 
and type IV collagens (C5533) were ordered from Sigma-Aldrich (St. Louis, MO) and 
cell binding/DNA domain (CBD) and heparin binding domain-2 (Hep-2) of Fn were 
ordered from Chemicon International (Temecula, CA). 
 
Plasmid construction and Protein purification   
Constructs for the expression of Histidine-tag fused with LigBCen1 (amino acids 
631-1013) was generated using the vector pQE30 (Qiagen, Alencia, CA)(Figure. 3.1A). 
Constructs for the expression of GST, GST fused with LigBCen2 (amino acids 
1014-1165), and GST fused with of LigBCen3 (amino acids 1166-1417) were generated 
using the vector pGEX-4T-2 (Amersham Pharmacia Biotech, Piscataway, NJ) (Figure. 
3.1A) . To perform the PCR reactions, the following forward and backward primers 
were utilized based on the ligB sequence [17].  These included LigBCen1 forward 
primer 5’ GGATCCATTGCTGAAATTAAAAAT 3’ and backward primer 5’ 
AAGCTTTTAAGTGATTTTGCTCTT 3’; LigBCen2 forward primer 5’ 
GGATCCACTGCGACTTACAAT 3’ and backward primer 5’ 
GTCGACTTAATTGGAACTATT 3’; LigBCen3 forward primer 5’ 
GGATCCTTTATAGGACATTGT 3’ and backward primer 5’ 
GTCGACTTAGTTTCCTTTTAC 3’. Primers were engineered to introduce a BamHI 
site at the 5’ end of each fragment and a stop codon followed by a SalI site at the 3’ end 
of each fragment. PCR products were sequentially digested with BamHI and SalI and 
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Figure. 3.1  (A) A schematic diagram showing the structure of LigB and the truncated 
LigB protein including LigBCen1, LigBCen2, and LigBCen3 used in this study. (B) A 
chart presenting the location of Fibronectin (Fn) and truncated Fn including N-terminal 
domain (NTD),  Gelatin binding domain (GBD), 70kDa domain (70kDa), Cell binding 
domain (CBD), and Heparin binding domain 2 (Hep-2) used in this study. 
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then ligated into pQE30 or pGEX-4T-2 cut with BamHI and SalI, respectively.  In this 
study, we purified the soluble form of the histidine-tag fused with LigBCen1 and the 
GST fused with LigBCen2, and LigBCen3 from E. coli as previously described [11].   
 
Isothermal Titration Calorimetry   
The experiments were carried out with CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25  as previously described ℃ [5]. In a typical 
experiment the cell contained 1ml of a solution of LigBCen1, LigBCen2, or LigBCen3 
and the syringe contained 250μl of a solution of full length Fn, N-terminal or gelatin 
binding domain of Fn at a concentration that was 20 times higher than the protein 
concentration in the cell. Both solutions were in phosphate based saline, pH 7.5. The 
titration was performed as follows: 25 injections of 10 μl (Table 3.1) with an stirring 
peed of 250rpm, and the delay time between the injections was 5min. Data were 
analyzed using Titration BindingWork 3.1 software (Calorimetry Science Corp. Lindon, 
UT, USA) fitting them to an independent binding model. The concentration of Fn and 
LigB used in this study was based on our preliminary dose titration experiment (data not 
shown). 
 
Fn binding assays by ELISA   
To determine the binding of LigBCen2 to full length Fn (positive control), N-terminal 
70kDa region (70kDa), NTD, GBD, CBD, or Hep-2 of Fn (Figure. 3.1B),  a series 
amounts (as indicated by Figure. 3.2. A)  of full length Fn or Fn were coated on 
microtiter plate wells,  incubated at 4oC for 16 hours and blocked with blocking buffer 
(100 μl/well) containing 3% BSA in PBS at RT for 2 hours. Then, 10 nM of 
GST-LigBCen2 or GST in 100μL PBS was added onto microtiter plate wells for 1 hour 
at 37oC.   
 70
  
For determination whether GBD and NTD have the same binding site on LigBCen2, 
10nM GST-LigBCen2 or GST  in 100μL PBS were incubated with a series 
concentration (0, 0.0625, 0.125, 0.25, 0.5, or 1μM) of GBD or NTD for 1 hour at 37oC  
prior to be added to 100μl of 1μM NTD or BSA coated on microtiter plate wells.  To 
evaluate the binding of LigBCen2 to other ECMs including full length Fn (positive 
control), fragments of Fn, laminin, or fibrinogen (Figure. 3.1B), a series amounts (as 
indicated by Figure. 3.3) of these ECMs were coated on microtiter plate wells incubated 
at 4oC for 16 hours and blocked with blocking buffer (100 μl/well) containing 3% BSA 
in PBS at RT for 2 hours. Then, 10 nM of GST-LigBCen2 or GST in 100μL PBS was 
added into microtiter plate wells for 1 hour at 37oC.  BSA or GST with the same 
concentration was used in all experiments as a negative control through the study (data 
not shown). 
To detect the binding of LigBCen2 to MDCK cells, MDCK cells (105) were incubated 
with 0, 1.25, 2.5, 5, or 10 nM of GST-LigBCen2 or GST (negative control) in 100 μl 
PBS for 1 hour at 37oC.  For measuring the binding inhibition of Leptospira to MDCK 
cells by LigBCen2, MDCK (105) cells were treated with 0, 1.25, 2.5, 5, or 10 nM of 
GST-LigBCen2 or GST (negative control) in 100 μl PBS for 1 hour at 37oC prior to the 
addition of  Leptospira (107) for 6 hours at 37oC.  To detect the binding of 
GST-LigBCen2 or GST, rabbit anti-GST (1:200x) and HRP-conjugated goat anti-rabbit 
IgG (1:1,000x) were used as primary and secondary antibodies, respectively. To 
measure the binding of Leptospira, hamster anit-Leptospira (1:200 x) and 
HRP-conjugated goat anti-hamster IgG (1:1,000 x) were used as primary and secondary 
antibodies, respectively. The percentage of attachment was determined relative to the 
attachment of serovar Pomona on untreated MDCK cells. After washing the plates 
thrice with PBST, (0.05% Tween 20 in PBS) 100μL of TMB (KPL, Gaithersburg, MD) 
was added to each well and incubated for 5 min. The reaction was stopped by adding 
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100μl of 0.5% hydrofluoric acid in each well. Each plate was read at 630nm by ELISA 
plate reader (Bioteck EL-312, Winoski, VT).  Each value represents the mean ± SEM 
of three trials in triplicate samples. Statistically significant (P<0.05) differences are 
indicated by *. 
   
Binding assays by Confocal Laser Scanning Microscopy (CLSM)   
To determine the binding inhibition of Leptospira to MDCK cells by LigBCen2, 106 
MDCK cell was treated by 50 nM of GST-LigBCen2 or GST (negative control) in 100 
μl of PBS for 1 hour at 37oC prior to be added by 108 Leptospira for 6 hours at 37oC. 
Fixation and immunofluorescence staining were followed as previously described with 
slight modification [5]. Briefly, Leptospira and MDCK cells were fixed in 2% 
praformaldehyde for 60min at room temperature (RT). Fixed bacteria were incubated in 
PBS containing 0.3% BSA for 10min at RT. The primary and secondary antibodies in 
PBS containing 0.3% BSA were incubated sequentially for 60min at RT.  For detecting 
the adhesion of Leptospira and the binding of GST-LigBCen2 or GST, rabbit anti-GST 
(1:250x) and hamster anti-Leptospira antibodies (1:250x) served as primary antibodies, 
and FITC conjugated goat anti-rabbit IgG (1:250x) and Alexa 594-conjugated goat 
anti-hamster IgG (1:250x) were used as secondary antibodies. The glass slides were 
mounted with coverslips using Prolong Antifade (Molecular Probe, Eugene, OR) 
viewed by Olympus Fluoview 500 confocal laser-scanning imaging system equipped 
with krypton, argon, and He-Ne lasers on an Olympus IX70 inverted microscope with a 
PLAPO 60X objective was used (Olympus, America, Inc., Melville, N.Y.). Confocal 
images were processed using Adobe Photoshop CS2 (San Jose, CA). The settings were 
identical for all captured images. For counting the attachment of Lepotspira to the 
MDCK cells, three fields were selected to count the number of binding organisms.  All 
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studies were repeated three times and the attachment of Leptospira to MDCK cells was 
blindly counted which was statistically significant.  
 
Statistical analysis   
Significance between samples was determined using the Student’s t-test following 
logarithmic transformation of the data. Two-tailed P-values were determined for each 
sample and a P-value <0.05 was considered significant. Each data point represents the 
mean standard error of the mean (SEM) of sample tested in triplicate.  An (*) indicates 
the result was statistically significant.  
 
Results  
LigBCen2, contributed to high affinity of Fn binding  
To localize the Fn-binding site on central variable region of LigBCen, three truncated 
LigBCen including LigBCen1, LigBCen2 and LigBCen3 (Figure. 3.1A) were 
expressed and purified to apply to isothermal titration calorimetry (ITC) titrated by Fn. 
(Table 3.1).  As shown on Table 3.1, the dissociation constant (Kd) for Fn binding to 
LigBCen1 and LigBCen2 were 7,200nM and 170nM, respectively.  Binding of 
LigBCen3 was not detected by ITC (data not shown). The interaction appeared to be 
exothermic with a favorable enthalpy and unfavorable entropy. LigBCen2 showed 
stronger Fn binding affinity than LigBCen1. 
  
NTD and GBD bind to LigBCen2    
To determine whether LigBCen2 could bind to fragments of Fn, GST-LigBCen2 or 
GST (data not shown) were added to a series concentration of full length Fn and Fn 
fragments such as 70kDa, NTD, GBD, CBD, Hep-2, or BSA coated microtiter plate 
wells. As shown on Figure. 3.2A, LigBCen2 bound to 70kDa of Fn including NTD and  
   
 
 
 
Table 3.1 Dissociation constant (Kd values) for the interaction of a range of truncated LigBCen with full length human Fn or NTD, 
GBD, or 70kDa from human Fn. 
Kd for the interaction with Truncated LigB LigB Residues
Full length Fn NTD GBD 70kDa 
 nM 
LigBCen1 631-1013 7200±170 bn/d bn/d bn/d 
LigBCen2 1014-1165 170±20 272±25 1200±108 148±9 
LigBCen3 1166-1417 an/f bn/d bn/d bn/d 
an/f, non-fittable 
bn/d, not determined 
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Figure. 3.2 NTD and GBD bind on LigBCen2 at different binding site (A). Binding of 
LigBCen2 to a series concentration of immobilized 70kDa, NTD, or GBD.  Ten nM of 
GST-LigBCen2 and GST (negative control and data not shown) were added to different 
concentration of full length Fn, 70kDa, NTD, GBD, CBD, Hep-2, or BSA coated wells 
(negative control). Bound proteins were measured by ELISA. (B). GBD couldn’t block 
the binding of LigBCen2 on immobilized NTD.  Ten nM of GST-LigBCen2 and GST 
(negative control and data not shown) were pre-treated with different concentration of 
NTD or GBD prior to be added on NTD or BSA (negative control) coated wells. Bound 
proteins were measured by ELISA. The percentage of binding was determined relative 
to the binding of untreated LigBCen2 on NTD. Each value represents the mean± SEM 
of three trials in triplicate samples. Statistically significant (P<0.05) is indicted by *. In 
(B), the mean of the value obtained from the NTD-BSA or GBD-BSA coated wells 
subtracted from all other data points. 
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Figure 3.3  LigBCen2 bind to Fn, laminin, and fibrinogen. Ten nM of GST-LigBCen2 
and GST (negative control and data not shown) were added to different concentration of 
full length Fn, laminin, fibrinogen, or BSA coated wells (negative control). Bound 
proteins were measured by ELISA. Each value represents the mean± SEM of three trials 
in triplicate samples. Statistically significant (P<0.05) is indicted by *. 
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GBD and full length Fn with high affinity than to that of NTD or GBD individually. 
However, LigBCen2 bound to NTD stronger than to GBD.   The dissociation constant 
(Kd) for LigBCen2 binding to 70kDa, NTD, and GBD were 148nM, 272nM and 
1,200nM, respectively (Table 3.1).   This result was in agreement to our ELISA results 
(Figure. 3.2A).  To reveal whether NTD and GBD bind to LigBCen2 on the same 
binding site, LigBCen2 were pre-treated with different concentrations of NTD, GBD or 
BSA (data not shown) prior to be incubated to NTD coated wells. As presented on 
Figure. 3.2B, pre-treatment of GBD could not reduce the binding of LigBCen2 on NTD 
and vice versa (data not shown). This result suggested that NTD and GBD bound to 
LigBCen2 on different binding site.  
 
Laminin and fibrinogen also bind to LigBCen2 
In order to reveal if there were other ECMs bind to LigBCen2, GST and 
GST-LigBCen2 were added into Fn, laminin or fibrinogen coated wells. As shown on 
Figure. 3.3, LigBCen2 was bound by Fn, laminin, and fibrinogen, and the binding to 
these ligands was dose dependent. We also performed the binding assays on type I or 
type IV collagen, but with negative results (data not shown).  
 
LigBCen2 mediate the attachment of Leptospira to MDCK cells   
To reveal whether LigBCen2 could bind on MDCK cells, a series amount of 
GST-LigBCen2 or GST were added to MDCK cells, and the binding of LigBCen2 to 
MDCK cells was detected by ELISA and immunofluorescence staining. Our results 
clearly showed that LigBCen2 bound to MDCK cells in a dose dependent manner 
(Figure. 3.4A).  Pretreatment of MDCK cells with LigBCen2 approximately reduced 
the attachment of Leptospira by 45%. The reduction of Leptospira attachment was also  
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Figure. 3.4 Binding of LigBCen2 to MDCK cells reduces leptospiral adhesion. (A) 
Binding of LigBCen2 to MDCK cells.  Different concentration of GST-LigBCen2 and 
GST (negative control) were added to MDCK cells. The binding of LigBCen2 to 
MDCK cells was measured by ELISA. (B) LigBCen2 inhibits the binding of Leptospira 
to MDCK cells.  MDCK cells were pre-treated with different concentration of 
GST-LigBCen2 and GST (negative control) prior to be addition of Leptospira.  The 
binding of Leptospira to MDCK cells was detected by ELISA. The reduced percentage 
of attachment was determined relative to the attachment of Leptospira on untreated 
MDCK cells. (C). LigBCen2 inhibits the binding of Leptospira to MDCK cells by 
CLSM.  MDCK cells were pre-treated with 50nM of GST-LigBCen2 and GST 
(negative control) prior to be addition of Leptospira. The binding of Leptospira or 
LigBCen2 to MDCK cells was examined by CLSM. In (A) and (B), each value 
represents the mean± SEM of three trials in triplicate samples. Statistically significant 
(P<0.05) is indicted by *. In (C), the CLSM settings were identical for all the captured 
images. Images were processed using Adobe Photoshop CS2
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dose dependent (Figure. 3.4B &C). Thus, LigBCen2 region may mediate the binding of 
Leptospira on MDCK cells. 
 
Discussion 
A pivotal factor for bacterial pathogenesis is the ability of the pathogenic organism 
to colonize host tissues.  Leptospira spp. possess on their cell surface a number of 
MSCRAMMs [3-5, 12]  that may promote the binding of the Leptospira to components 
of the host ECMs and play a pivotal role in leptospiral virulence. LigB, a Leptospira 
outer membrane protein proved to be an adhesin molecule, was reported to have 
significant Fn binding activities [4, 5]. LigB also showed sequence similarity with 
known bacteria adhesins, invasin from Y. pseudotuberculosis and intimin from E  coli 
[13]. Moreover, both adhesins contained immunoglobin like domain similar to LigB 
and interact with integrin, the receptor of host [14, 15]. The integrin binding site on the 
intimin was located on C-terminal 190 amino acids including its immunoglobulin like 
domain D3 and domain D4 [16], and the integrin binding site on the invasin was located 
on C-terminal 192 amino acids including an immunoglobulin like domain domain [13].  
We truncated the LigBCen into three subconstructs, LigBCen1, 2 and 3. By using ITC, 
we found that LigBCen2 (containing 152 amino acids) could bind Fn with high affinity 
(Table 3.1). 
   It was recognized that LigB possess a strong Fn binding region on its 
immunoglobulin (Ig) like repeated motifs and a weaker Fn binding site on its c-terminal 
non-repeated region [4, 5].  To perform a further fine binding site mapping on LigB, 
LigCen was truncated into LigBCen1, 2 and 3 and we found that LigBCen2 could bind 
to both NTD and GBD of Fn, but with a higher affinity to NTD than to GBD (Figure. 3.2. 
A &Table 3.1). However,  we are unable to identify a similar Fn-binding motif on 
LigBCen2 from other known Fn-binding proteins. 
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Lig proteins also bound to type 1 and type IV collagen, laminin and fibrinogen [4].  
Therefore, it is important to determine whether LigBCen2 binds these ligands.  In this 
study, we found that LigBCen2 also bound to laminin and fibrinogen, but not type I and 
type IV collagens (Figure. 3.3).  This is not surprising since it has been reported that 
fibrinogen and elastin bound to the same region within the A domain of Fn binding 
protein A of Staphylococcus aureus [17]. The interaction with various ligands may 
enhance the binding of leptospires to host cells.    
         Since pathogenic Leptospira spp. adhere to renal tubular epithelial cells and 
induce severe tubulointerstitial nephritis leading to renal failure [18], it is possible that 
LigB is responsible for the binding of Leptospira to renal tubular epithelium by 
interacting with ECMs. Our results indicated that a region with 152 amino acid 
(LigBCen2) also bound (Figure. 3.4A and C) and blocked the binding of Leptospira on 
MDCK cells (Figure. 3.4B and C).  These results could elucidate the region of LigB 
mediating the Leptospira adhesion on host cells. 
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CHAPTER 4 
CALCIUM BINDS TO LEPTOSPIRAL IMMUNOGLOBULIN-LIKE PROTEIN, 
LIGB AND MODULATES FIBRONECTIN BINDING 
 
Introduction 
Leptospira spp. are spirochetes including pathogenic species, Leptospira 
interrogans as well as saprophytic species, Leptospira biflexa. Leptospirosis, a zoonotic 
disease caused by Leptospira spp., is widely distributed in developing countries and has 
reemerged in the United States (1). The severe form of leptospirosis, Weil’s syndrome, 
includes an acute febrile illness associated with multi-organ damage such as liver failure 
(jaundice), renal failure (nephritis), pulmonary hemorrhage and meningitis (2) with a 
mortality rate up to 15% if not treated (3). Several virulence factors of this organism 
have been identified including the sphingomyelinases, serine proteases, zinc-dependant 
proteases, collagenase (4), LipL32 (5), lipopolysaccharide (6), a novel factor H, 
laminin and Fn-binding protein (Lsa24 or Len) (7-9), Loa22 (10), and 
immunoglobulin-like proteins, Lig proteins (11-13). 
Lig proteins include LigA and LigB, possess bacterial immunoglobulin-like (Big) 
domains with 90 amino acid repeats, have identical 630 amino acid residues at the 
N-terminal of LigA and LigB, but their C-terminals are variable (11-13). In addition, 
LigB also encodes a C-terminal, non-repeat domain with 771 amino acid residues (11, 
12). LigA and LigB may serve as Microbial Surface Components Recognizing 
Adhesive Matrix Molecules  that allow pathogenic Leptospira to bind to host 
extracellular matrix  components such as Fn, fibrinogen, laminin, and collagen (14, 15). 
A high affinity Fn binding region of LigB, designated LigBCen2, contains 152 amino 
acids that include part of an immunoglobulin-like domain and a non-repeated region 
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(16). The expression of Lig proteins are regulated by osmolarity (17). Lig proteins may 
also serve as good vaccine candidates and/or diagnostic antigens (12, 18, 19). 
Calcium plays a pivotal role in bacterial physiological activities such as cell cycle, 
cell division (20), competence (21), pathogenesis (22), signal transduction (23), motility 
and chemotaxis (24, 25). Apart from these functions, it is also known that host-pathogen 
interactions of some bacteria are affected by calcium (26, 27). Several types of 
calcium-binding regions have been identified which include EF-hand domain, 
leukotoxin or hemolysin-type calcium-binding domain (28, 29), and orphan motifs in 
which oxygen atoms provided by several charged glutamate or aspartate residues are 
used in ligation (30). Lig proteins do not contain any of the known Ca2+-binding 
domains. However, LigBCen2 shows sequence similarity to the c-type lectin domain of 
other adhesins including invasin of Yersinia pseudotuberculosis and intimin of 
Escherichia coli (12).  
Even though Lig proteins likely play a significant role in pathogenicity, little is 
known about the mechanisms of action of these Lig proteins. We undertook this study to 
identify novel properties of Lig proteins. Based on the structural homology of 
immunoglobulin-like fold with lens β　-crystallins type Greek key motif (31), we 
wondered if Lig proteins would bind Ca2+. We, therefore performed these studies and 
report that calcium binds to the high affinity Fn binding region of LigB, LigBCen2. 
Ca2+-binding increases the stability of the protein and significantly influences the 
conformation of LigBCen2. Further, we demonstrate that Ca2+-binding modulates the 
binding of LigB to NTD of Fn, suggesting that it has a significant role in bacterial 
infection. 
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Materials and Methods 
Reagents and antibodies 
Calcium GreenTM-1 was obtained from Molecular Probe (Eugene, OR). Fibronectin 
(human plasma fibronectin), NTD of Fn, ethylene glycol tetraacetic acid (EGTA), 
sodium chloride, sodium phosphate monobasic, sodium phosphate dibasic, and calcium 
chloride were from Sigma-Aldrich (St. Louis, MO). 
 
Plasmid construction and Protein purification 
 The construct for the expression of Histidine-tag fused with LigBCen2 (amino acids 
1014-1156) was generated using the vector pQE30 (Qiagen, Alencia, CA). Construction, 
expression, and purification procedures were as previously described (16, 19).   
 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
Standard analysis procedures were performed by the Soil and Plant Laboratory, Cornell 
University to analyze the total mineral and heavy metal content by using ICP-OES 
(Varian, Inc., Palo Alto, CA). Prepared samples included fresh, phosphate buffered 
saline (PBS) and 70 μM of LigBCen2 either untreated or treated with 2 mM CaCl2 or 5 
mM EGTA, pH 7.0 for 1 hour at room temperature. Unbound calcium and EGTA were 
removed to trace levels (< 0.1 μg/ml) via dialysis against PBS buffer. 
 
45Ca overlay 
Calcium-binding to protein was done by 45Ca overlay method as described previously 
(32). Basically, 150-200 μg of protein was spotted onto a nitrocellulose membrane using 
a dot-blot apparatus. The membrane was rinsed three times in a solution containing 10 
mM imidazole-HCl (pH 6.8), 60 mM KCl and 5 mM MgCl2 for one hour and then 
incubated for 15 minutes at 25°C in the same buffer containing 1 mCi/liter of 45Ca. The 
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membrane was then rinsed twice in 45% ethanol, blotted, dried and exposed to a 
phosphorimager screen. The signal was read in a PhosphorImager (Fuji Bas-1800). 
 
Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass 
spectrometry 
The molecular weight of purified LigBCen2 protein was analyzed using MALDI-TOF 
mass spectrometer recorded on an Applied Biosystem 4700 Mass Spectrometer 
(Applied Biosystem. Foster City, CA). Prepared samples included 70 μM of LigBCen2 
untreated or treated with 2 mM CaCl2, pH 7, for 1 hour at room temperature. Unbound 
calcium was removed via dialysis against deionized water. 
 
Energy Dispersive Spectrometry (EDS) 
EDS analyses were performed with a JEOL 8900 Electron Probe Microanalyzer (JEOL, 
Ltd. Tokyo, Japan). The operating conditions were 10 kV acceleration voltages. Sample 
preparation was described as mentioned in the section ‘MALDI-TOF mass 
spectrometry’. Water was removed by lyophilization (Labconco, Kansas City, MS) 
from all of the samples, and a powder form of each sample was applied to EDS. 
 
Isothermal Titration Calorimetry (ITC) 
The experiments were carried out with CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25°C as previously described (16). Before the ITC 
experiment, traces of calcium from LigBCen2 solution were removed via dialysis. In a 
typical ITC experiment, the cell contained 1 ml of a solution of MgCl2 or CaCl2 treated 
or untreated LigBCen2 and the syringe contained 250 μl of a solution of NTD, calcium 
chloride or magnesium chloride at a concentration that was indicated on table 4.2. Both 
solutions were in phosphate based saline (pH 7.5). The titration was performed as 
 87
follows: 25 injections of 10 μl with a stirring speed of 250 rpm, and the delay time 
between the injections was 5 minutes. Data were analyzed using Titration Binding 
Work 3.1 software (Calorimetry Science Corp. Lindon, UT, USA) fitting them to an 
independent binding model.  
 
Differential Scanning Calorimetry (DSC) 
Excess heat capacity Cp(T) of LigBCen2 with or without CaCl2 was measured using a 
DSC Q1000 microcalorimeter (Waters. New Castle, DE). Degassed samples containing 
3 µM of LigBCen2 with or without 2 mM of CaCl2 or buffer were heated at 10 K/h scan 
rate. Heat Capacity, Cp(T) data were recorded, corrected for buffer baseline, and 
normalized to the amount of the sample. The TA Universal Analysis software (Waters, 
New Castle, DE) was used for the data analysis and display. All calorimetric 
experiments in this study were repeated 3 times to ensure reproducibility. 
 
Circular dichroism (CD) spectrometry 
CD spectra were recorded on a Jasco J-815 spectropolarimeter under N2 atmosphere at 
room temperature (25°C) in a 0.02 and 0.5 cm path length quartz cell for far- and 
near-UV respectively with 8 accumulations. Aliquots of calcium chloride solution were 
added to the protein solution and incubated for 5 minutes. All spectra were recorded in 
50 mM Tris buffer, pH 7, containing 50 mM KCl. In a melting temperature experiments, 
2 μM of LigBCen2 in the absence or presence of 2 mM CaCl2 was subjected to thermal 
unfolding, and data were collected at 1°C/minute increments from 25°C to 70°C 
recording the ellipticity at 215 nm, with 30 seconds temperature equilibrations, 
followed by 30 second data averaging. In order to measure the melting point, a first 
order derivative was applied to the results from the melting experiment. In all CD 
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experiments, the background spectrum of buffer without protein was subtracted from 
the protein containing spectra.  
 
Fluorescence Spectrometry 
Fluorescence emission spectra were measured on a Hitachi F4500 spectrofluorometer 
(Hitachi. San Jose, CA). All spectra were recorded in correct spectrum mode of the 
instrument using excitation and emission band passes of 5 nm. The intrinsic Trp 
fluorescence of protein was recorded by exciting the solution at 295 nm and measuring 
the emission in the 300-400 nm regions. For calcium or magnesium titration, 0.1, 0.3, 
0.5, 0.8, 1.0 mM of calcium chloride or magnesium chloride was mixed with 10 μM of 
LigBCen2 and spectra were recorded after 3 minutes. Calcium- or magnesium-saturated 
LigBCen2 protein was further titrated with magnesium or calcium, respectively and 
spectra were recorded as mentioned above, until saturation was reached. 
 For the ANS fluorescence experiment, ANS binding was checked by adding 100 
μM ANS solution (10 mM stock in 100% methanol) to a protein solution (18 µM), 
incubated for two minutes and spectra were recorded between 400 and 600 nm. Next, 
LigBCen2 was treated with 100 µM EGTA or 100 µM CaCl2, after that four titration of 
fibronectin (1 mg/ml), 0.5 μl each, was done, after 5 minutes of incubation and spectra 
were measured at an excitation wavelength of 295 nm. 
 In a calcium competition experiment, 20 μM of Calcium GreenTM-1 was mixed 
with or without 30 μM of LigBCen2 and 100 μl per well was dispensed into a micro titer 
plate and incubated with 0.1, 0.2, 0.4, 1, 2, 4, 10, 20, 40 μM of CaCl2 in PBS pH 7.0 for 
5 minutes. Enhanced fluorescence due to binding of free calcium and Calcium 
GreenTM-1 was monitored at 528 nm with excitation at 485 nm using a SynergyTM HT 
multi-detection micro plate reader (Bio-TEK instruments, Inc. Winooski, VT). The 
association constant, KA, was deduced using Scatchard plot and rearrangement of the 
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Chang-Prusoff equation was used to calculate the dessociation constant (KD) of 
LigBCen2 and calcium (33). 
    
Kapp is the apparent dissociation constant measured in the presence of a concentration of 
LigBCen2 in Calcium GreenTM-1 solution with calcium, KDdye or KDLigBCen2 is the KD of 
calcium with Calcium GreenTM-1 or LigBCen2. All spectra were recorded in the correct 
spectrum mode excitation and emission band passes of 5 nm each and corrected for 
volume changes before further analysis. All measurements were performed at 25ºC. 
 
Fn binding assays by ELISA 
To determine the binding of untreated or calcium treated LigBCen2 to NTD, a serial 
concentrations of NTD or BSA (negative reference) were coated on microtiter plate 
wells and blocked subsequently as previously described (16). 10 nM of untreated or 2 
mM of CaCl2 treated GST-LigBCen2 or GST in 100 μl PBS was added onto microtiter 
plate wells and incubated for 1 hour at 37°C.  
 To detect the binding of GST-LigBCen2 or GST, rabbit anti-GST (1:200x) and 
HRP-conjugated goat anti-rabbit IgG (1:1,000x) were used as primary and secondary 
antibodies, respectively (16). After washing the plates thrice with PBST, (0.05% 
Tween20 in PBS) 100 μl of TMB (KPL, Gaithersburg, MD) was added to each well and 
incubated for 5 min. The reaction was stopped by adding 100 μl of 0.5% hydrofluoric 
acid in each well. Each plate was read at 630 nm using an ELISA plate reader (Bioteck 
EL-312, Winoski, VT).  Each value represents the mean ± SEM of three trials in 
triplicate samples. Statistically significant (P<0.05) differences are indicated by *. 
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Figure 4.1 (A) Schematic representation of various domains and regions of LigB. 
Boxes 1-12 indicate various bacterial immunoglobulin-like domains. (B) Sequence 
alignment of LigBCen2 with C-type lectin like domain. Fn binding site and C-type 
lectin like domains (CTLD) of L. interrogans serovar Pomona LigB (LigBCen2), 
integrin binding site and CTLD of Y. pseudotuberculosis invasin (Inv192), and Tir 
binding site and CTLD of enteropathogenic E. coli intimin (Int190) were aligned, with 
gaps introduced to maximize the alignment. Black and gray colored residues indicated 
the conserved residues, and the homology was performed with EMBL-EBI ClustalW. 
(http://www.ebi.ac.uk/clustalw/) 
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Statistical analysis 
Each data point represents the mean standard error of the mean (SEM) of sample tested 
in triplicate.  Data were analyzed by Student’s t test and statistically significant 
differences were claimed at p values < 0.05. 
 
Results 
The sequence of LigBCen2 is similar to C-type lectin domains of invasin and 
intimin 
 Previously, Lig proteins including LigA and LigB have been shown to bind to ECM 
(14, 15) and LigBCen2, the central region of LigB, annotated as LigBCen2 (Figure. 
4.1A) was selected for further functional studies (16). The sequence was selected from 
amino acids 1014 to 1165 residue of LigB as seen in Figure. 4.1B.  Interestingly, this 
region contains the bacterial Ig like (Big) domain and the non-repeat region of 46 amino 
acids (16). Proteins that contain this domain are found in a variety of bacterial and phage 
surface proteins such as intimins or invasins, which is a bacterial cell-adhesion molecule 
that mediates intimate bacterial host-cell interaction (34, 35). It contains three domains; 
two immunoglobulin-like domains and a C-type lectin-like module implying that 
carbohydrate recognition may be important in intimin-mediated cell adhesion. However, 
the exact functions of these proteins, barring some studies on fibronectin interactions, 
are not known (16). 
 
Rationale of Ca2+-binding 
As mentioned above, nothing is known about the function of Lig proteins, except that 
they are thought to play a role in virulence or infection. We were, therefore, interested in 
identifying the functions of these important proteins. Structurally, these proteins belong  
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Table 4.1 The concentration of the metal ions detected by ICP-optical emission 
 
 Ca Mn Co Cu Cd Mg Zn 
LigBCen2 
with Ca2+ 
4.505 
μg/mL 
belowa belowa belowa belowa belowa belowa
LigBCen2 
with EGTA 
belowa belowa belowa belowa belowa belowa belowa
LigBCen2 belowa belowa belowa belowa belowa belowa belowa
abelow, the concentration below 0.1 μg/mL 
 
 
 
 
 
 
  
 
Figure 4.2 Ca2+-binding characterized by EDS and MALDI-TOF mass spectroscopy. EDS analysis of the lyophilized (A) 
calcium-treated LigBCen2 or (B) untreated LigBCen2. Arrows indicate the locations of signal for calcium. The live time and 
accumulative voltage were 60 seconds and 10 kV respectively. (C) MALDI-TOF mass spectra of LigBCen2 in the absence 
(LigBCen2) or presence (LigBCen2 + Ca2+)    of 1 mM of CaCl2. The number indicated on the peaks represents the molecular 
weight of LigBCen2. 
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to the immunoglobulin fold also called the bacterial immunoglobulin (BIG) fold. In one 
of the earlier studies, the structural and functional similarities were assessed between 
various proteins of Greek key/immunoglobulin fold (31). Among the proteins selected 
for functional prediction, lens γ　 -crystallins and immunoglobulin functions were 
chosen. It is important to mention that both proteins possess the Greek key type fold 
(31). This prompted us to look for the function of Lig proteins in the context of lens 
γ　 -crystallins. The exact function of lens γ　 -crystallins is not known. However, we 
have shown earlier that β　-crystallins belong to a different family of low affinity 
Ca2+-binding proteins (36, 37). Based on the fold similarities, we predicted that these 
Lig proteins might bind Ca2+. Therefore, we assessed Ca2+-binding to LigBCen2 by a 
number of methods as described below. 
  
Probing of Ca2+-binding to LigBCen2 by ICP-OES, EDS, 45Ca overlay and 
MALDI-TOF mass spectrometric analysis 
Since there is no known motif in LigBCen2 for Ca2+-binding, it was necessary to probe 
Ca2+-binding by a number of methods to examine the specificity of Ca2+ binding. First, 
we probed Ca2+-binding to LigBCen2 by ICP-OES. Untreated or EGTA or calcium 
chloride treated LigBCen2 were applied to ICP-OES. As shown in Table 4.1, calcium 
was found only in calcium chloride treated LigBCen2, and not in untreated or EGTA 
treated LigBCen2. The results indicate that calcium binds to LigBCen2 since there was 
no Ca2+-binding to EGTA treated or untreated LigBCen2. To further confirm the 
Ca2+-binding activity revealed by ICP-OES, Ca2+-binding to LigBCen2 was assessed by 
EDS. As seen in Figure. 4.2(A) and 2(B), a prominent calcium signal was seen in 
Ca2+-bound LigBCen2 instead of the apo form of LigBCen2. We also performed 45Ca 
binding to LigBCen2 using a well known method of overlay (38). Seen as a dark spot on 
the membrane, radioactive calcium 45Ca binds to LigBCen2, thereby confirming the  
  
 
 
Table 4.2 Dissociation constant (Kd values) for the interaction of calcium or magnesium and LigBCen2 in the presence or absence of 
2 mM calcium chloride or magnesium chloride. 
 
[LigBCen2] [CaCl2] [MgCl2] ΔH ΔS KD n 
mM mM mM kcal mol-1 cal mol-1 K-1 μM  
0.03 1 - -0.73±0.03 -0.02 6.09±0.1 3.75±0.1 
0.02a 0.48 - -80.43±9.59 -0.24 5.34±0.9 4.04±0.1 
0.02 - 0.42 -244.42±57.7 -0.79 9.17±0.2 1.05±0.05 
0.02b - 0.20 -63.38±4.13 -0.18 8.64±0.2 1.37±0.1 
a in the presence of 2 mM magnesium chloride. 
b in the presence of 2 mM calcium chloride. 
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Figure 4.3 Stoichiometry of Ca2+ binding.  (A) Binding affinity determined by the ITC 
profile of LigBCen2 with calcium chloride. Data of heat change obtained with ligand 
(Ca2+) titration shown in the upper panel. In the lower panel, the solid lines represent the 
best fits to a single-site binding model data after peak (■) integration, subtraction of 
blank titration data (not shown), and concentration normalization. Molar heats of 
binding are plotted vs the molar ratio of Ca2+ to protein. Binding potency of protein with 
ligand KD is 7.5μM. The thermodynamic data that were obtained from ITC are shown in 
Table 4.2. (B) and (C) represent the competition experiment between Calcium 
GreenTM-1 interacting with calcium mixed with 30 μM of LigBCen2 or without 
LigBCen2.  (B) The increase of fluorescence intensity as a function of calcium 
concentration. ΔF represents the difference in the values of the emitted spectra upon 
addition of various concentrations of calcium. (C) Scatchard plot for the calculation of 
association constant for Calcium GreenTM-1 binding by holo form of 
Ca2+-boundLigBCen2 or with Ca2+ alone, rearrangement of the Chang-Prusoff equation  
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Figure 4.4 Conformational changes of LigBCen2 after addition of Ca2+ monitored by 
CD and fluorescence. (A) Far-UV CD spectra of LigBCen2 were recorded in presence 
of calcium. Protein concentration was 80 μg/ml in 50 mM Tris-HCl (pH 7.0) and 50 mM 
KCl. Spectra were recorded with a 0.02 cm path length cuvette. Aliquots of calcium 
chloride solution were added to a final concentration of 0, 50, 150, 250, 400 and 750 μM 
to the protein solution and CD spectra recorded. (B) Near-UV CD spectra of LigBCen2. 
Protein concentration of 1 mg/ml in buffer containing 50 mM Tris-HCl (pH 7.0) and 50 
mM KCl was used in a 0.5 cm pathlength cuvette. Calcium chloride was added to the 
final concentrations of 150, 400, 500 and 750 μM. Direction of arrows indicates 
increasing order of calcium addition. (C) Intrinsic fluorescence spectrum of LigBCen2 
in the presence and absence of Ca2+. 10 μM of LigBCen2 in 50 mM Tris (pH 7.0), 50 
mM KCl and 1 mM DTT was excited at 295 nm. The figure shows Trp fluorescence in 
the presence of 0, 0.1, 0.3, 0.5, 0.8 and 1.0 mM of calcium. (D) Fluorescence emission 
spectra of ANS-LigBCen2 complex in the presence of 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, and 
1.0mM of calcium chloride. The excitation wavelength was set at 375 nm. The buffer 
consisted of 50 mM Tris (pH 7.0), 50 mM KCl and 1 mM DTT. 
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specificity of Ca2+-binding to the protein (Figure. 4.2C). Further, the molecular weight 
of holo form of LigBCen2 (LigBCen2 + Ca2+ in Figure. 4.2D) is higher (18,292 Da) 
than that of apo form of LigBCen2 (18,131 Da) (LigBCen2 in Figure. 4.2D) further 
indicating that calcium binds to LigBCen2 (Figure. 4.2D). Since there was a 161 Da 
difference in the molecular weight between holo and apo forms, it is likely that at least 
four Ca2+ molecules were bound to LigBCen2. (see materials and methods) was used to 
obtain the KD of calcium and LigBCen2 (Kd = 6.01 ± 0.2 μM). 
 
Stoichiometry of Ca2+-binding to LigBCen2 by ITC 
The above results of mass spectroscopy and 45Ca binding demonstrate that LigBCen2 is 
a Ca2+-binding protein. We next assessed the affinity and stoichiometry of the 
Ca2+-binding to LigBCen2 by ITC. To measure the Ca2+-binding affinity to LigBCen2 
quantitatively, a titration of calcium chloride to LigBCen2 was performed by ITC 
(Figure. 4.3A and 3B). As shown in Table 4.2, the dissociation constant (KD) for 
calcium binding to LigBCen2 was 6 μM. The binding appeared to be an exothermic 
reaction with a favorable enthalpy and unfavorable entropy. Next, we examined if 
LigBCen2 also binds Mg2+. As presented in Figure. 4.3C, 4.3D, and Table 4.2, Mg2+ 
also binds to LigBCen2 (KD = 9 μM) (Figure. 4.3). We also examined if Mg2+ can 
replace Ca2+ using ITC. We did not see any competition of Mg2+ to replace Ca2+ bound 
to LigBCen2, which is possibly due to higher affinity of LigBCen2 for Ca2+ than Mg2+. 
(Table 4.2) 
 
Ca2+ and Calcium Green dye competition experiments 
A calcium competition experiment using the dye, Calcium GreenTM-1 was performed to 
quantitatively confirm the binding of calcium to LigBCen2. When calcium chloride was 
added either to the dye or dye mixed with LigBCen2, the fluorescence was significantly 
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reduced, indicating that LigBCen2 was able to compete with the dye by binding calcium 
(Figure. 4.4A). The binding data were plotted using Scatchard plot (Figure. 4.4B) and 
analyzed by Rearrangement of the Chang-Prusoff equation. KD of calcium-binding to 
LigBCen2 was calculated as 6 μM. The Kd value thus obtained was close to that 
calculated from ITC (Kd = 6 μM, Table 4.2). 
 
Conformational studies of Ca2+ binding to LigBCen2 
Ca2+ binding influences the secondary and tertiary structure monitored by 
circular dichroism 
In the far-UV CD spectrum of the apo form of LigBCen2, a broad negative peak at 
215-208 nm is seen (Figure. 4.5A), suggesting that LigBCen2 is largely in a β-sheet 
conformation. However, the cross over point is below 200 nm suggesting that the 
protein is partially unstructured. Addition of Ca2+ increases the negative value of 
ellipticity as well as red shift the cross over points suggesting that upon binding Ca2+, 
the protein is folded and gains more β-sheet conformation (Figure. 4.5A).  
  Near-UV CD of LigBCen2 is shown in Figure 5B. There are one Trp, five Tyr 
and two Phe in this protein domain. In the near-UV CD, there are distinct bands (peaks) 
at 288 and 278 nm with a broad but strong peak at about 258-266 nm. The strong 
ellipticity of this peak (258-266 nm) suggests that Phe residues are either immobilized 
or interacting with neighboring residues. Two peaks at 288 and 292 nm represent the 1Lb 
bands of Trp, whereas the peak at 278 is due to Tyr. Addition of Ca2+ brings significant 
changes in the near-UV CD spectrum (Figure. 4.5B). The ellipticity decreases over the 
entire range and a band for Trp transition appeared at about 302 nm, and some bands (at 
288 and 302) becomes negative in Ca2+ bound protein. These data suggest that Ca2+ 
binding imparts significant changes in the protein conformation.  
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Figure 4.5 Thermal stability measured by CD and DSC. (A) Thermal unfolding 
transitions of apo and holo forms of LigBCen2 monitored by CD. Unfolding of 2 μM of 
LigBCen2 either in the presence of 1 mM calcium chloride or absence  was followed 
by CD, measuring ellipticity at 215 nm from 25 to 70°C. A transition point was obtained 
found in both apo- and holo-proteins. The melting temperatures were determined by the 
location of the peak in the plot of the derivative of ellipticity versus temperature. The 
midpoints of transitions for apo and holo proteins are 50.7 ± 0.9°C and 54.8 ± 0.5°C 
respectively. (B) Molar heat capacity [kcal/(mol.K)] was plotted against the temperature 
(°C ) for thermal denaturation of 3 μM of LigBCen2 in the absence or in the presence of 
calcium chloride (1 mM) was monitored by DSC. Transitions occur with midpoint 
temperatures of 50.02 ± 0.34°C and 55.71  ± 0.88°C for apo and holo proteins 
respectively. 
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Figure 4.6 Calcium influences the interaction of LigBCen2 with NTD of fibronectin, 
monitored by fluorescence and CD. (A) Titration of NTD of Fn with LigBCen2 in the 
presence of Ca2+. Decrease in fluorescence intensity was observed after addition of 0.5, 
1.0, 1.5 and 2.0 μg of NTD (1 mg/ml) to LigBCen2 (10 μM) in the presence of 500 μM 
calcium chloride. (B) Similar experiment in the presence of 100 μM EGTA (in the 
absence of Ca2+) (C) Far-UV CD spectra of LigBCen2 with NTD of Fn in the presence, 
or (D) in the absence of calcium. 0.5, 1.0, 1.5 and 2.0 μl of 1 mg/ml NTD was incubated  
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Ca2+ binding influences the fluorescence spectra of LigBCen2 
Intrinsic Trp fluorescence of LigBCen2 is unusual in the sense that it shows a doublet or 
two peaks at 318 and 328 nm in its emission spectra (Figure. 4.6). Maximum emission 
by Trp fluorescence is seen at 318 nm suggesting that this single Trp is buried in a 
highly hydrophobic core of the protein. This unique phenomenon is rarely observed in 
with LigBCen2 for 15 minutes along with either 250 μM CaCl2 or 100 μM EGTA and 
spectra were recorded using 0.2 mm path length cuvette. proteins but has been 
documented in 　-crystallin (39) and  RNaseP (40) In the case of RNaseP, it has been 
demonstrated that the emission doublet is due to the hydrophobic interaction of Trp with 
two Phe residues in the excited state (40). Therefore, in case of LigBCen2, it appears 
that hydrophobic interaction among the lone Trp60 and two Phe residues at positions 41 
and 42 can form a complex when excited. When titrated with Ca2+, fluorescence 
intensity decreases significantly (10-15% decrease at 318 nm) suggesting that upon 
binding Ca2+, there are conformational changes in the protein and Trp moves towards a 
more non-polar environment.  
 We also examined the influence of Mg2+ on LigBCen2 conformation. As seen in 
Figure. 4.6B, addition of Mg2+ decreases the Trp fluorescence in the same way as Ca2+ 
suggesting that upon binding Mg2+, the protein undergoes conformational changes. 
Mg2+-saturated LigBCen2 was further titrated with Ca2+. Ca2+ was able to induce further 
changes in the fluorescence emission spectra of Mg2+-saturated protein (Figure. 4.6C), 
suggesting that Ca2+ is able to replace Mg2+ owing to higher affinity. The surface 
hydrophobicity of LigBCen2 was assessed by ANS binding. There was a weak 
fluorescence emission suggesting that the protein is largely hydrophilic and binds ANS 
very weakly. In order to further characterize if there is any change in hydrophobicity 
upon Ca2+-binding, the ANS-LigBCen2 complex was titrated by Ca2+. There was an  
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Figure 4.7 Ca2+ influence Fn binding to LigBCen2 analyzed by near-UV CD, ELISA 
and Stains-all (A) Near-UV CD spectra of LigBCen2 and NTD in the presence of 250 
µM CaCl2. 0.5, 1.0, 1.5 and 2.0 μl of 1 mg/ml NTD was added to 0.5 mg/ml LigBCen2 
in presence of 250 μM CaCl2 and CD spectra were recorded and corrected for buffer and 
Fn. (B) Fn binding to LigBCen2 assayed by ELISA. Binding of GST-LigBCen2 or GST 
in the presence or absence of Ca2+ to varying concentrations (1.0, 0.5, 0.25, 0.12, 0.062, 
0.037 μM) of immobilized NTD or BSA (negative control and data not shown). 10 nM 
of apo or holo GST-LigBCen2 or GST were added to a serial dilution of NTD or BSA 
coated wells. Bound proteins were estimated by ELISA. Each value represents the 
mean± SEM of three trials in triplicate samples. Statistically significant (P<0.05) is 
indicted by *. (C) and (D): The induced CD spectrum of the dye Stains-all (60μM) in 2 
mM MOPS, pH 7.2 containing 30% ethylene glycol. 5 µM protein was incubated with 
dye for 10 min, (C) in presence of 200 M CaCl　 2 and (D) in absence of CaCl2 (presence 
of 100 μM EDTA), followed by addition of 0.5, 1.0 and 2 µl of NTD (1 mg/ml) to 1.6ml 
protein solution and CD spectrum  recorded from 700 to 400 nm. 
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increase in ANS binding intensity with a blue shift of about 4-5 nm suggesting that Ca2+ 
binding changes the surface hydrophobicity of the protein (Figure. 4.6D). 
 
Ca2+ binding increases the conformational stability of LigBCen2 
In order to gain more insight into the possible role of Ca2+ binding on protein stability, 
thermodynamic properties of thermal unfolding of LigBCen2, with or without calcium, 
were obtained by CD and DSC. The midpoint of unfolding was calculated by 
monitoring the change in ellipticity (in the CD) at 215 nm. As shown in Figure. 4.7A, 
the mid-point of LigBCen2 unfolding increased from 47.8 ± 1.2°C to 53.9 ± 0.8°C when 
Ca2+ was added. On the other hand, a shift in the midpoint of transition curves from 
50.08 ± 1.05°C for apo-LigBCen2 to 55.00 ± 1.01°C for Ca2+-bound LigBCen2 was 
also calculated by DSC (Figure. 4.7B). Taken together, these data indicate that 
Ca2+-binding stabilizes the overall structure of LigBCen2 significantly. 
 
Implications of Ca2+-binding to the functions of LigBCen2 
Our results confirm the hitherto unknown property of Ca2+-binding by Lig proteins, 
whose functions are not yet fully understood. This is the first report confirming that a 
bacterial immunoglobulin domain is a Ca2+-binding domain. We have recently shown 
that LigBCen2 binds strongly to the N-terminal domain (NTD), but very weak to the 
gelatin binding domain (GBD) of fibronectin (16). We, therefore studied if this binding 
is Ca2+-dependent or is modulated by Ca2+. 
 
Calcium modulates NTD of fibronectin binding to LigBCen2 
LigBCen2 possesses a high affinity Fn binding site and binds to the NTD of Fn (16). 
Since Ca2+-binding stabilizes LigBCen2 conformation, we assayed for NTD binding to 
LigBCen2 by ELISA in the presence and absence of Ca2+. As shown in Figure. 4.7A, 
  
 
 
 
 
Table 4.3 Dissociation constant (Kd values) for the interaction of NTD of Fn and LigBCen2 in the presence or absence of calcium 
chloride. 
 
Dissociation constant  LigBCen2 and Fn in the presence of CaCl2 LigBCen2 and Fn in the absence of CaCl2 
KD (nM) 85±2 272±25a 
areported previously (16) 
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holo-LigBCen2 binds the NTD more strongly than apo-LigBCen2. Similarly, the 
binding affinity of the NTD to holo-LigBCen2 was increased (Kd = 85 nM) compare to 
apo-protein (Kd = 272 nM) (Table 4.3) (16). These results suggest that Ca2+-binding to 
LigBCen2 assists the interaction with the NTD of Fn. 
 
Ca2+ influences the binding of LigBCen2 with fibronectin as monitored by 
fluorescence 
It is known that LigBCen2 strongly binds to Fn (16). In order to determine if Fn binding 
to LigBCen2 is Ca2+-dependent or independent, we performed Trp fluorescence 
titration of LigBCen2 by Fn in the presence or absence of Ca2+. As seen in Figure 4.7B, 
there was a significant decrease in fluorescence (up to 20%) in performed in the 
presence of Ca2+. There was an insignificant decrease when titration was performed in 
the absence of Ca2+. These data suggest that Fn interaction with LigBCen2 depends on 
the presence of Ca2+. In the absence of Ca2+, there is only a weak interaction between 
these two proteins. 
 
Fn binding to LigBCen2 monitored by CD 
We monitored the binding of the NTD of Fn with LigBCen2 using far-UV CD. Varying 
concentrations of NTD were added to the LigBCen2 solution in the presence of Ca2+. 
The spectra were corrected for the NTD signal by subtracting the appropriate blank as 
mentioned in the experimental section. Addition of NTD decreases the ellipticity to a 
great extent (Figure. 4.7C). The ellipticity in the region below 200 nm was more 
negative (as seen for a coiled protein) at the Lig:NTD ratio of about 1:2. When these 
experiments were performed in the absence of Ca2+ (in the presence of EGTA), the 
influence was comparatively very weak (Figure. 4.7C). It is interesting to note that there 
is no significant change in the tertiary structure upon binding NTD when monitored by 
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near-UV CD (Figure. 4.7D). Only minor changes were seen when the interaction was 
performed in the presence of Ca2+. The above results suggest that the NTD of Fn 
influences the conformation of LigBCen2 significantly in the presence of Ca2+.  
 
Discussion 
A number of studies on various Lig proteins have investigated their physiological 
roles and functions in pathogenicity still their functions and structural properties are not 
yet known (12, 13, 18, 19). This work was undertaken to understand the conformational 
and unique features of these proteins by which they are involved in pathogenesis. We 
for the first time, demonstrate a novel feature of Lig proteins, i.e., Ca2+-binding. Since 
there is no known Ca2+-binding motif in these proteins, this is a novel and significant 
finding. Furthermore, we demonstrate that Ca2+-binding modulates the protein 
structures and the interaction of Lig with extra cellular matrix proteins, such as Fn.  
 
LigB is a Ca2+-binding protein 
Our results confirm Lig proteins as a Ca2+-binding protein despite the lack of a known 
Ca2+-binding motif in these proteins such as an EF-hand motif, C2 domain or 
hemolysin-type motif (30). Besides these known motifs, some bacterial proteins also 
bind Ca2+ through oxygen atoms provided by several charged glutamate or aspartate 
residues (30). Interestingly, there are five Asp and three Glu residues present in the 
tandem repeats of LigBCen2. However, often these motifs are less well defined and not 
easy to specify because of the absence of structural data for these proteins. It appears 
that Lig has a novel, orphan Ca2+-binding motif which needs to be identified. Taking 
into account the similarities between various Greek key motifs (31), we suggest that Lig 
proteins should have a motif for Ca2+-binding similar to that seen in lens 
　　-crystallins (32). This motif is shown to bind Ca2+ in many proteins, such as Protein 
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S (41), spherulin 3a (42), caulollin (43), yersinia crystallins (44), though this motif still 
needs to be more clearly defined by structural studies on various diverse proteins. We 
suggest that a motif similar to that of 　　-crystallins is present in LigB protein though 
it needs to be verified by structural means. Extensive structural studies to identify this 
motif and its comparison with crystallin-type Greek key motif are underway. There is a 
possibility that proteins of the Big domain would bind Ca2+, thus forming a new family 
of Ca2+-binding proteins. 
 
LigBCen2 is partially unstructured in apo form 
Significant changes in LigBCen2 conformation occur upon binding Ca2+. It appears that 
this Lig domain is partially unstructured and folds upon binding Ca2+. Similar results 
have been noted in some members of the lens βγ-crystallin superfamily, such as 
microbial crystallins (36, 43-44). Another similarity of LigBCen2 with 　　-crystallin 
domain is the tendency of domain-domain interaction or homodimerization. There is a 
significant tertiary fold in apo-LigBCen2, suggesting that this protein is globally well 
folded. However, upon binding Ca2+, there are significant changes in the tertiary 
structure of LigBCen2. These changes may differ those seen in many calcium sensors, 
such as neuronal calcium sensor-1 (45), since these sensors have poor tertiary structures 
in the apo form.  
The concentration of calcium in Leptospira spp. infected hosts (in vivo) is generally 
higher than in the environment, and LigB is an essential virulence factor required by 
Leptospira spp. to infect the host (13). Thus, a higher concentration of calcium inside 
the host tissues is available to bind to LigB, which would fold the protein and increase 
its structural stability, and thus help in the protection of the bacterium. This also 
explains the fifty year old observation of Johnson and Gary (1963) about the absolute 
requirement of calcium and magnesium for the growth and survival of the bacterium 
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(46). This might explain how Leptospira spp. adapt and survive in vivo and highlights 
the importance of LigB for leptospiral infection. 
 
Leptospirosis is intervened by Ca2+ via Lig proteins 
We present a novel case of Lig interaction with Fn which is Ca2+ dependent. It has been 
reported that ClfA, a fibrinogen-binding MSCRAMM serving as a clumping factor of 
Staphylococcus aureus, has a Ca2+-dependent inhibitory site for the interaction of ClfA 
and fibrinogen (47). However, in this case, Ca2+ was found to enhance the binding 
affinity of LigBCen2 to the NTD of Fn significantly. LigB has been shown to be an 
adhesin of Leptospira spp., and assists bacterial attachment to some ECMs including Fn 
to mediate their adhesion (15, 16). Thus, the increase of binding affinity of LigBCen2 to 
the NTD in the presence of Ca2+ indicates that the interaction between LigB and Fn 
would be stronger in vivo due to the presence and ever availability of calcium in the host. 
Thus Leptospira spp. would bind to Fn and other ECMs strongly or weakly to the 
infected host depending on the presence of calcium within the tissues. Therefore, we can 
readily propose a hypothetical but largely acceptable mechanism of infection involving 
Ca2+ and Lig proteins. Furthermore, our data suggest that these factors should be 
considered while designing optimum therapy for the treatment of leptospirosis, such as 
inclusion of calcium chelators, which might minimize the interaction between Lig and 
extracellular matrix proteins. 
In conclusion, we demonstrate that LigB is a novel Ca2+-binding protein which binds 
Ca2+ with high affinity. Ca2+-binding stabilizes its structure, and influences its local as 
well as global conformation. This work would add one more class of bacterial 
Ca2+-binding protein to list of proteins in bacteria (30). The physiological impact of this 
study is on the identification of Ca2+ as a factor for modulating Fn binding to LigB, and 
possibly with other ECMs, thus would have implications in pathogenesis. Our work 
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presents a case of a novel bacterial Ca2+-binding protein, and would help in designing 
better therapy using calcium chelators for bacterial infection.
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CHAPTER 5 
FIBRONECTIN BINDS TO AND INDUCES CONFORMATIONAL CHANGE 
IN A DISORDERED REGION OF LEPTOSPIRA INTERROGANS 
IMMUNOGLOBULIN-LIKE PROTEIN LIGB 
 
Introduction 
Leptospira interrogans is a pathogenic spirochete that causes leptospirosis 
throughout the world, especially in developing countries but also in regions of the 
United States where it has reemerged (1). Weil’s syndrome, a severe form of this 
disease, is an acute febrile illness associated with multi-organ damage including liver 
failure (jaundice), renal failure (nephritis), pulmonary hemorrhage and meningitis (1), 
and has a 15% mortality rate if not treated (2). The molecular pathogenesis of 
leptospirosis is poorly understood and the bacterial virulence factors involved are 
largely unknown. Recently, several potential Leptospira virulence factors have been 
described, including sphingomyelinases, serine proteases, zinc-dependent proteases, 
collagenase (3), LipL32 (4), lipopolysaccharide (5), a novel factor H, laminin and 
Fn-binding protein (Lsa24 or Len) (6-8), Loa 22 (9), and Leptospiral 
immunoglobulin-like (Lig) proteins (10-12).  
Lig proteins, including LigA, LigB, and LigC, contain multiple 
immunoglobulin-like repeat domains (13 in LigA, 12 in LigB and LigC) (10-12). 
Interestingly, the first 630 residues, from the N-terminus to the first half of the seventh 
immunoglobulin-like domain, are conserved between LigA and LigB, but the rest of the 
immunoglobulin-like domains are variable (10-12) between the two proteins. Also, a 
non-immunoglobulin-like repeat region found on the C-terminal tail of LigB is not 
found in LigA (10-12). Lig proteins are categorized as microbial surface components 
recognizing adhesive matrix molecules (MSCRAMM) due to their ability to bind to 
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eukaryotic cells (13) through their interactions with extracellular matrix components 
including fibronectin (Fn), laminin, and collagens (13,14). Previously, a high-affinity 
Fn-binding region was localized to LigBCen2, which includes the partial 11th and 
complete 12th immunoglobulin-like repeat region and the first 47 amino acids of the 
non-repeat regions of LigB (15). LigBCen2 was shown to bind to both the N-terminal 
domain (NTD) and the gelatin binding domain (GBD) of Fn. The addition of calcium 
induces a conformational change in LigBCen2 and enhances binding between 
LigBCen2 and the NTD of Fn (15).  
The first step in the process of bacterial infection is cellular adhesion, mediated by 
bacterial adhesins interacting with various components of the extracellular matrix 
(ECM) (16). Known interaction modes between Fn and bacterial Fn-binding proteins 
include the β-zipper (17,18) and the cationic cradle (19). It was recently discovered that 
the Fn-binding domains in certain Fn-binding proteins are disordered and extended but 
gain structure upon binding to the NTD of Fn (20-22).  
We have performed a fine-mapping study of the NTD-binding site on LigBCen2 
and identified this site as LigBCen2NR, a portion of the non-repeat region (AA 
1119-1165). The addition of NTD promotes the folding of LigBCen2NR from a 
disordered and extended structure to a folded structure. This finding is notable since 
LigBCen2NR is located in the non-immunoglobulin-like region of LigB, as compared 
with other Fn-binding proteins such as Staphylococcus aureus FnbpA and FnbpB (23), 
Streptococcus dysgalactiae FnBB (17), and S. pyogenes SfbI and SfbII (24). Thus, the 
binding mode appears to be similar to the known β -zipper mechanism, but unique in 
sequence-specific interactions. This finding provides the fundamental groundwork for 
the development of a therapeutic agent to target this interaction in order to prevent or 
treat Leptospira infection.  
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Materials and Methods 
Reagents and antibodies 
rabbit anti-GST antibody and HRP-conjugated goat anti-rabbit antibody were ordered 
from Molecular Probe (Eugene, OR) and Zymed (San Diego, CA) respectively. NTD or 
GBD of Fn, aldolase, bovine serum albumin, ovalbumin, chymotrypsinogen A, 
ribonuclease A, aprotinin, insulin chain B, sodium chloride, sodium phosphate 
monobasic, and sodium phosphate dibasic were purchased from Sigma-Aldrich (St. 
Louis, MO). 
 
Plasmid construction and Protein purification 
The construction, expression, and purification of LigCon (amino acids 1-630) were 
performed as described previously (12). Constructs for the expression of 
histidine-tagged or GST fused LigBCen2 (amino acids 1014-1156) and GST were 
generated using the vector pQE30 (Qiagen, Alencia, CA) and/or pGEX-4T-2 (GE 
Healthcare Bio-Science Corp., Piscataway, NJ), respectively, as previously described 
(14). Constructs for the expression of histidine-tagged or GST fused LigBCen2R 
(amino acids 1014-1123) and LigBCen2NR (amino acids 1119-1165) were generated 
using the vector pQE30 and pGEX-4T-2 (Figure. 5.1). To perform the PCR reactions, 
the following forward and backward primers were utilized (14): LigBCen2R forward 
primer 5’ GGATCCACTGCGACTTACAAT 3’ and backward primer 5’ 
GTCGACCGTGTCCGTTTTGTT 3’; LigBCen2NR forward primer 5’ 
CGGGATCCAACAAAACGGACACG 3’ and backward primer 5’ 
CGGTCGACATTGGAACTATTAAT 3’. Primers were engineered to introduce a 
BamHI site at the 5’ end of each fragment and a stop codon followed by a SalI site at the 
3’ end of each fragment. PCR products were sequentially digested with BamHI and SalI 
and then ligated into pQE30 or pGEX-4T-2 cut with BamHI and SalI, respectively. In 
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this study, we purified the soluble form of the histidine-tag or GST fused with 
LigBCen2, LigBCen2R, or LigBCen2NR from E. coli as previously described (25). Tris 
buffer (25mM Tris and 150 mM sodium chloride at pH 7.0) containing 100 μM of 
calcium chloride was used in all experiments as we have previously shown that calcium 
enhances the binding of LigBCen2 to NTD (15) and that both LigBCen2R and 
LigBCen2NR bind calcium (data not shown).  
 
NMR Sample Preparation and Experiments 
E. coli harboring the expression plasmid for His-tagged LigBCen2 were cultured in M9 
minimal media. The recombinant LigBCen2 (retaining the 6-His tag) was labeled with 
15NH4Cl (Cambridge Isotopes, Cambridge, MA), expressed, and purified as previously 
described (26). The purified 15N-labeled LigBCen2 was dialyzed against Tris buffer 
with 100 μM calcium chloride at pH 6.0 and concentrated to 0.95mM (0.3 mL) using the 
Amicon Ultra centrifugal filter (Millipore, Billerica, MA). For some spectra, 
15N-labeled LigBCen2 was also mixed with 1.44mM of (unlabeled) NTD. 
NMR spectra were recorded at 25 oC on a Varian Inova 600 MHz spectrometer 
equipped with a triple-resonance [H,C,N] z-axis pulse-field gradient probe. 
Two-dimensional 15N-1H fast-HSQC spectra were recorded with spectral widths of 2.4 
kHz in t1 (400 real + imaginary data points) and 10 kHz in t2 (2048 real + imaginary 
data points) (27), with 16 or 32 transients per free induction decay for LigBCen2 in the 
absence or presence of NTD, and a recycle delay of 1.0 sec. NMR data were processed 
and analyzed using the software tools nmrPipe, nmrDraw, and Pipp (28,29). Data were 
apodized using a phase-shifted sine-bell function and zero-filled prior to Fourier 
transformation.  
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Figure 5.1  A schematic diagram showing the location of the truncated LigBCen2 
protein including the LigBCen2R and LigBCen2NR constructs used in this study. 
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Surface Plasmon Resonance (SPR) 
Association and dissociation rate constants for LigBCen2/NTD binding were measured 
by SPR analysis performed with a Biacore 2000 instrument (GE Healthcare 
Bio-Science, Piscataway, NJ) at 26.7oC. 1 μM of His-tagged LigBCen2 in Tris buffer 
containing 100 μM CaCl2 was immobilized on a NTA chip (GE Healthcare Bio-Science) 
conjugated with 500 μM nickel sulfate. Serial concentrations (100, 200, 400, 800 nM) 
of NTD were injected into the flow cells at a flow rate of 5 μL/min over the immobilized 
LigBCen2. All experiments are duplicated. All sensogram data have been corrected by 
subtracting data from a control cell injected with Tris buffer. Kinetic parameters were 
obtained by fitting the data to the one-step biomolecular association reaction model (1:1 
Langmuir model) with the curve-fitting BIAevaluation software, version 3.0. 
 
ELISA Fn binding assays 
To determine the binding of GST-LigBCen2, GST-LigBCen2R, GST-LigBCen2NR, or 
GST-LigCon (negative control) to the NTD of Fn, 1 μM of NTD was coated on 
microtiter plate wells, incubated at 4oC for 16 hours and blocked with blocking buffer 
(100 μl/well) containing 3% BSA in Tris buffer with 100 μM calcium chloride at room 
temperature (RT) for 2 hours. Then, serial concentrations (as indicated by Figure. 
 5.3A) of GST-LigBCen2, GST-LigBCen2R, GST-LigBCen2NR, or GST-LigCon in 
100 μL Tris buffer with 100 μM calcium chloride were added to the microtiter plate 
wells for 1 hour at 37oC. To detect the binding of GST-LigBCen2, GST-LigBCen2R, 
GST-LigBCen2NR, or GST-LigCon, rabbit anti-GST (1:200x) and HRP-conjugated 
goat anti-rabbit IgG (1:1,000x) were used as primary and secondary antibodies, 
respectively. After washing the plates thrice with TBST, (0.05% Tween 20 100 μM 
calcium chloride in Tris buffer) 100 μL of TMB (KPL, Gaithersburg, MD) was added to 
each well and incubated for 5 min. The reaction was stopped by adding 100 μl of 0.5% 
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hydrofluoric acid to each well. Each plate was read at 630nm using an ELISA plate 
reader (Bioteck EL-312, Winoski, VT). Each value represents the mean ± SEM of three 
trials in triplicate samples. Statistically significant (P<0.05) differences are indicated by 
*. 
 
Isothermal Titration Calorimetry (ITC) 
The experiments were carried out with a CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25oC as previously described (14). In a typical 
experiment, the cell contained 1 ml of a solution of NTD and the syringe contained 250 
μl of a solution of LigBCen2R or LigBCen2NR. The concentrations of LigBCen2R, 
LigBCen2NR, and NTD are described in Table 5.1. Both solutions were in Tris buffer 
with 100 μM calcium chloride. The titration was performed in 25 injections of 10 μl 
with a stirring speed of 250 rpm, and the delay time between the injections was 5 min. 
Data were analyzed using Titration Binding Work 3.1 software (Calorimetry Science 
Corp. Lindon, UT, USA) fitting them to an independent binding model.  
 
Prediction of Protein Disorder 
The LigBCen2NR folding prediction was carried out using PONDR, a software 
package containing VL-XT, XL1_XT, and VL3, which predict naturally disordered 
regions (30-32). PONDR can be used as a Web Service for remote and automatic data 
processing by accessing the following URL: www.pondr.com. The analyses were 
performed using default values. 
 
Differential Scanning Calorimetry (DSC) 
The excess heat capacity Cp(T) of LigBCen2, LigBCen2R, or LigBCen2NR was 
measured using a DSC Q1000 microcalorimeter (Waters, New Castle, DE). Degassed 
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samples containing 3 µM of LigBCen2, LigBCen2R, LigBCen2NR or Tris buffer with 
100 μM calcium chloride were heated at 10 K/h scan rate. Heat Capacities, cp(T), data 
were recorded, corrected for buffer baseline, and normalized to the amount of the 
samples. The TA Universal Analysis software (Waters, New Castle, DE) was used for 
the data analysis and display. All calorimetric experiments in this study were repeated 3 
times to ensure reproducibility. 
 
Gel Permeation Chromatography (GPC) 
LigBCen2, LigBCen2R, and LigBCen2NR were analyzed for their partition coefficient 
(Kav) and effective radii (Stokes radii, Rs) in Tris buffer with 100 μM calcium chloride  
using a Superdex 200 HR 10/30 column (GE Healthcare Bio-Sceince) attached to a fast 
protein liquid chromatography (GE Healthcare Bio-Sceince) system. Protein samples 
were preequilibrated with Tris buffer with 100 μM calcium chloride, and eluted with the 
same buffer at a flow rate of 0.5 mL/min. The column was calibrated using a low 
molecular weight gel filtration calibration kit (GE Healthcare Bio-Sceince). The 
standard globular proteins contained in the kit were ribonuclease A (13,700 Da), 
chymotrypsinogen (25,000 Da), Ovalbumin (43,000 Da), and albumin (67,000 Da). 
Blue dextran 2000 (2,000,000Da) (GE Healthcare Bio-Sceince), and Aldolase (158,000 
Da) were used to indicate the void volume (Vo) and the total volume (Vt), respectively. 
The elution volume (Ve) of each sample was measured. To define the relationships 
between the elution volumes of protein samples and their respective molecular weight, 
the Kav value for each protein was calculated using the equation 
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where Vo and Vt for the column used were 7.96 and 23.56 mL, respectively. Kav values 
of standard and LigBCen2, LigBCen2R, or LigBCen2NR were plotted against the 
logarithm of the protein molecular weights to fit the equation shown as follows (33). 
 
Where a and b are constants. Rs of the proteins were determined using sample elution 
volumes and standard curves as described in the calibration kit (Amersham Pharmacia 
Biotech, Piscataway, NJ). 
 
Dynamic Light Scattering (DLS) 
One mg per mL of LigBCen2, LigBCen2R, or LigBCen2NR was dialyzed against 
prefiltered (0.22 μm Millipore filters) Tris buffer with 100 μM calcium chloride. The 
samples were placed in a 1mL plastic cuvette. The standard globular proteins including 
albumin (67,000 Da), ovalbumin (43,000 Da), chymotrypsinogen A (25,000 Da), 
ribonuclease A (13,700 Da), aprotinin (6,500 Da), or insulin chain B (3,400 Da) were 
used to generate the calibration curve of globular proteins. The automated 
measurements were collected with a Zetasizer Nano ZS instrument (Malvern 
Instruments Ltd., Worcestershire, United Kingdom), using a 2 min equilibrium delay at 
each measurement. The data were adjusted using the method of cumulants to obtain the 
hydrodynamic radius (Rh). The logarithms of the Rh values of standards and LigBCen2, 
LigBCen2R, or LigBCen2NR were plotted against the logarithm of the protein 
molecular weights to fit the equation  
 
where a and b are constants. 
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Intrinsic Viscosity measurements 
The viscosities of the LigBCen2, LigBCen2R, and LigBCen2NR were measured using 
a Cannon-Ubbelohde Semi-Micro Dilution Viscometer (No. 25 9722-H50, Cannon 
Instrument Co., State College, PA) with a viscometer constant, 0.002044 mm2/s2, at 
25oC. Before measuring the viscosities, 1mL of each protein at concentrations of 0.5, 
0.75, 1, and 1.5 mg/mL were dialyzed overnight against Tris buffer with 100 μM 
calcium chloride, with or without 6M guanidine hydrochloride, and the same buffer was 
used as a reference solution. The specific viscosity (ηsp) was determined as previously 
described (34). Specific viscosity / concentration of untreated or 6M guanidine 
hydrochloride-treated LigBCen2, LigBCen2R, or LigBCen2NR were plotted against 
the concentration of proteins, and the intrinsic viscosity [η] was calculated using the 
following equation:  
 
Where c is protein concentration and k is a dimensionless constant. The values of [η] 
expected for a denatured protein shown in Table 5.3 were obtained from the following 
equation (34): 
 
where n is the number of residues in the protein. 
 
Circular dichroism (CD) spectroscopy 
CD analysis was performed on an Aviv 215 spectropolarimeter (Lakewood, NJ) under 
N2 atmosphere. CD spectra were measured at RT (25oC) in a 1-cm path length quartz 
cell. Spectra of LigBCen2, LigBCen2R or LigBCen2NR were recorded in Tris buffer 
with 100 μM calcium chloride at a protein concentration of 10 μM. Three spectra were 
recorded for each condition from 190 to 250 nm for far-UV CD in 1 nm increments. In 
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the thermal denaturation experiment, 10 μM of LigBCen2, LigBCen2R, LigBCen2NR 
were used, and data were collected at 2°C/minute increments from 20°C to 100°C 
recording the ellipticity at 205 nm, with 30 second temperature equilibrations, followed 
by 30 second data averaging. In order to measure the melting point, the first order 
derivative of the melting curve was taken. Structural changes in LigBCen2R and 
LigBCen2NR upon binding to the NTD of Fn were examined by analyzing changes in 
the CD spectrum. LigBCen2R (10 μM) or LigBCen2NR (10 μM) was preincubated 
with or without the NTD (10 μM) of Fn for 1 hour at 25oC, and the far-UV CD spectra 
were recorded as described above. The changes of the CD spectra upon 
NTD-LigBCen2R or NTD-LigBCen2NR interaction were determined by 
computationally subtracting the ellipticity of the NTD-LigBCen2R or 
NTD-LigBCen2NR complex from the added spectra of the free forms of interacting 
proteins. The deconvolution of the resulting spectra was performed as described above. 
In all CD experiments, the background spectrum of buffer without protein was 
subtracted from the protein spectra. CD spectra were initially analyzed by the software 
accompanying the spectrophotometer. Analysis of spectra to extrapolate secondary 
structures was performed by Dichroweb (35) 
(http://www.cryst.bbk.ac.uk/cdweb/html/home.html) using the K2D and Selcon 3 
analysis programs (36,37). 
 
Fluorescence Spectroscopy 
Fluorescence emission spectra were measured on a Hitachi F4500 spectrofluorometer 
(Hitachi. San Jose, CA). All spectra were recorded in the correct spectrum mode of the 
instrument using excitation and emission band-passes of 5 nm. The intrinsic tryptophan 
fluorescence of the protein was recorded by exciting the solution at 295 nm and 
measuring the emission between 305-400 nm. For the LigBCen2NR/NTD binding  
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Figure 5.2  NMR provides evidence for distinct structured and disordered regions of 
LigBCen2. (A) The 1H-15N HSQC of apo LigBCen2 exhibits a set of well-dispersed 
peaks, indicative of folded, beta-rich residues, and a set of sharper peaks clustered 
toward the center, indicative of residues in an unstructured region. This is emphasized 
by (B) the HSQC viewed at a higher contour level. The number of peaks indicative of 
folded and unfolded residues roughly matches the number of residues expected to adopt 
the Ig-like fold of repeat regions 11 and 12 and the number of residues included from the 
non-repeat region, respectively. (C) When unlabeled NTD is added at an equimolar 
concentration, most of the sharp, clustered peaks either disappear or are greatly 
diminished in intensity while the well-dispersed peaks corresponding to folded protein 
remain largely unperturbed, as highlighted by (D) the overlay of this spectrum with the 
apo LigBCen2 spectrum. The disappearance of the peaks corresponding to the 
unstructured region(s) of the LigBCen2 construct suggests that the non-repeat sequence 
selectively binds to NTD. represents the mean ± standard error of the mean (SEM) of 
samples tested in triplicate. An (*) indicates the result was statistically significant.  
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experiment, the emission spectra of untreated or LigBCen2NR (10 μM) treated with 
NTD (10 μM) were taken. LigBCen2NR contains no tryptophan; therefore, for the 
LigBCen2NR/NTD binding experiment, the spectrum of LigBCen2NR in isolation was 
essentially background and was subtracted from the spectrum for the mixture. 
 
Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass 
spectrometry 
The molecular weight of samples of purified LigBCen2, LigBCen2R, or LigBCen2NR 
were analyzed using MALDI-TOF mass spectra recorded on an Applied Biosystems 
4700 Mass Spectrometer (Applied Biosystems, Foster City, CA). Prepared samples 
included 10 μM of LigBCen2, LigBCen2R, or LigBCen2NR in deionized water. 
 
Statistical analysis   
Significance between samples was determined using the Student’s t-test following 
logarithmic transformation of the data. Two-tailed P-values were determined for each 
sample and a P-value <0.05 was considered significant. Each data point fold predicted 
for repeat regions 11 and 12, which would place backbone N-H groups in unique 
chemical environments and would cause the corresponding 15N-1H correlation peaks to 
appear at widely varying positions in the NMR spectrum. In contrast, for a dynamically 
unstructured polypeptide, the corresponding 15N-1H correlation peaks are stronger due 
to increased motion, and cluster to similar regions of the spectrum due to the more 
uniform chemical environment of the solvent. A set of such peaks is clearly present, as 
highlighted by the LigBCen2 15N-1H spectrum at a higher contour level (Figure. 5.2B). 
The number of peaks associated with folded and unfolded sets of N-H groups roughly 
matches the number of residues expected to adopt the 　-sheet rich fold of the 12th and 
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partial 11th Ig-like repeats (LigBCen2R) and the number of residues included from the 
non-repeat region (LigBCen2NR), respectively. 
 
Results 
Identification of the binding sites of NTD on LigBCen2 
In order to investigate the general structural properties of LigBCen2 and its interactions 
with Fn, uniformly 15N-labeled LigBCen2 was prepared, and two-dimensional 15N-1H 
chemical shift correlation NMR experiments were performed in the absence and 
presence of an equimolar amount of unlabeled NTD (Figure. 5.2. A-D). 
 The NMR spectrum of apo LigBCen2 shows evidence for distinct structured and 
unstructured regions, with a set of highly resolved peaks dispersed across both 
dimensions of the spectrum and another set of peaks of higher intensity clustered toward 
the center of the spectrum (Figure. 5.2A and B). The number of well-dispersed peaks 
and their positions are consistent with the β-sheet rich immunoglobulin-like When 
1.44mM of unlabeled NTD was added to 0.95mM of 15N-LigBCen2, the well-dispersed 
peaks corresponding to folded protein remained largely unperturbed, while most of the 
sharp, clustered peaks either disappeared or were greatly diminished in intensity (Figure. 
5.2C) as highlighted by the overlay of this spectrum with the apo LigBCen2 spectrum 
(Figure. 5.2D). Interestingly, application of a TROSY-based 15N-1H HSQC experiment 
useful for very large proteins (38) did not recover the lost peaks (data not shown). These 
results demonstrate that NTD does not bind to the structured region of LigBCen2. The 
nature and number of peaks that are affected by NTD addition suggest that NTD 
specifically binds to LigBCen2NR and results in chemical exchange in the intermediate 
rate regime, where the peaks whose chemical environment changes between 
conformational states are broadened beyond the level of detection. 
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 In order to test the possibility that the peak disappearance is due to sampling 
between free and bound states, surface plasmon resonance (SPR) was performed to 
measure the binding kinetics for the LigBCen2-NTD interaction at pH 6.0 and 26.7 °C 
to correspond to the NMR conditions (Fig. 5.7). Based on the rates obtained, (kon = 2.28 
× 105 ± 0.23 × 105s-1M-1, koff = 2.47 × 10-2 ± 0.16 × 10-2 s-1), the kex should be 112 ± 11 
s-1 at the conditions of the NMR sample (1.44 mM NTD, 0.95 mM LigBCen2, [NTD]free 
= 0.49 mM). Resonances undergoing exchange broadening due to ligand binding 
usually refocus at saturation. Given the unusually slow off-rate of binding, at saturating 
concentrations of NTD the spectrum of LigBCen2 should show a single set of peaks 
reflecting the bound state. A saturation of >99% was predicted for the NMR sample, 
assuming simple two-state binding with a KD of 93 nM (15). Therefore, the 
line-broadening observed for the NMR sample is not due to exchange between free and 
bound states. One possible explanation is the formation of a ‘fuzzy complex,’ or a 
dynamic ensemble of conformational states, upon binding NTD. This has been 
previously observed for other intrinsically disordered proteins, including the 
NTD-binding SfbI of S. pyogenes (39,40). Regardless of the origin of the peak 
disappearance, the NMR experiments indicate that NTD interacts specifically with the 
disordered region of LigBCen2 in the intact construct.  
In order to evaluate the pH sensitivity of the LigBCen2-NTD interaction, the SPR 
measurements were performed at both pH 6.0 and 7.0. The dissociation constants 
calculated at each pH (KD = koff/kon = 109 ± 8 nM at pH 6.0, 95.5 ± 1.4 nM at pH 7.0) are 
in good agreement with each other, and the value at pH 7.0 is in excellent agreement 
with the previously reported KD of 93 ± 8 nM at pH 7.0 (15). The kinetic rates at each 
pH were also in close agreement with each other (kon = 2.72 ± 0.19 × 105 s-1M-1, koff = 
2.6 ± 0.22 × 10-2 s-1 at pH 7.0). All subsequent biophysical measurements were 
performed at pH 7.0. 
  
 
 
 
 
Table 5.1 Thermodynamic parameters for the interaction of NTD and LigBCen2R or LigBCen2NR 
LigB LigB Residues [LigB] [NTD] ΔH TΔS ΔG KD n 
  μM μM kcal mol-1 kcal mol-1 kcal mol-1 nM  
LigBCen2NR 1119-1165 362 61 13.13±1.55 22.25 -9.12 379±16 0.94±0.01 
LigBCen2R 1014-1123 118 5.9 n/fa n/fa n/fa n/fa n/fa 
n/fa, non-fittable. 
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Figure. 5.3  Determination of binding constant and thermodynamics of the 
LigBCen2NR/NTD interaction by ELISA and ITC. (A)  Binding of serial 
concentrations of LigBCen2NR to immobilized NTD by ELISA. Serial concentrations 
of GST-LigBCen2R, GST-LigBCen2NR, GST-LigBCen2 (positive reference), or 
GST-LigCon (negative reference) were added to 1μM of NTD or BSA coated wells 
(negative control, data not shown). (B) Determination of the binding affinity by ITC. 
The cell contained 1 ml of NTD and the syringe contained 250 μl of LigBCen2NR 
(upper panel) Heat differences obtained from 25 injections of LigBCen2NR; (lower 
panel) Integrated curve with experimental data (◆) and the best fit (—). The 
thermodynamic parameters are shown in Table 5.1. 
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In order to test the NMR-derived hypothesis that NTD interacts with specifically 
with LigBCen2NR, various concentrations of GST-LigCon (a truncation that cannot 
interact with Fn, used as a negative control) GST-LigBCen2 (positive control), 
GST-LigBCen2R, GST-LigBCen2NR, and GST were added to a NTD coated 
microtiter plate. As shown in Figure. 5.3A, LigBCen2NR binds NTD, but no NTD 
binding was observed for LigBCen2R or LigCon (Fig. 5.1) (13,14). These results were 
also confirmed by isothermal titration calorimetry (ITC) experiments. LigBCen2NR 
binding to NTD is an endothermic reaction (unfavorable enthalpy, favorable entropy) 
with a dissociation constant (KD) of 379 nM (Fig. 5.3B and Table 5.1). The favorable 
entropy suggests that the complex formation of LigBCen2 and NTD involves 
significant hydrophobic interactions. By contrast, ITC experiments demonstrate that 
LigBCen2R does not bind to NTD (Table 5.1). Both ELISA and ITC results support the 
NMR-derived hypothesis that LigBCen2NR, the non-immunoglobulin-like domain 
47-residue region of LigBCen2, selectively binds to NTD. 
 
LigBCen2NR possesses a disordered and unfolded structure 
To further characterize the structural properties of LigBCen2NR and investigate the 
NMR-derived hypothesis that this region is unstructured, the amino acid sequence of 
LigBCen2NR was analyzed by PONDR, a software tool used to predict naturally 
disordered protein regions. More than half of the residues in LigBCen2NR (all but 
residues 1146-1164) were predicted to be disordered by VLXT in the PONDR software 
package. In addition, a highly disordered structure was also predicted in LigBCen2NR 
by XL1_XT and VL3 in the PONDR software package (data not shown). 
In order to confirm this sequence-based prediction, the secondary structure of 
LigBCen2, LigBCen2R, or LigBCen2NR was examined by far-UV CD. As presented in 
Figure. 5.4A, both LigBCen2 and LigBCen2R contain significant β-sheet structure  
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Figure. 5.4 Analysis of LigBCen2, LigBCen2R, or LigBCen2NR by Far-UV CD, GPC, 
DLS, and viscometry. (A) Far-UV CD analysis of LigBCen2, LigBCen2R, and 
LigBCen2NR. The molar ellipticity, Φ, was measured from 190 to 250 nm for 10 μM of 
each protein in Tris buffer with 100μM calcium chloride. (B) Gel Permeation 
chromatography of standard molecular mass markers, LigBCen2, LigBCen2R, and 
LigBCen2NR. The partition coefficient (Kav) is plotted as a function of the molecular 
weight of each individual protein on a log scale. (C) Dynamic light scattering of 
standard molecular mass markers, LigBCen2, LigBCen2R, and LigBCen2NR. The 
hydrodynamic radius (Rh) is plotted as a function of the molecular weight of each 
individual protein on a log-log scale. For (C) and (D), the molecular weights of the 
standards are indicated in Materials and Methods, and the molecular weight of 
LigBCen2, LigBCen2R, or LigBCen2NR are indicated in Table 5.2. (D) Determination 
of the intrinsic viscosity of proteins under native or denaturing conditions. The specific 
viscosity/concentration versus concentration is plotted for LigBCen2, LigBCen2R, and 
LigBCen2NR in Tris buffer with 100μM calcium chloride and with or without 6M 
guanidine hydrochloride. The intercept at the y axis is the intrinsic viscosity. 
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Table 5.2 Estimated radii of recombinant LigBCen2, LigBCen2R, and LigBCen2NR 
 Calculated 
mass 
Mass 
Spectroscopy 
Expected Rs from 
GPC calibration curve
Rs from GPC Expected Rh from 
DLS calibration curve
Rh from DLS
 Da Da Nm nm Nm nm 
LigBCen2 18130.97 18131.60 2.05 1.95 2.04 2.07 
LigBCen2R 13473.76 13416.81 1.67 2.07 1.75 1.71 
LigBCen2NR 5956.57 5929.34 0.62 1.93 0.93 1.97 
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(40% in LigBCen2 and 55% in LigBCen2R). However, LigBCen2NR contains 65% 
random coil. Thus, compared to LigBCen2R, LigBCen2NR possesses a highly 
disordered and unfolded structure, in agreement with the NMR analysis of LigBCen2 
presented above.  
 
Gel permeation chromatography and dynamic light scattering indicate 
LigBCen2NR adopts an extended structure 
Most proteins containing disordered structures are extended instead of globular and 
highly packed. Due to differences in the hydrodynamic properties (such as the Stokes 
radius, Rs, and the partition coefficient, Kav) of globular and extended proteins, gel 
permeation chromatography is a powerful technique to determine if a protein is 
unfolded. The Kav of LigBCen2, LigBCen2R, LigBCen2NR, and other globular protein 
standards were determined by the elution volume (Ve) obtained from gel permeation 
chromatography and calculated by equation 1 above. In addition, Kav was plotted 
against the logarithm of molecular weight, and a calibration curve of globular proteins 
was made by using the data from the globular protein standards. Compared to 
LigBCen2 and LigBCen2R, the value of Kav for LigBCen2NR was far from the 
calibration curve and less than expected for a globular protein with a similar molecular 
mass (Figure. 5.4B). These results indicate that LigBCen2NR is not a globular protein. 
Similarly, the Rs value of LigBCen2NR revealed by gel permeation chromatography 
(1.93nm) is significantly larger than expected for a globular protein (0.62 nm) (Table 
5.2), suggesting that LigBCen2NR forms an extended structure.  
The hydrodynamic radii (Rh) of LigBCen2, LigBCen2R, LigBCen2NR, and 
globular protein standards were measured using dynamic light scattering to confirm the 
results from the gel permeation chromatography measurements. The Rh value of 
LigBCen2 or LigBCen2R was close to the value of the globular proteins possessing a 
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similar molecular mass (Figure. 5.4C and Table 5.2). However, the Rh value of 
LigBCen2NR (1.97 nm) was significant larger than that of globular proteins with a 
similar molecular mass (0.94 nm) (Figure. 5.4C and Table 5.2). The distinctly larger Rh 
of LigBCen2NR suggested that it is a highly extended protein, consistent with the 
results obtained from gel permeation chromatography. 
 
Intrinsic viscosity measurements suggest that LigBCen2NR is extended and 
denatured 
Measurement of intrinsic viscosity is a well-known method to determine if a protein is 
denatured because of the direct relationship between the number of residues of a 
denatured protein and its intrinsic viscosity, as shown in equation 5 in Materials and 
Methods. For extended or denatured proteins, intrinsic viscosity is also generally larger 
than for folded proteins (21). 
To further examine if LigBCen2NR is denatured and extended, the viscosities of 
LigBCen2, LigBCen2R, and LigBCen2NR were measured. The specific viscosity over 
protein concentration was plotted against concentration, as shown in Figure. 5.4D. The 
data were fitted to equation 4 in Materials and Methods to obtain intrinsic viscosities, 
and these values were compared to the values expected for denatured proteins, as 
calculated by equation 5. As shown in Figure. 5.4D and Table 5.3, the intrinsic viscosity 
of untreated LigBCen2 or LigBCen2R measured by viscometry was smaller than that of 
LigBCen2 or LigBCen2R treated with guanidine hydrochloride. However, the intrinsic 
viscosities of both guanidine hydrochloride-treated and untreated LigBCen2NR were 
close to the intrinsic viscosity expected for a denatured protein, as calculated by 
equation 5. Taken together, these results indicate that LigBCen2NR is denatured and 
extended. 
 
  
 
 
 
 
Table 5.3 Intrinsic viscosity of recombinant LigBCen2, LigBCen2R, and LigBCen2NR 
 measured [η] from viscometry predicted [η] for denatured protein 
 0M GnHCl 6M GnHCl  
LigBCen2 9.55 22.23 21.39 
LigBCen2R 4.75 20.45 17.87 
LigBCen2NR 10.76 10.98 10.20 
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Figure. 5.5  Thermal unfolding transitions of LigBCen2, LigBCen2R, or 
LigBCen2NR as measured by CD and DSC. (A) Thermal unfolding of 10 μM of 
LigBCen2, LigBCen2R, or LigBCen2NR was observed by CD, measuring ellipticity at 
205 nm from 20  to 100oC. A transition point was identified for LigBCen2 and 
LigBCen2R but not for LigBCen2NR. The melting temperatures were determined by 
the location of the peak in the derivative of the ellipticity curve, as shown in the lower 
panel. The transition midpoints of LigBCen2 and LigBCen2R are 54.0 ± 0.5oC and 58.1 
± 0.8oC, respectively. (B) Thermal unfolding transitions of LigBCen2, LigBCen2R, and 
LigBCen2NR measured by DSC. Molar heat capacity [kcal/(mol．K)] was plotted 
against temperature (oC) from 20 to 80oC for 3 μM of LigBCen2, LigBCen2R, or 
LigBCen2NR. The dot line indicated that the midpoint temperatures of the transitions 
for LigBCen2 and LigBCen2R are 54.2 ± 0.4 oC  and 57.3  ± 0.2 oC, respectively. 
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Figure 5.6 Modification of the Far-UV CD spectrum of LigBCen2NR upon NTD 
binding. Far UV spectra of the apo forms and mixtures of 10 μM of NTD and 10μM of 
either LigBCen2NR (A) or LigBCen2R (B). The ellipticities shown in (A) are those of 
uncomplexed LigBCen2NR (----), complexed NTD and LigBCen2NR after subtraction 
of the NTD CD spectrum (—-—), and the CD spectrum of 10 μM NTD (—). The 
ellipticities in (B) are those of LigBCen2R (----), a mixture of NTD and LigBCen2R 
after subtraction of the NTD CD spectrum (—-— ), and the CD spectrum of 10 μM 
NTD (—). (C) The far UV spectra of mixtures of NTD and LigBCen2NR (---) or 
LigBCen2R (—) after subtraction of the CD spectra of both apo NTD and apo 
LigBCen2NR or LigBCen2R. 
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CD and DSC thermal unfolding experiments further indicate that LigBCen2NR 
has an unfolded structure 
In order to gain more insight on the conformation of LigBCen2, LigBCen2, LigBCen2R, 
and LigBCen2NR were subjected to thermal unfolding experiments using CD 
spectrophotometry and DSC. As shown in Figure. 5.5A, the melting points of 
LigBCen2 and LigBCen2R are 54.0 ± 0.5oC and 58.1 ± 0.8oC, respectively, as measured 
by monitoring the CD signal at 205 nm from 20 to 80 oC. The higher melting 
temperature for LigBCen2R indicates that presence of LigBCen2NR reduces the 
thermal stability of LigBCen2R. The midpoint of the DSC transition curves for 
LigBCen2 (54.2 ± 0.4oC) and LigBCen2R (57.3 ± 0.2 oC) are consistent with the 
CD-derived melting points (Figure. 5.5B). Compared with the results of LigBCen2 and 
LigBCen2R, no obvious cooperative unfolding transition of LigBCen2NR was 
observed (Figure. 5.5). Therefore, both thermal and chemical denaturation experiments 
indicate that LigBCen2NR has an unfolded structure. 
   
The conformation of LigBCen2NR changes upon the addition of NTD 
In order to determine if the binding of NTD affects the structure of LigBCen2NR, the 
CD spectra of NTD, LigBCen2NR (Figure. 5.6A), and NTD mixed with LigBCen2R or 
LigBCen2NR were recorded (Figure. 5.6B and C). The NTD spectrum and either the 
LigBCen2R or the LigBCen2NR spectrum were added as a comparison to assess 
conformational changes upon binding. Consistently, the far-UV CD spectrum of the  
NTD presented on Figure. 5.6A is similar to that published previously (20,21,41) since a 
minimum in intensity was located around 215 nm, and two peaks were located around 
200 nm and 230 nm, respectively due to tyrosine side chains (42,43). As shown in 
Figure. 5.6A and B, the spectrum of apo LigBCen2NR and complexed 
NTD-LigBCen2NR after subtraction of the NTD CD spectrum are significantly  
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Figure 5.7   SPR sensograms of LigBCen2/NTD binding. 1 μM of Recombinant 
Histdine-tag LigBCen2 was immobilized on the surface of Ni-NTA chip. NTD was 
flowed through the chip in Tris Buffer containing 100μM CaCl2 at pH 6, and the 
concentrations of NTD were ranging from 800 to 0 nM (from top to bottom). The 
average response of duplicate experiments (◇) and the fitted curve (—) are shown. The 
KD, kon, koff were obtained from the average of duplicate experiments (KD = 109 ± 8 nM, 
kon = 2.28 × 105 ± 0.23 × 105 s-1M-1 koff = 2.47 × 10-2 ± 0.16 × 10-2 s-1). 
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Figure. 5.8  The intrinsic tryptophan fluorescence of NTD (10 μM) in the absence (—) 
and presence (---) of LigBCen2NR (10 μM). 
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different, but the spectrum of apo LigBCen2R cannot be distinguished from a mixture 
of NTD and LigBCen2R after subtraction of the NTD CD spectrum. Therefore, 
conformational changes occur upon binding of NTD to LigBCen2NR. In order to clarify 
whether NTD or LigBCen2NR change conformation after binding, the intrinsic 
fluorescence spectra of unbound or LigBCen2NR-bound NTD were measured. In a 
previous study, it was shown that conformational changes in NTD are easily detected by 
intrinsic tryptophan fluorescence due to the presence of seven tryptophan residues in 
NTD that are sensitive to small changes in environment (20). Furthermore, because of 
the absence of tryptophan in LigBCen2NR, the intrinsic fluorescence spectrum of  
NTD-bound LigBCen2NR reflects only the conformation of NTD. The addition of 
LigBCen2NR did not significantly change the fluorescence spectrum of NTD (Figure 
5.8), which suggests that binding of LigBCen2NR does not significantly alter the 
chemical environment of the tryptophan residues of NTD. This observation, which 
suggests that NTD does not undergo significant conformational rearrangement upon 
binding, has been reported previously for binding of a domain of FnbA from S. 
dysgalactiae to NTD, and it is thought to be generally true for many NTD-binding 
MSCRAMMs that NTD remains conformationally unchanged upon binding (20). Thus, 
the difference between the CD spectrum of the LigBCen2-NTD complex and the sum of 
the spectra of the individual components shown in Figure 5.6C is considered to be due 
to conformational changes in LigBCen2NR and not NTD. The CD spectra of free and 
complexed LigBCen2NR were analyzed by software to quantitate secondary structure 
before after binding of NTD (Figure 5.6 A). The results of analysis show that 
LigBCen2NR gains secondary structure upon the addition of NTD because the 
percentage of random coil dramatically decreases (from 65% to 46%), whereas the 
β-sheet composition increases (from 28 % to 48%). However, the α–helix composition 
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changes little (from 7% to 6%). This indicates that binding of NTD may cause 
LigBCen2NR to adopt a β-sheet rich structure. 
 
Discussion 
MSCRAMM is a class of well-known adhesin proteins that enable microbes to 
attach to host cells by binding to their ECMs. LigB binds to Fn, fibrinogen, laminin, 
elastin, proelastin and collagen, and hence likely plays a substantial role in adhesion for 
pathogenic Leptospira (13-15,44,45). We have shown that LigBCen2 strongly binds to 
the NTD, and weakly binds to the GBD, of Fn (14) (NTD, KD = 272 nM; GBD, KD = 
1200 nM). LigBCen2 contains an immunoglobulin-like repeat region, LigBCen2R, and 
a non-repeat 47-residue region, LigBCen2NR. In this study, two-dimensional NMR 
spectroscopy revealed both folded and disordered regions of LigBCen2, demonstrated 
that the folded region does not bind to NTD, and indicated that the disordered region 
specifically interacts with NTD. Using ELISA and ITC, we found that LigBCen2NR 
indeed binds to NTD. However, the binding affinity of LigBCen2NR/NTD (KD = 379 
nM) (Table 5.1) is four-fold lower than LigBCen2/NTD (KD = 93 nM) (15). It is not 
presently clear why this is true, but it may suggest that residues near the interface 
between LigBCen2R and LigBCen2NR may play a substantial role in binding and that 
severing the two regions reduces their binding capacity. In protein binding studies of 
intrinsically disordered proteins, it is not uncommon for regions flanking binding 
elements to contribute to binding without directly contacting the binding partner (40). A 
similarly unexplained reduction in binding affinity has previously been observed for 
truncated forms of BBK32 from B. burgdorferi (21). Further study is needed to clarify 
this result. 
      The N-terminal domain of BBK32 (AA56-205) from B. burgdorferi possesses 
Fn-binding activity but lacks secondary structure (21). Additional Fn-binding proteins 
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previously shown to be disordered include FNBD-D, the D1-D3 repeat region of FnbpA 
from S. aereus, FNBD-A and FNBD-B, the A1-A3 and B1-B3 repeat regions of FnbA 
and FnbB from S. dysgalactiae, FNBD-P, and the P1-P4 repeat regions of Sfb from S. 
pyogens (20). These Fn-binding regions change their conformation to a folded form 
upon binding to NTD (20,21,23). Similarly, upon binding to NTD LigBCen2NR folds 
into a β-strand rich structure, much like the D123 domain of FnbPA or the N-terminal of 
BBK32 (21). High-resolution structures of the complex between the B3 region of FnbB 
and the first and the second type I module of Fn (17,18), the complex between the first 
or the fifth Fn binding region of FnbpA, and the second to the fifth type I module of Fn 
(23,39,46) all indicate that a two β-strand complex, called a β-zipper, mediates those 
interactions. The binding of Sfb and BBK32 to NTD are also accomplished through the 
β-zipper interaction (23,39,46). The β-strand rich conformation formed by 
LigBCen2NR after binding NTD observed via far-UV CD spectroscopy suggests that 
the binding of LigBCen2NR to NTD might be also mediated by a β-zipper interaction. 
However, the entropy-driven interaction of LigBCen2NR and NTD is distinct from the 
enthalpy-driven binding of other bacterial proteins known to bind NTD via the β-zipper 
interaction (Table 5.1) (23,39,46). In addition, we are unable to identify substantial 
sequence similarity between LigBCen2NR and BBK32 or other Fn binding proteins, so 
additional study is needed to further characterized the binding between LigBCen2NR 
and NTD. 
 The on-rate of LigBCen2-NTD binding obtained from surface plasmon resonance 
(SPR) is on the order of 105 M-1s-1, three orders of magnitude below rates expected for 
diffusion-limited two state binding (108-109 M-1s-1) (47).  This indicates that additional 
processes occur either before or concurrently with association of LigBCen2 with NTD. 
The observed increase in secondary structure of LigBCen2NR upon binding may 
account for this.  
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The off-rate of the NTD-LigBCen2 complex is also strikingly slow, yielding a 
residence time on the order of 40 s. This may be an important feature for the role of 
LigB in infection. Recent experiments (48,49) have suggested that a small koff of a 
drug-target complex is an important predictor, in some cases more than a small KD, of in 
vivo efficacy. This is because in vivo the concentration of ligand is often not constant, 
but instead influenced by absorption, distribution, metabolism, and excretion (ADME). 
In some cases, this leads to a greater dependence on koff of the overall duration of the 
complex. Since a bacterial adhesin is challenged by many of the same limitations to 
concentration as a drug, it is interesting to speculate that the slow off-rate reported here 
is evolutionarily optimized to avoid clearance, while the slow on-rate may be optimized 
to facilitate movement through the host. 
 We have demonstrated that the region of LigBCen2 that mediates its interaction 
with the NTD of Fn is localized to LigBCen2NR. LigBCen2NR has a disordered 
structure that dramatically increases its β-strand content after binding to NTD.  
Disordered proteins often alter their conformations when binding their partners (50). 
One possible role of protein disorder in protein-protein interactions is the large 
accessible surface area per residue contributed by the disordered protein  (18,51). The 
unfavorable decrease in the entropy of LigBCen2NR upon binding NTD due to the 
disorder-order transition is offset by a larger increase in entropy, possibly due to 
hydrophobic interactions, as demonstrated by ITC. Another advantage of protein 
disorder in binding is that coupled folding and binding usually contributes high 
specificity and low affinity to the interaction (50). 
In conclusion, the moderate affinity and slow kinetics of the LigBCen2NR 
interaction with the NTD of Fn might aid in Leptospira infection of a host organism by 
increasing the time it remains adhered to cells while simultaneously facilitating efficient 
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transmission within the host.  These intriguing results motivate further study of the role 
this disordered region plays in the pathogenesis of leptospiral infection. 
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CHAPTER 6 
BINDING AFFINITY TO THE GELATIN BINDING DOMAIN OF 
FIBRONECTIN IS ENHANCED BY THE IG-LIKE REPEAT DOMAINS OF 
LEPTOSPIRA LIG PROTEINS THROUGH MULTIVALENCY 
 
Introduction  
Microbial Surface Components Recognizing Adhesive Matrix Molecules 
(MSCRAMMs) are a group of proteins located on the surface of microbes (1). They are 
able to contribute to microbial adhesion by binding to extracellular matrixes (ECMs) of 
host cells and initiate infection (1). Fibronectin (Fn), a 220 kDa ECM that forms a dimer 
by disulfide linkage, is composed of three different modules and several different 
domains including an N-terminal domain (NTD), a gelatin-binding domain (GBD), a 
cell binding domain (CBD), a heparin binding domain II, and a fibrin binding domain II 
(2,3). Fn plays a pivotal role in bacterial-host interaction by interacting with 
MSCRAMMs (4). These MSCRAMMs may bind to NTD, GBD (5-7) or heparin 
binding domain II (8,9).  
 In the past, several potential ECM binding proteins of Leptospira spp. have been 
identified; these include Lig proteins (10-16), LipL32 (17-20), Leptospira 
endostatin-like proteins (Len) (21,22), Lsa21 (23) and TLYC(24). Lig proteins, 
including LigA, LigB and LigC, contain 13, 12, and 13 Ig-like domains, respectively 
(25-27). The N-terminal 630 amino acid residues of LigA and LigB are identical, but the 
C-termini are variable (25-27). Unlike LigA, LigB and LigC possess a 
non-immunoglobulin (Ig)-like region in their C-termini (26,27). Lig proteins also serve 
as vaccine candidates and diagnostic antigens (26,28-32). Lig proteins are members of 
MSCRAMMs due to their ability to bind fibronectin (Fn), laminin, collagen, fibrinogen, 
elastin, and tropoelastin of host cells (10-16). Moreover, LigBCen2, which contains 
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LigBCen2R, the partial 11th and full 12th Ig-like domains, and LigBCen2NR, the 
C-terminal 47 non-Ig-like region, binds to NTD and GBD of Fn with high affinity that is 
enhanced by calcium binding (11,16). In a recent report, LigBCen2NR is found to be a 
disordered protein and is able to fold upon NTD binding (13). 
      Multivalency has advantages over monovalency for binding affinity through 
avidity (33,34). The off-rate of a multivalent species is much slower than that of a 
monomer, therefore, avidity is higher, and this may be advantageous for ligand binding 
receptors that require dimerization for activity (35).  Because multivalency increases 
binding affinity through avidity, we engineered proteins containing 90 amino acid 
Ig-like repeats of the variable regions of LigA and LigB of Leptospira and studied their 
interaction with GBD of Fn.  In this study, LigBCen2R was found to interact with GBD, 
and Isothermal Titration Calorimetry (ITC) and surface plasmon resonance (SPR) were 
used to monitor the binding of GBD to Fn by proteins containing different numbers of 
90 amino acid Ig-like repeats of the variable region of LigA or LigB. In addition, the 
GBD binding activity expanded to most of the Ig-like repeats on the variable regions of 
LigA and LigB through multivalency. A large gain in affinity was achieved through an 
avidity effect, with the terminal domains, 13th or 12th Ig-like repeat of LigA or LigB 
(LigAVar7’-13 and LigBCen7’-12) enhancing binding affinity approximately 43 and 
24 fold, respectively compared to recombinant proteins without this terminal repeat.  
The enhanced avidity might be due to the compact structures formed in LigAVar7’-13 
and LigBCen7’-12 mediated by interdomain interaction. 
 
Materials and Methods 
Bacterial strains and cell culture 
Leptospira interrogans serovar Pomona (NVSL1427–35–093002) was used as 
previously described (34). All experiments were performed with virulent, low-passage 
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strains obtained by passage through golden syrian hamsters as previously described 
(34). Leptospires were grown in EMJH medium at 30oC for less than 5 passages and 
growth was monitored by dark-field microscopy. Madin–Darby canine kidney 
(MDCK) cells (ATCC CCL34) were cultured in Dulbecco minimum essential medium 
(DMEM) containing 10% fetal bovine serum (Gibco Laboratories, Grand Island, NY). 
Cells were grown at 37oC in a humidified atmosphere with 5% CO2. 
 
Reagents and antibodies 
rabbit anti-GST antibody was ordered from Molecular Probes (Eugene, OR). 
HRP-conjugated goat anti-rabbit antibody and HRP-conjugated streptavidin were 
ordered from KPL (Gaithersburg, MD). Alexa Fluor 488 C5 maleimide and 
tris-(-2-carboxyethyl) phosphine (TCEP) were purchased from Molecular Probe 
(Carlsbad, CA). Gelatin binding domain of human plasma fibronectin (GBD) and 
bovine serum albumin (BSA), Tris-HCl, calcium chloride, sodium phosphate dehydrate, 
and sodium chloride were ordered from Sigma-Aldrich (St. Louis, MO). D2O was 
ordered from Cambridge isotope Laboratories (Andover, MA) 
 
Plasmid construction 
All constructs used in this study were cloned into either a pGEX-4T-2 vector (GE 
Healthcare , Piscataway, NJ) or a pQE-30 vector (Qiagen, Alencia, CA) and purified as 
Glutathione-S-Transferase (GST) or Histidine tagged fusion proteins (Table 6.1 and 
Figure. 6.1) (15,16). To make all the above constructs, PCR reactions were performed 
by utilizing the primers described in Table 6.2. For constructing LigAVar7’-8, 
LigAVar7’-9, LigAVar7’-10, LigAVar7-11, LigAVar7’-12, LigAVar9, LigAVar10, 
LigAVar11, LigAVar12, and LigAVar13, primers were engineered to introduce a 
BamHI site at the 5’ end and a SalI site at the 3’ end of each fragment.  For constructing  
 Table 6.1 The sources of clones used in this study 
Clone Vector Source Tag Reference 
LigBCon pGEX4T2 Residues 1-630 of LigB from L. interrogans GST-tag 33 
LigAVar7’-8 pGEX4T2 Residues 631-765 of LigA from L. interrogans GST tag 51 
LigAVar7’-9 pGEX4T2 Residues 631-856 of LigB from L. interrogans GST tag This study 
LigAVar7’-10 pGEX4T2 Residues 631-897 of LigB from L. interrogans GST tag This study 
LigAVar7’-11 pGEX4T2 Residues 631-1038 of LigB from L. interrogans GST tag This study 
LigAVar7’-12 pGEX4T2 Residues 631-1140 of LigB from L. interrogans GST tag This study 
LigAVar7’-13 pGEX4T2 Residues 631-1224 of LigB from L. interrogans GST tag 33 
LigAVar9 pQE30 Residues 756-856 of LigA from L. interrogans Histidine tag 51 
LigAVar10 pQE30 Residues 847-946of LigA from L. interrogans Histidine tag 51 
LigAVar11 pQE30 Residues 938-1038 of LigA from L. interrogans Histidine tag 51 
LigAVar12 pQE30 Residues 1029-1140 of LigA from L. interrogans Histidine tag 51 
LigAVar13 pQE30 Residues 1131-1225 of LigA from L. interrogans Histidine tag 51 
LigBVar7’-8 pQE30 Residues 631-756 of LigB from L. interrogans Histidine tag 27 
LigBVar7’-9 pQE30 Residues 631-850 of LigB from L. interrogans Histidine tag This study 
LigBVar7’-10 pQE30 Residues 631-941 of LigB from L. interrogans Histidine tag This study 
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Table 6.1 (Continued) 
Clone Vector Source Tag Reference 
LigBVar7’-11 pQE30 Residues 631-1033 of LigB from L. interrogans Histidine tag This study 
LigBVar7’-12 pQE30 Residues 631-1124 of LigB from L. interrogans Histidine tag This study 
LigBCen pQE30 Residues 631-1417 of LigB from L. interrogans Histidine tag 32 
LigBVar9 pQE30 Residues 755-850 of LigB from L. interrogans Histidine tag 27 
LigBVar10 pQE30 Residues 846-941 of LigB from L. interrogans Histidine tag 27 
LigBVar11 pQE30 Residues 942-1028 of LigB from L. interrogans Histidine tag 27 
LigBCen2 pQE30 Residues 1014-1165 of LigB from L. interrogans Histidine tag 23 
LigBCen2R pGEX4T2 Residues 1014-1124 of LigB from L. interrogans GST-tag 24 
LigBCen2NR pGEX4T2 Residues 1120-1165 of LigB from L. interrogans GST-tag 24 
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Table 6.2 Primer Table 
Primer/Vector Sequence* 
LigAVar7’-8fp/pGEX4T2** GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-8rp GCGTCGACATTGAAGTAAGAATT 
LigAVar7’-9fp/pGEX4T2 GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-9rp GCGTCGACCTCAATAAGTTCCGC 
LigAVar7’-10fp/pGEX4T2 GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-10rp GCGTCGACCGAAACTACTTTAGC 
LigAVar7’-11fp/pGEX4T2 GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-11rp GCGTCGACGTAACGAAGAAGCGC 
LigAVar7’-12fp/pGEX4T2 GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-12rp GCGTCGACATTTACTATACCACT 
LigAVar9fp/pQE30*** GCGGATCCTACCGTTACTCCCGC 
LigAVar9rp GCGTCGACCTCAATAAGTTCCGC 
LigAVar10fp/pQE30 GCGGATCCTTATCCGTTACCGCA 
LigAVar10rp GCGTCGACCGAAACTACTTTAGC 
LigAVar11fp/pQE30 GCGGATCCTTCCAAGTTACTCCG 
LigAVar11rp GCGTCGACGTAACGAAGAAGCGC 
LigAVar12fp/pQE30 GCGGATCCTTGAATGTCACTCCA 
LigAVar12rp GCGTCGACATTTACTATACCACT 
LigAVar13fp/pQE30 GCGGATCCGTTACGGTTACGGAA 
LigAVar13rp GCGTCGACTTATGGCTCCGTTTT 
LigBCen7’-9fp/pQE30 CGCGGATCCATTGCTGAAATT 
LigBCen7’-9rp CGCCCTGCAGAATCGGAATTGG 
LigBCen7’-10fp/pQE30 CGCGGATCCATTGCTGAAATT 
LigBCen7’-10rp CGCCCTGCAGAAAATTTATTTTATT 
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Table 6.2 (Continued)  
Primer/Vector Sequence* 
LigBCen7’-11fp/pQE30 CGCGGATCCATTGCTGAAATT 
LigBCen7’-11rp CGCCCTGCAGGACCGTTATGTC 
LigBCen7’-12fp/pQE30 CGGCATGCATTGCTGAAATT 
LigBCen7’-12rp CGAAGCTTGTTTACTGTGAGAAT 
LigBCen2RW1073Cf**** TCTTCGGTTACATGTTCCAGCTCAAAT 
LigBCen2RW1073Cr ATTTGAGCTGGAACATGTAACCGAAGA 
6F1fp/pPICZα# CGGAATTCTGTGTCACAGACAGT 
6F1rp CGGCGGCCGCCTCTTGGCAGCTGAC 
1F22F2fp/pPICZα CGGAATTCACAGCTGTAACCCAG 
1F22F2rp CGGCGGCCGCGATTTCCTCGTGGG 
7F1fp/pET-THGT$ CGGAATTCTGCACAACCAATGAA 
7F1rp CGGCGGCCGCCTGATCTCGAAGCTG 
8F1fp/pET-THGT CGGAATTCTGCATTGTTGATGAC 
8F1rp CGGCGGCCGCTTGGTCGACGGGATC 
9F1fp/pET-THGT CGGAATTCTGCCAGGATTCAGAG 
9F1rp CGGCGGCCGCTGAGCTTGGATAGGT 
* The restriction enzyme cutting sites are underlined. ** GE Healthcare, Piscataway, NJ, 
*** Qiagen Inc., Volencia, CA, **** Primers used for site directed mutagenesis. # 
Invitrogen, Carlsbad, CA, $ Obtained from the Cornell protein production and 
characterization core facility, Cornell University. 
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Figure 6.1   A schematic diagram showing the structure of truncated (A) LigA, (B) 
LigB , and (C) Fn used in this study. 
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6F1, 1F22F2, 7F1, 8F1, and 9F1, primers were engineered to introduce an EcoRI site at the 
5’ end and a NotI site at the 3’ end of each fragment. For constructing LigBCen7’-9, 
LigBCen7’-10, LigBCen7’-11, LigBCen7’-12, primers were engineered to introduce a 
BamHI site at the 5’ end and a PstI site at the 3’ end of each fragment. For constructing 
LigBCen7’-12, primers were engineered to introduce a SphI site at the 5’ end and a 
HindIII site at the 3’ end of each fragment. PCR products were sequentially digested 
with BamHI and SalI, EcoRI and NotI, BamHI and PstI, or SphI and HindIII and then 
ligated into pQE30, pGEX-4T-2, pPICZα or pET-THGT cut with BamHI and SalI, 
EcoRI and NotI, BamHI and PstI or, SphI and HindIII, respectively as previously 
described (15,31). For LigBCen2RW1073C mutant construction, the manufacturer’s 
instructions of the Quickchange mutagenesis kit (Strategene, La Jolla, CA) were 
followed and has been described previously (15). 
 
GBD binding assays by ELISA 
1 μM of GBD or BSA (negative control and data not shown) in Tris buffer (25mM Tris 
and 150mM sodium chloride, pH 7.0) containing 100 μM of calcium chloride were 
coated onto microtiter plate wells as described previously (11). 100μL of different 
concentrations of GST fused LigBCon (negative control), LigBCen2 (positive control), 
LigBCen2R, or LigBCen2NR, (Figure. 6.2A), or biotinylated LigAVar7’-8, LigAVar9, 
LigAVar10, LigAVar11, LigAVar12, LigAVar13, LigBCen7’-8, LigBCen9, 
LigBCen10, LigBCen11, LigBCen7’-12 (positive control), LigAVar7’-13 (positive 
control), or LigCon (negative control) in Tris buffer containing 100 μM of calcium 
chloride were added subsequently (Figure. 6.3A and B). To measure the interaction of 
GBD and GST fusion proteins, rabbit anti-GST (1:200) and horseradish 
peroxidase-conjugated goat anti-rabbit IgG (1:1000) served as primary and secondary 
antibodies. To detect binding of the biotinylated proteins, HRP-conjugated streptavidin 
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(1:1000) was added to each well at RT for 1 hour prior to washing the wells thrice with 
TBST. The measurement of binding by ELISA was as described previously (15,16).  
To determine the dissociation constant (Kd), the data were fitted by the following 
equation using KaleidaGraph software (Version 2.1.3 Abelbeck software, Reading, PA), 
and the calculated Kd are listed in Table 6.3.  
 
 
Cell binding and inhibition assays by ELISA 
To detect the binding of truncated Lig proteins to MDCK cells, MDCK cells (105) 
were incubated with 0, 0.08, 0.16, 0.3125, 0.625, 1.25, 2.5, or 5 μM of biotinylated 
LigBCen (positive control), GST (negative control), or truncated Lig proteins in 100 
μL PBS for 1 h at 37℃ (Figure. 6.6A and B). For measuring the binding inhibition of 
Leptospira to MDCK cells by truncated Lig proteins, MDCK (105) cells were treated 
with 0, 0.08, 0.16, 0.3125, 0.625, 1.25, 2.5, or 5 μM of truncated Lig proteins, LigBCen 
(positive control), or GST (negative control) in 100 μL PBS for 1 h at 37℃ prior to the 
addition of Leptospira (107) for 6 h at 37℃ (Figure. 6.6C and D). To detect the binding 
of biotinylated Lig proteins, HRP-conjugated streptoavidine (1:1000 ×) was added 
subsequently. To measure the binding of Leptospira, hamster anit-Leptospira (1:200×) 
and HRP-conjugated goat anti-hamster IgG (1:1000×) were used as primary and 
secondary antibodies, respectively. The percentage of attachment was determined 
relative to the attachment of serovar Pomona on untreated MDCK cells. The 
measurement of binding by ELISA was as described previously (15,16). Each value 
represents the mean ± SEM of three trials in triplicate samples. Statistically significant 
(P < 0.05) differences are indicated by *. 
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Surface Plasmon Resonance (SPR) 
Association and dissociation rate constants for the interaction of Lig proteins and GBD 
were measured by SPR analysis performed with a Biacore 2000 instrument (GE 
Healthcare) at 25oC. 1.5μM of each His-tagged Lig protein, including LigAVar7’-8, 
LigVar10, LigAVar11, LigAVar12, LigAVar13, LigBCen7’-8, LigBCen9, or 
LigBCen2R in Tris buffer containing 100 μM calcium chloride, was immobilized on a 
NTA chip (GE Healthcare) conjugated with 500 μM nickel sulfate. Serial 
concentrations (0, 0.625, 1.25, 2.5, 5, 10, 20, 40μM) of GBD were injected into the flow 
cell at a flow rate of 5 μL/min over the immobilized Lig proteins. All experiments were 
duplicated. All sensogram data have been corrected by subtracting data from a control 
cell injected with Tris buffer containing 100 μM calcium chloride. Kinetic parameters 
were obtained by fitting the data to the one-step biomolecular association reaction 
model (1:1 Langmuir model) with the curve-fitting BIAevaluation software, version 
3.0. 
 
Isothermal Titration Calorimetry (ITC) 
The experiments were carried out with a CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25oC as previously described (15). In a typical 
experiment, the cell contained 1 ml of a GBD solution, 6F1, 1F22F2, 7F1, 8F1, or 9F1 and 
the syringe contained 250 μl of a solution of LigBCen2R, LigAVar7’-8, LigAVar7’-9, 
LigAVar7’-10, LigAVar7’-11, LigAVar7’-12, LigAVar7’-13, LigBCen7’-8, 
LigBCen7’-9, LigBCen7’-10, LigBCen7’-11, or LigBCen7’-12. The concentration of 
LigBCen2R and GBD were 127μM and 6μM. The concentration of GBD and truncated 
Lig proteins are detailed in Table 6.4. Both solutions were in Tris buffer containing 100 
μM of calcium chloride. The titration was performed as follows: 25 injections of 10 μl 
with a stirring speed of 250 rpm with a delay time between injections of 5min. Data 
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were analyzed using Titration Binding Work 3.1 software (Calorimetry Science Corp. 
Lindon, UT, USA) fitting them to an independent binding model.  
 
Steady State Fluorescence Measurement 
Steady state fluorescence emissions were measured on a Hitachi F7500 
spectrofluorometer (Hitachi. San Jose, CA). All spectra were recorded in correct 
spectrum mode of the instrument using excitation and emission band passes of 2 nm. In 
order to measure the binding of GBD to LigBCen2R, LigBCen2RW1073C was 
expressed and labeled with Alexa-488. The labeling of Alexa-488 to 
LigBCen2RW1073C by the interaction of the cystein of LigBCen2RW1073 with Alexa 
Fluor 488 C5 maleimide was performed following the manufacturer’s instructions 
(Molecular probe). For the GBD titration, 1.62, 3.12, 6.25, 12.5, 25μM of GBD in Tris 
buffer containing 100μM of calcium chloride was mixed with 1μM of Alexa-488 
labeled LigBCen2RW1073C in the same buffer. The fluorescence from Alexa-488 
probe of Alexa-488 labeled LigBCen2RW1073C was recorded at the excitation 
wavelength of 490 nm, and the emission wavelength ranged from 500 to 600nm. All 
spectra were recorded at 25oC after 5 minutes. Furthermore, the spectra of the various 
concentrations of GBD indicated above were also recorded and used to subtract the 
spectra of each Alexa-488 labeled LigBCen2RW1073C in the addition of certain 
concentrations of GBD. To determine the dissociation constant (KD), the fluorescence 
intensities at 518nm were recorded and fitted by the following equation using 
KaleidaGraph software (Version 2.1.3 Abelbeck software):  
  
Where Fmax is the fluorescence intensity of Alexa-488 labeled LigBCen2RW1073C 
protein in the absence of GBD, and Fmin indicates the fluorescence intensity of 
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Alexa-488 labeled LigBCen2RW1073C saturated with GBD.  In addition, F is the 
fluorescence intensity of Alexa-488 labeled LigBCen2RW1073C in the presence of 
various concentrations of GBD. All of the measurements were corrected for dilution and 
for inner filter effect.   
 
Dynamic Light Scattering (DLS) 
One mg per mL of LigAVar7’-8, LigAVar7’-9, LigAVar7’-10, LigAVar7’-11, 
LigAVar7’-12, LigAVar7’-13, LigBVar7’-8, LigBVar7’-9, LigBVar7’-10, 
LigBVar7’-11, or LigBVar7’-12 was dialyzed against prefiltered (0.22 μm Millipore 
filters) Tris buffer with 100 μM calcium chloride. The samples were placed in a 1mL 
plastic cuvette. The standard globular proteins including albumin (67,000 Da), 
ovalbumin (43,000 Da), chymotrypsinogen A (25,000 Da), ribonuclease A (13,700 Da), 
aprotinin (6,500 Da), or insulin chain B (3,400 Da) were used to generate the calibration 
curve of globular proteins. The automated measurements were collected with a 
Zetasizer Nano ZS instrument (Malvern Instruments Ltd., Worcestershire, United 
Kingdom), using a 2 min equilibrium delay at each measurement. The data were 
adjusted using the method of cumulants to obtain the hydrodynamic radius (Rh). The 
logarithms of the Rh values of standards and above proteins were plotted against the 
logarithm of the protein molecular weights to fit the equation  
 
where a and b are constants. 
 
Raman Spectroscopy 
LigAVar7’-12, LigAVar7’-13, LigBCen7’-11, LigBCen7’-12 or the mixture of certain 
Ig-like domains of LigA or LigB was concentrated with an Amincon ultrafiltration 
device (Millipore, Billerica, MA) to the final concentration as 3mg/mL determined by 
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UV absorption spectrophotometry and dialyzed against Tris buffer with 100μM of 
calcium chloride (36). For the experiments performed in D2O, the proteins were 
lyophilized, dissolved by D2O, and stored at 4oC for 20 hours prior to acquisition of 
Raman spectra. A 10μL aliquot of the protein solution was applied to a Renishaw InVia 
micro-Raman spectrophotometer using long-range 50× objective, 30sec. integration, 
and 10% laser power (785nm excitation; 8mW at 100%)(37). The spectra were 
corrected by subtracting the buffer and background. Peak height was normalized to 
1002cm-1 band of phenylalanine as the internal standard(36). 
 
Circular dichroism (CD) spectroscopy 
CD analysis was performed on an Aviv 215 spectropolarimeter (Lakewood, NJ) under 
N2 atmosphere. CD spectra were measured at RT (25oC) in a 1-cm path length quartz 
cell. Spectra of 10 μM of LigBCen2R, and LigBCen2RW1073C were recorded in Tris 
buffer with 100μM calcium chloride. Structural changes in LigBCen2R upon binding to 
the GBD of Fn were examined by analyzing changes in the CD spectrum. To determine 
the secondary structure, three far-UV CD spectra of all those proteins mentioned above 
were recorded from 190 to 250 nm for far-UV CD in 1 nm increments at 25oC. The 
background spectrum of buffer without protein was subtracted from the protein spectra. 
CD spectra were initially analyzed by the software accompanying the 
spectrophotometer. Analysis of spectra to extrapolate secondary structures was 
performed by Dichroweb (http://www.cryst.bbk.ac.uk/cdweb/html/home.html) using 
the K2D and Selcon 3 analysis programs (11,12). 
 
Transmission Electron Microscopy (TEM) 
10μM of a small drop of LigAVar7’-12, LigAVar7’-13, LigBCen7’-11, or 
LigBCen7’-12 was added to an extremely thin copper grid. After drying for 5 min,  
  
 
 
 
 
 
Table 6.3 The Dissociation constants and Kinetic data of GBD-Lig interactions determined by ELISA and SPR. 
The association and dissociation data of the interactions were fitted locally using one the step biomolecular reaction model (1:1 
Langmuir model : A + B AB), which resulted in optimum mathematical fits reflected by the lowest Chi values. The values for 
association rate constants (kon), dissociation rate constants (koff), and dissociation constants (KD) were calculated from the binding 
data by BIAevaluation software. 
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 Analyte kon koff KDa KDb 
 M-1S-1×103 S-1×10-3 M-1×10-6 M-1×10-6 
LigAVar7’-8 0.75±0.05 5.01±0.82 6.68±0.80 6.75±0.10 
LigAVar9 n.d.c n.d.c n.d.c n.b.d 
LigAVar10 1.19±0.43 5.06±0.25 4.25±0.72 3.94±0.32 
LigAVar11 1.19±0.49 5.99±0.13 5.04±0.32 4.70±0.24 
LigAVar12 2.36±0.38 6.78±0.84 2.87±0.30 2.44±0.87 
LigAVar13 0.51±0.09 5.30±0.43 10.40±2.53 10.96±0.41 
LigBCen7’-8 3.57±0.25 9.63±0.18 2.69±0.70 2.27±0.15 
LigBCen9 0.56±0.03 4.73±0.24 8.39±0.81 8.37±0.72 
LigBCen10 n.d.c n.d.c n.d.c n.b.d 
LigBCen11 n.d.c n.d.c n.d.c n.b.d 
LigBCen2R 4.83±0.54 9.23±0.24 1.91±0.40 1.89±0.22 
a determined by SPR 
b determined by ELISA 
c not determined 
d no binding
176 
 177
Figure 6.2  Determination of binding constant, kinetics and thermodynamics of the 
LigBCen2R/NTD interaction by ELISA, SPR, and ITC. (A) Binding of serial 
concentrations of LigBCen2NR to immobilized NTD by ELISA. Serial concentrations 
of GST-LigBCen2R, GST-LigBCen2NR, GST-LigBCen2 (positive control), or 
GST-LigCon (negative control) were added to 1μM of GBD or BSA coated wells 
(negative control, data not shown). (B) SPR analysis of LigBCen2R interacting with 
GBD. 1.5μM of Recombinant Histidine-tagged LigBCen2R was immobilized on the 
surface of a Ni-NTA chip. GBD in Tris Buffer containing 100μM CaCl2 at pH 7.5 
flowed through the chip and the concentrations of GBD ranged from 40 to 0.625μM 
(from top to bottom). The KD, kon, and koff were obtained from the average of duplicate 
experiments shown in Table 2. (C) Determination of the binding affinity by ITC. The 
cell contained 1 ml of GBD and the syringe contained 250 μl of LigBCen2R (upper 
panel). Heat differences obtained from 25 injections of LigBCen2R; (lower panel). 
Integrated curve with experimental data (◇) and the best fit (—). The thermodynamic 
parameters are shown as the average of duplicate experiments (KD = 1.80 ± 0.14μM, ΔH 
= -26.72 ± 2.40 kcal mol-1, TΔS = -18.91 ± 2.35 kcal mol-1 K-1), and the molar ratio of 
LigBCen2R to GBD is 1:1. (D) Fluorescence spectrum of Alexa-488 labeled 
LigBCen2RW1073C in the presence and absence of GBD.  One μM of Alexa-488 
labeled LigBCen2RW1073C in Tris buffer was excited at 485 nm. Aliquots of GBD 
from respective stock solutions were added. The figure shows Alexa488 fluorescence in 
the presence of 0, 1.62, 3.12, 6.25, 12.5, 25μM of GBD (Inner plot). The determination 
of KD of Alexa488 labeled LigBCen2RW1073C and GBD by monitoring the quenching 
fluorescence intensity of Alexa488 labeled LigBCen2RW1073C titrated by GBD. The 
emission wavelength recorded in this figure was 513nm, and KD was revealed by fitting 
the data point into the equation described in materials and methods (KD = 2.03±0.4μM).  
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negative staining was performed by adding 5μL methylamine tungstate to the protein 
samples. The sample was examined in a FEI Tecnai G2 T12 Spirit TEM STEM (FEI, 
Hillsboro, OR). Typically, the magnification was 50,000×. 
 
Statistical analysis 
Significant differences between samples were determined using the Student’s t-test 
following logarithmic transformation of the data. Two-tailed P-values were determined 
for each sample and a P-value <0.05 was considered significant. Each data point 
represents the mean + standard error of the mean (SEM) for each sample tested in 
triplicate.  An (*) indicates the result was statistically significant. 
 
Results 
GBD binds to LigBCen2R 
In order to fine map the GBD binding site of LigBCen2, LigBCen2 was truncated into 
LigBCen2R and LigBCen2NR (13).  LigBCen2R and LigBCen2NR were then tested 
to determine if they can bind to GBD.  LigCon, a conserved region of both LigA and B, 
was included as a negative control since it does not bind to Fn (11,12). GBD could 
immobilize LigBCen2R, but not LigBCen2NR (Figure. 6.2A). Moreover, ITC and SPR 
were also applied to measure the binding of LigBCen2R to GBD. The KD obtained from 
both experiments (ITC, KD = 1.80μM; SPR, KD = 1.91μM) agreed with the binding 
affinity of LigBCen2R-GBD obtained by ELISA (KD = 1.89μM) (Figure. 6.2B and C, 
Table 6.3). Moreover, the favorable enthalpy and unfavorable entropy obtained from 
the ITC experiment suggests the interaction is driven by enthalpy and mediated by 
hydrogen bonds or charge-charge interactions (Figure. 6.2C). Significant quenching 
(approximately16% decrease) was found in the Alexa-488 fluorescence spectra of 
Alexa-488 labeled LigBCen2RW1073C, a LigBCen2 mutant lacking its sole  
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Figure 6.3  Localization of the GBD-binding domains on Lig proteins. (A and B) 
Various concentrations (0, 0.3125, 0.625, 1.25, 2.5, 5, 10, 20μM) of biotinylated 
LigCon (negative control), and (A) LigAVar7’-13 (positive control), LigAVar7’-8, 
LigAVar9, LigAVar10, LigAVar11, LigAVar12, LigAVar13, (B) LigBCen7’-12 
(positive control), LigBCen7’-8, LigBCen9, LigBCen10, LigBCen11 were added to 
wells coated with 1μM of GBD or BSA (negative control and data not shown) in Tris 
buffer. The binding of biotinylated proteins to GBD was measured by ELISA. For all 
experiments, each value represents the mean± SEM of three trials in triplicate samples. 
Statistically significant (p＜0.05) differences compared to the negative control are 
indicated by an asterisk. (C and D) SPR analysis of Ig-like domains of Lig interacting 
with GBD 1.5 μM of Recombinant Histdine-tag (C) LigAVar7’-8, LigAVar10, 
LigAVar11, LigAVar12, LigAVar13, (D) LigBCen7’-8, LigBCen9, or LigBCen2R was 
immobilized on the surface of Ni-NTA chip. GBD in Tris Buffer containing 100μM 
CaCl2 at pH 7.5 was flowed through the chip and the concentration of GBD ranged from 
40 to 0.625 μM. Only the response sensograms of the 40 μM of GBD are shown. The KD, 
kon, koff were obtained from the average of duplicate experiments shown in Table 6.3. 
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tryptophan, when GBD was added with dose dependence confirming that GBD binding 
induces conformational changes in LigBCen2R (Figure. 6.2D). The undistinguished 
far-UV CD spectra of LigBCen2R and LigBCen2RW1073C (Figure. 6.9) and the KD of 
the interaction of GBD-LigBCen2RW1073C determined by florescence spectroscopy 
(KD = 1.93μM) is close to that of the GBD-LigBCen2R interaction determined above 
and rules out the possibility that the mutation alters the structure of LigBCen2R or the 
binding of LigBCen2R and GBD. 
 
Determination that Ig-like domains interact with GBD 
Since LigBCen2R containing the partial 11th and full 12th Ig-like domain of LigB shows 
GBD binding activity, we used ELISA to investigate whether the variable regions of 
LigA and LigB interact with GBD. As presented in Figure. 6.3A and B, LigAVar7’-8, 
LigAVar10, LigAVar11, LigAVar12, and LigAVar13 in LigA and LigBCen7’-8 and 
LigBCen9 of LigB are able to bind GBD (LigAVar7’-8, KD = 6.75μM; LigAVar10, KD 
= 3.94μM; LigAVar11, KD = 4.70μM; LigAVar12, KD = 2.44μM, LigAVar13, KD = 
10.96μM; LigBCen7’-8, KD = 2.27μM; LigBCen9, KD = 8.37μM) (Table 6.3). 
Furthermore, a similar KD obtained from SPR also confirms the binding of certain 
variable regions of LigA and LigB with GBD (LigAVar7’-8, KD = 6.68μM; LigAVar10, 
KD = 4.25μM; LigAVar11, KD = 5.04μM; LigAVar12, KD = 2.87μM, LigAVar13, KD = 
10.39μM; LigBCen7’-8, KD = 2.69μM; LigBCen9, KD = 8.44μM)(Figure. 6.3C and D, 
Table 6.3). These results suggest that the GBD also binds to certain variable regions of 
LigA and LigB. 
 
 
 
 
  
Table 6.4 Thermodynamic parameters for the interaction of GBD and truncated Lig proteins 
 [Lig Proteins] [GBD] ΔH TΔS KD ΔG n 1/n 
 μM μM kcal mol-1 kcal mol-1 K-1 μM kcal mol-1 Lig: GBD GBD: Lig
LigAVar7’-8 20 1 -28.65±5.14 -21.62 6.75±0.11 -7.02 1.010±0.04 0.99 
LigAVar7’-9 20 1 -29.24±4.75 -22.15 6.11±0.12 -7.08 1.020±0.08 0.98 
LigAVar7’-10 20 1 -25.32±2.27 -18.04 4.35±0.43 -7.28 0.510±0.02 1.96 
LigAVar7’-11 10 1 -22.08±3.31 -14.60 3.13±0.48 -7.47 0.335±0.05 2.98 
LigAVar7’-12 10 2 -30.79±1.74 -23.16 2.41±0.29 -7.63 0.255±0.09 3.92 
LigAVar7’-13 10 2.5 -70.96±0.73 -62.47 0.055±0.02 -9.85 0.204±0.04 4.90 
LigBCen7’-8 20 1 -20.37±3.62 -12.71 2.28±0.09 -7.66 0.985±0.03 1.01 
LigBCen7’-9 20 1 -21.05±5.02 -13.06 1.31±0.19 -7.99 0.520±0.05 1.92 
LigBCen7’-10 20 1 -26.72±1.92 -18.75 1.35±0.19 -7.97 0.510±0.04 1.96 
LigBCen7’-11 20 1 -29.01±4.23 -21.06 1.39±0.08 -7.95 0.479±0.08 2.08 
LigBCen7’-12 10 1 -57.93±2.74 -48.09 0.056±0.007 -9.84 0.320±0.018 3.12 
 
183 
 184
 
 
 
 
 
 
Figure. 6.4  ITC isotherms showing the binding of GBD to various length LigA 
constructs. The cell contained 1 ml of GBD and the syringe contained 250μl of (A) 
LigAVar7’-8, (B) LigAVar7’-9, (C) LigAVar7’-10, (D) LigAVar7’-11, (E) 
LigAVar7’-12, (F) LigAVar7’-13 (upper panel). Heat differences obtained from 25 
injections of truncated LigA (lower panel); Integrated curve with experimental data (◇) 
and the best fit (—). The thermodynamic parameters are shown as the average of 
duplicate experiments in Table 6.4.  
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Figure. 6.5  ITC isotherms showing the binding of GBD to various length LigB 
constructs. The cell contained 1 ml of GBD and the syringe contained 250μl of (A) 
LigBCen7’-8, (B) LigBCen7’-9, (C) LigBCen7’-10, (D) LigBCen7’-11, (E) 
LigBCen7’-12 (upper panel). Heat differences obtained from 25 injections of truncated 
LigB (lower panel); Integrated curve with experimental data (◇) and the best fit (—). 
The thermodynamic parameters are shown as the average of duplicate experiments in 
Table 6.4. 
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Figure. 6.6  Multivalent binding of Lig proteins to MDCK cells reduces leptospiral 
adhesion. (A and B) Binding of truncated Lig proteins to MDCK cells.  Various 
concentrations (0.08, 0.16, 0.3125, 0.625, 1.25, 2.5, 5μM) of biotinylated LigCon 
(negative control), LigBCen (positive control), and (A) LigAVar7’-13, LigAVar7’-12, 
LigAVar7’-11, LigAVar7’-10, LigAVar7’-9, LigAVar7’-8, (B) LigBCen7’-12, 
LigBCen7’-11, LigBCen7’-10, LigBCen7’-9, LigBCen7’-8 were added to MDCK cells 
(105), and binding was measured by ELISA. (C and D) Truncated Lig proteins inhibit 
the binding of Leptospira to MDCK cells. MDCK cells were incubated with various 
concentrations (0.08, 0.16, 0.3125, 0.625, 1.25, 2.5, 5μM) of biotinylated -LigB1706-1716, 
or biotin (negative control) (C) LigAVar7’-13, LigAVar7’-12, LigAVar7’-11, 
LigAVar7’-10, LigAVar7’-9, LigAVar7’-8, (D) LigBCen7’-12, LigBCen7’-11, 
LigBCen7’-10, LigBCen7’-9, LigBCen7’-8 prior to the addition of Leptospira (107). 
The adhesion of Leptospira to MDCK cells (105) was detected by ELISA. The reduced 
percentage of attachment was determined relative to the attachment of Leptospira on 
untreated MDCK cells. Each value represents the mean± SEM of three trials in triplicate 
samples. Statistically significant values (P<0.05) are indicted by *. 
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Ig-like domains of Lig proteins interact with GBD and MDCK cells through 
multivalency 
Multivalency is a strategy by which a pathogen’s virulence factors containing tandem 
repeated regions interact with their binding partners (33). In order to investigate if 
multivalency is adopted by the repeated Ig-like domains of Lig proteins to bind to GBD, 
the truncated proteins of each construct of the variable regions of LigA ad LigB were 
purified.  The stoichiometry and binding affinities of those truncated proteins and GBD 
were measured by ITC. As shown in Figure. 6.4 and 6.5 a slight increase in affinity 
toward GBD was observed as the number of Ig-like domains increased. (LigAVar7’-8, 
KD = 6.75μM; LigAVar7’-9, KD = 6.11μM; LigAVar7’-10, KD = 4.35μM; 
LigAVar7’-11, KD = 3.13μM; LigAVar7’-12, KD = 2.41μM; LigBCen7’-8, KD = 
2.28μM; LigBCen7’-9, KD = 1.31μM; LigBCen7’-10, KD = 1.35μM; LigBCen7’-11, KD 
= 1.39μM) (Table 6.4). Interestingly, the last Ig-like domain of both LigA and LigB 
contributed more than the other Ig-like domains because the GBD binding affinity of 
LigAVar7’-13 and LigBCen7’-12 increased 43 fold and 24 fold, respectively compared 
to that of LigAVar7’-12 and LigBCen7’-11, the truncated proteins lacking the last 
Ig-like domain (LigAVar7’-13, KD = 0.055μM; LigBCen7’-12, KD = 0.056μM). This 
suggests the possibility of cooperative binding in each LigAVar7’-13-GBD and 
LigBCen7’-12-GBD interaction. On the other hand, based on the one-site binding 
model, the 1/n values are in agreement with the stoichiometry of GBD to Lig predicted 
by the different binding affinities of various Ig-like domains reported above (Table 6.4 
and 6.4). These results indicate that Lig proteins bind to GBD through multivalency. In 
order to show the physiological relevance of the multivalent binding between Lig 
proteins and GBD, the interaction of truncated Lig proteins and MDCK cells was 
detected by ELISA. As shown in Figure. 6.6A and B, the more Ig-like domains included 
in the Lig constructs, the greater the binding of Lig proteins to MDCK cells.  
 189
 
 
 
 
 
 
 
 
Table 6.5 Estimated radii of recombinant truncated Lig proteins 
Truncated Lig 
proteins 
Rh Truncated Lig 
proteins 
Rh 
 nm  nm 
LigAVar7’-8 1.57 LigBCen7’-8 1.56 
LigAVar7’-9 2.35 LigBCen7’-9 2.46 
LigAVar7’-10 3.81 LigBCen7’-10 3.62 
LigAVar7’-11 5.25 LigBCen7’-11 5.37 
LigAVar7’-12 6.03 LigBCen7’-12 3.45 
LigAVar7’-13 3.79   
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Figure 6.7 Terminal Ig-like domains contribute to the compact structure of Lig proteins. 
(A) Dynamic light scattering of standard molecular mass markers, LigAVar7’-13, 
LigAVar7’-12, LigAVar7’-11, LigAVar7’-10, LigAVar7’-9, LigAVar7’-8, 
LigBCen7’-12, LigBCen7’-11, LigBCen7’-10, LigBCen7’-9, LigBCen7’-8. The 
hydrodynamic radius (Rh) is plotted as a function of the molecular weight of each 
individual protein on a log-log scale. The molecular weights of the standards are 
indicated in Materials and Methods, and the molecular weight of the truncated Lig 
proteins are indicated in Table 5. (B to E) Comparative Raman spectroscopy of 
full-length LigAVar7’-12, LigAVar7’-13, LigBCen7’-11, LigBCen7’-12 and a 
stoichiometic mixture of its composite domains. The Raman spectra of full length or 
stoichiometrically mixed separated Ig-like domains of (B) LigAVar7’-12, (C) 
LigAVar7’-13, (D) LigBCen7’-11, and (E) LigBCen7’-12 were recorded in D2O and 
H2O. 
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    Surprisingly, the terminal domains of Lig proteins also proved pivotal since the 
binding was strongly promoted when the Lig constructs contained the terminal Ig-like 
domains (Figure. 6.6A and B). Similarly, the inhibition of leptospiral adhesion to 
MDCK cells was also mediated by multivalent binding between Ig-like domains and 
cells due to the more significant inhibition when the cells were pre-mixed with the 
truncated Lig roteins including more Ig-like domains (Figure. 6.6C and D). The ability 
or Lg proteins to inhibit bind was also significantly increased when the constructs 
included the last Ig-like domains (Figure. 6.6C and D). 
 
The terminal Ig-like domains contribute to compact structures of Lig proteins 
LigAVar13 and LigBCen12, the terminal Ig-like domains of Lig proteins, play a very 
important role in GBD binding, but the GBD binding affinity of LigAVar13 or 
LigBCen12 (LigAVar13, KD=10.39±2.53 uM;  LigBCen2R (containing LigBCen12), 
KD= 1.91±0.40 uM) alone was not significantly different from that of other Ig-like 
domains   (Table 6.4). Therefore, the global structure of Lig proteins with the terminal 
domains plays an important role in the binding affinity of Lig protein and GBD.  As 
presented in Table 6.5, the hydrodynamic radii (Rh) of truncated Lig proteins and other 
standard globular proteins were determined by dynamic light scattering. In addition, the 
logarithm of Rh was plotted against the molecular mass of each standard using equation 
3 in Materials and Methods, and a calibration curve of each globular protein or each 
truncated Lig protein was constructed (Figure. 6.7A). According to the results in Figure. 
6.7A, the Rh values for LigAVar7’-13 and LigBCen7’-12 are comparably closing to that 
of the calibration curve of the globular protein standard suggesting both LigAVar7’-13 
and LigBCen7-12 are globular proteins that possesses  compact structures. However, 
the Rh of truncated Lig proteins without terminal Ig-like domains aligned in calibration 
curves distinct from the curve established by the Rh of the globular protein standards 
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indicating that the Lig proteins without the terminal Ig-like domains are not globular 
proteins (Figure. 6.7A and Table 6.5) but still possess a folded structure, especially with 
a rich β-strand due to the positive peak in 1241nm and 1244nm (amide III band) of the 
Raman spectra of LigAVar7’-12 and LigBCen7’-11, respectively (Figure. 6.7B and C). 
In order to test if interdomain interactions contribute to the compact structure of 
truncated Lig proteins with terminal domains, LigAVar7’-13, LigAVar7’-12, 
LigBCen7’-12, LigBCen7’-11, and stoichiometric mixture of Ig-like domains were 
pplied to Raman spectrophotometer in H2O or D2O. The deuterium-exchange reaction 
showed a more significant isotopic effect on the amide III band than the amide I band.  
To elucidate the secondary structure of the proteins (38), the amide III band in the 
spectra of truncated Lig proteins were specifically identified in this study. As shown on 
Figure. 6.7B, C, D, and E, the positive peak in 1241 cm-1, 1249 cm-1, 1244 cm-1, 1240 
cm-1 (amide III) observed in the spectra of full-length or stoichiometrically mixed 
LigAVar7’-12, LigAVar7’-13, LigBCen7’-11, and LigBCen7’-12 in H2O indicated that 
certain Lig truncations harbor a β-strand structure, which confirmed the previous 
findings for Ig-like domains of LigB (13,15,16,38). The positive peak at 938 cm-1, 939 
cm-1, 940 cm-1, 941 cm-1, and 986 cm-1 (amide III) in the spectra of Lig proteins 
measured in D2O support the conclusion that truncated Lig proteins contain a β-strand 
rich structure (Figure. 6.7B, C, D, and E)(38). Interestingly, the hydrogen-deuterium 
exchange (NH → ND) in full-length LigAVar7’-13 or LigBCen7’-12 was not as 
significant as that of stoichiometric mixture of Ig-like domains due to lower intensities 
of the β-strand marker,  1249 cm-1 and 1240 cm-1 in the spectrum of full-length 
LigAVar7’-13 or LigBCen7’-12 than stoichiometrically mixed ones (Figure. 6.7C and 
E), but similar results cannot be found in  LigAVar7’-12 or LigBCen7’-11 (1241 cm-1 
in LigAVar7’-12 1241 cm-1 in LigBCen7’-11)(Figure. 6.7B and D). The results indicate 
that H/D exchange is more protected in full-length LigAVar7’-13 and LigBCen7’-12 
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compared to stoichiometrically mixed or separated Ig-like domains. However, the 
protection is the same between full-length LigAVar7’-12 and LigBCen7’-11 and their 
stoichiometric mixtures of Ig-like domains. Overall, it proposed that more interdomain 
interactions exist in the truncated Lig proteins with terminal Ig-like domains, and the 
interdomain interactions might contribute to the compact structures of Lig proteins. 
 
Terminal Ig-like domains assist the formation of the round shaped Lig proteins 
To gain more insight into the contribution of the terminal Ig-like domains to the shape 
of Lig proteins, transmission electron microscope (TEM) was performed to detect the 
shape of LigAVar7’-12, LigAVar7’-13, LigBCen7’-11, and LigBCen7’-12. As shown 
on Figure. 6.8A and C, both LigAVar7’-12 and LigBCen7’-11 form elongated 
structures. However, the shape of LigAVar7’-13 and LigBCen7’-12, which include the 
terminal Ig-like domains, form round shapes consistent with the above results that the 
terminal domains aid the formation of compact structures of Lig proteins (Figure. 6.8B 
and D). 
 
Discussions 
Leptospira Ig-like (Lig) proteins are MSCRAMMs that assist pathogen 
attachment by binding to Fn, collagen, laminin, fibrinogen, elastin, and tropoelastin 
(11-16). We previously reported that the Lig binding site to the NTD of Fn was located 
on a disordered region containing 47 amino acids residues of a non-Ig-like domain of 
LigB called LigBCen2NR (13). In this study, LigBCen2R, containing the partial 11th 
and full 12th Ig-like domain of LigB, was demonstrated to interact with GBD of Fn 
(Figure. 6.2).  LigBCen2R showed no sequence similarity to any other GBD binding 
proteins, so a novel GBD binding motif is located on Ig-like domains of LigA and LigB 
variable regions. 
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Figure 6.8 Terminal Ig-like domains contribute to the round shape of Lig proteins. 
Transmission Electron Microscopic image of (A) LigAVar7’-12, (B) LigAVar7’-13, (C) 
LigBCen7’-11, and (D) LigBCen7’-12. (10nm scale bar). 
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Figure 6.9  W1073C mutation cannot affect the structure of LigBCen2R. Far-UV CD 
analysis of LigBCen2R and LigBCen2R. The molar ellipticity, Φ, was measured from 
190 to 250 nm for 10μM of each protein in Tris buffer with 100μM of calcium chloride. 
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     In addition to LigBCen2R, other variable regions of Ig-like domains of LigA and 
LigB were also found to possess GBD binding activities but with different strengths 
(Figure. 6.3 and Table 6.3). Furthermore, the diversified KD of different variable regions 
of the Ig-like domains of LigA and LigB characterized by distinct association rate 
constants (kon) (5×10-4 to 5×10-3 M-1S-1) but similar dissociation rate constants 
(koff)( 5×10-3 to 9×10-3 M-1S-1) suggests that there might be a conserved GBD binding 
motif completely or partially distributed in various variable regions of the Ig-like 
domains of Lig proteins (Table 6.3). This is not surprising because the amino acid 
sequences of each Ig-like domain of Lig proteins are divergent (26,27), and this 
inheritable difference in sequences influences not only the binding affinity to Fn but 
also to elastin and tropoelastin, as reported previously (15). In addition, similar 
phenomena were also described in the interaction between a staphylococcal Fn binding 
rotein, FnBPA, and NTD of Fn (39). On the other hand, the comparably weaker KD and 
smaller kon of GBD and Ig-like domains of LigA or LigB compared to other Fn binding 
proteins indicates a possible role of Lig proteins in transmission of Leptospira (40,41), 
and this phenomenon was also discovered in the NTD binding region of LigB, 
LigBCen2NR (13).  
     Multivalency is widely used by bacteria to mediate biomolecular interactions 
including carbohydrate-protein interaction or protein-protein interaction because it 
enhances the binding affinity and efficacy between two molecules (33,34). Recently, it 
was revealed that some bacterial Fn binding proteins with tandem repeated domains can 
also take advantage of these multivalent domains (39,42,43). For example, 11 Fn 
binding repeated regions (FnBR) in FnBPA and FnBPB of Staphylococcus aureus are 
associated with the binding of NTD of Fn with various affinities (39,42). Furthermore, 
the constructs covering three FnBRs of FnBPA have 44 to 250 fold greater affinity to 
NTD than that of a construct containing just two FnBRs (D1-2, KD = 0.25μM; D2-3, KD 
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= 0.044μM; D1-3, KD = 0.001μM) (42). In this study, we found that most of the variable 
regions of LigA and LigB could collaborate to interact with GBD (Figure. 6.4 and Table 
6.2), but the slight enhancement of binding affinity contributed by each construct was 
roughly dependent on the increased number of Ig-like domains it contained (Figure. 6.4, 
6.5, and Table 6.4). It is inferred that Lig proteins bind to GBD through both 
multivalency and a cooperative binding model. On the other hand, the Ig-like domains 
of Lig proteins collaborated to make attachment to MDCK cells more efficient (Figure. 
6.6). Thus, these results indicate multivalent binding of Ig-like domains of Lig proteins 
to not only Fn but also other ECMs such as elastin, laminin, and collagen. Previously, 
the repeat domains of Eap (extracellular adherence protein) from Staphylococcus 
aureus were found to  cooperatively assist bacterial aggregation, adherence, and host 
cell invasion (44). Multivalent EspFU repeats are required to induce the efficient 
activation of actin polymerization to facilitate the entry of Escherichia coli (33). 
Therefore, multivalent binding of bacterial proteins could be a convergent strategy of 
different pathogenic bacteria and this strategy may play a pivotal role in the pathogensis 
bacterial infection.  
      Surprisingly, Lig proteins lacking the last Ig-like domain bound to GBD much 
more weakly than the constructs containing the whole variable domain (LigAVar7’-12, 
KD = 2.41 μM; LigAVar7’-13, KD = 0.055 μM; LigBCen7’-11, KD = 1.39 μM; 
LigBCen7’-12, KD = 0.056 μM)(Figure. 6,4E and F, Figure. 6.5D and E, Table 6.3), but 
the binding affinity between GBD and the last Ig-like domain of LigA or LigB, 
LigAVar13 or LigBCen2R (LigAVar13, KD = 10.39 μM; LigBCen2R, KD = 1.91 
μM)(Figure. 6.5 and Table 6.3) was low. Clearly, the terminal domain of Lig protein 
serves an important role but is not required for GBD binding.  In addition, the increased 
affinity of LigAVar7’-13-GBD or LigBCen7’-12-GBD could be attributed to the 
precipitously reduced enthalpy compared to LigAVar7’-12-GBD or 
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LigBCen7’-11-GBD (Table 6.4). Interestingly, the structural differences of the Lig 
constructs with or without terminal domain were also revealed by DLS, Raman 
spectrometry, and TEM, and all indicated that Lig protens with the terminal Ig-like 
domains exhibit compact structures attributable to interdomain interactions (Figure. 6.7 
and 6.8). In a previous study, multiple repeat domains of Eap from Staphylococcus 
aureus could form an elongated but structured conformation mediated by interdomain 
interaction (45). Thus, the structure of protein-ligand interactions requires substantial 
cooperative interdomain interaction. In addition, this specific compact structure may be 
important for physiological functions of Lig proteins since the construct with the 
terminal domains (LigAVar7’-13 and LigBCen7’-12) possess a high affinity binding to 
GBD and MDCK cells described above (Table 6.4 and Figure. 6.6). It also suggests that 
the conformation changes of both LigAVar7’-13 and LigBCen7’-12 made them easier 
to access GBD resulting in a greater reduction in enthalpy due to more charge-charge 
interactions or hydrogen bonds formed between Lig proteins and GBD. 
      Fibronectin serves different roles mediated by distinct domains and isoforms. 
Two Fn isoforms include soluble plasma Fn and insoluble cellular Fn (2,3). 
MSCRAMMs are a group of proteins that allow pathogens to either attach on host cells 
by binding to cellular ECMs or to be decorated by plasma Fn to evade the host immune 
response in the blood stream (1). Multivalency, which promotes higher binding avidity 
and efficiency, has been described for some MSCRAMMs such as the FnBR of SfbI of 
Streptococcus pyogenes and FnBPA or FnBPB of Staphylococcus aureus (39,42,43). 
Thus, Leptospira Lig proteins, which possess 90 amino acid Ig-like repeated domains 
that bind to Fn, could be reasonably inferred to serve a similar role. Recently, a novel 
role for MSCRAMMs was ascribed to a 70kDa domain that includes the NTD and GBD 
of Fn. Both the NTD and GBD contain IGD motifs, called migration stimulating factor 
(MSF) located on 3F1, 5F1, 7F1, and 9F1, which mediate fibroblast migration (46,47). 
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Whether Lig proteins aid Leptospira spp. infection through this strategy waits to be 
determined.    
       In conclusion, we have fine mapped the GBD binding sites on LigBCen2 and 
found GBD binds to LigBCen2R, the partial 11th and full 12th Ig-like domains.  
Furthermore,  most of the individual Ig-like domains from the variable region of Lig A 
and LigB were also bound by GBD but with divergent affinities. Multivalent binding 
was proved to mediate the GBD-Lig proteins interaction and MDCK cell adhesion, and 
the terminal Ig-like domain serves a role for the formation of compact and round 
structures and a substantial but nonessential role for the interaction. Further studies on 
the function of Lig proteins interacting with GBD are needed and are currently being 
investigated in our laboratory. 
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CHAPTER 7 
FIBRONECTIN-BINDING ACTIVITY ON A SURFACE-EXPOSED DOMAIN 
WITHIN THE C-TERMINAL VARIABLE REGION OF LEPTOSPIRA 
INTERROGANS LIGB PROTEIN 
 
Introduction 
Leptospirosis, caused by infection with pathogenic Leptospira spp., is a serious 
zoonosis with world-wide distribution [1]. Leptospira (from the Greek leptos, “thin”, 
and the Latin spira, “coil”) are thin, filamentous (0.1-0.2 μm wide x 6-12 μm long) 
spirochetes which can be transmitted to people and animals both by direct and indirect 
contact [2]. These spirochetes usually penetrate through mucosal surfaces and/or skin 
wounds and disseminate to several organs, especially the kidney, liver and lungs. 
Infection may lead to Weil’s disease, which results in liver failure (jaundice), renal 
failure (nephritis), pulmonary hemorrhage and/or meningitis [2]. Human leptospirosis is 
often waterborne, and most commonly occurs in tropical areas of the world [2] However, 
studies indicate that leptospirosis is on the rise in the United States, particularly among 
individuals exposed to the pathogen through recreational swimming or through 
exposure to infected urban rat populations [3; 4].  
Many microbial pathogens produce Microbial Surface Components Recognizing 
Adhesive Matrix Molecules (MSCRAMM) to facilitate their colonization of host 
tissues during initial infection [5]. Pathogenic leptospires bind to mammalian cells, such 
as MDCK cells [6], often via the extracellular matrix (ECM) [7; 8]. Several adhesion 
molecules have been identified from Leptospira spp. including a 36 kDa protein that 
binds Fn [9], a leptospiral endostatin-like protein (Len) that binds to Fn and laminin [10; 
11], Lsa21 and LipL32 which bind to Fn, laminin and collagen [12-14], and Lig proteins, 
which bind to Fn, laminin, collagen, fibrinogen, elastin, and tropoelastin [15-17].  
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 Leptospiral immunoglobulin-like proteins, LigA and LigB, possess 12 and 13 
immunoglobulin-like (Ig-like) domains, respectively [18-20]. Such Ig-like repeats are 
also found in known bacterial adhesion proteins including invasin from Yersinia 
pseudotuberculosis and intimin from Escherichia coli [18-20]. A key environmental 
signal, i.e., osmolarity, controls the expression of LigA and LigB, enabling pathogenic 
Leptospira to bind to host cells [21; 22]. The binding of LigB to Fn is also modulated by 
calcium [23]. These studies indicate that Lig proteins are pivotal virulence factors of 
pathogenic Leptospira spp.  
In previous studies, LigB has been shown to possess Fn-binding activity [15; 16; 
23; 24] which mediates adhesion of Leptospira bacteria to host cells [16; 24]. Moreover, 
high and low affinity Fn-binding sites were located on LigB within the LigBCen and the 
C-terminal variable (LigBCtv) regions (Figure. 7.1A), respectively [16; 24]. In this 
study, we have further identified the exact location of  Fn binding site of LigBCtv to 
five amino acid regions  from 1708 to1712, with the sequence LIPAD. These residues, 
located in a surface-exposed domain, are also conserved on LigB and LigC derived 
from other pathogenic Leptospira serovars. Furthermore, this sequence binds to the 15th 
type III module of Fn, a novel binding site for bacterial Fn-binding proteins. The 
kinetics of the interaction are strikingly slow, with an off rate (koff = 0.0129 Sec-1, Figure. 
7.7) far below typical rates for protein-protein interactions and near the range of rates 
for drugs, such as inhibitors of HIV-1 protease [25]. In vitro binding assays yield a KD 
of 8.06 ± 0.11 μM of LigB1706-1716 for Fn, and pretreatment of MDCK cells with 
LigB1706-1716, which includes the LIPAD Fn-binding site, inhibits leptospiral binding by 
39%. This significant inhibition by a short peptide demonstrates the importance of this 
sequence in adhesion of the pathogen to target tissues.  
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Figure 7.1  Identification of the LigB C-terminal Fn-binding region and its Fn-binding 
residues.  (A). A schematic diagram showing the structure of LigB and the truncated 
LigB C-terminal regions including LigBCtv, LigBCtv1, LigBCtv2, LigBCtv3, and 
LigBCtv4 used in the Fn-binding assay. (B). The Fn-binding activity of LigBCtv1, 
LigBCtv2, LigBCtv3, and LigBCtv4 regions. (C). The Fn-binding activity of the 
peptides (30 mers) corresponding to the amino acids of LigBCtv. (D). The synthetic 
peptide sequences (11 mers) with overlapping regions used to identify the essential 
amino acids (indicated in bold) required for Fn-binding. (E). The synthetic peptides as 
indicated in D used in the Fn-binding assays. (F). wild-type (LigB1706-1716) and mutant 
(LigBL1708A, LigBI1709A, LigBP1710A, and LigBD1712A) peptides used in the identification 
of the essential amino acids binding to Fn. Various concentrations (40μM, 20μM, 10μM, 
5μM, 2.5μM, 1.25μM, 0.625μM) of each tested biotinylated-protein or -peptide, 
-BBK3256-205 (positive control; B, C, E, and F), -LigBCon (negative control; B) or 
-scrambled peptide (negative control; C, E and F) were used in this study.  The binding 
of each of these proteins or peptides to Fn was measured by ELISA, and each value 
represents the mean ± SEM of three trials in triplicate samples (B, C, E, and F). 
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Material and Methods 
Bacterial strains and Cell Culture 
L. interrogans serovar Pomona (NVSL1427-35-093002) was used as previously 
described [35]. All experiments were performed with virulent, low-passage strains 
obtained by passage in golden syrian hamsters as previously described [35]. Leptospires 
were grown in EMJH medium at 30 oC for less than 5 passages; growth was monitored 
by dark-field microscopy. A high passage culture of this strain (50 in vitro passages) 
was also used. Madin-Darby canine kidney (MDCK) cells (ATCC CCL34TM) were 
cultured in Dulbecco’s minimum essential medium (DMEM) containing 10% fetal 
bovine serum (GIBCO Laboratories, Grand Island, N.Y.). Cells were grown at 37oC in a 
humidified atmosphere with 5% CO2. 
 
Reagents and antibodies 
Horseradish peroxidase (HRP)-conjugated goat anti-hamster antibody and 
HRP-conjugated goat anti-mouse antibody were purchased from Zymed (San Diego, 
CA). HRP conjugated streptavidin was purchased from Biosource (Camarillo, CA). 
Alexa 594 conjugated goat anti-hamster antibody, Alexa 488-conjugated goat 
anti-hamster antibody, Alexa 647 conjugated goat anti-rabbit antibody, and FITC 
conjugated streptavidin were purchased from Molecular Probes (Eugene, OR). 120 kDa 
cell-binding domain (CBD: F1904) or 40 kDa domain containing heparin-binding 
domain and type III module 15 (40 kDa; F1903) of Fn were purchased from Chemicon 
International (Temecula, CA). Rabbit anti-LipL32 antibody were prepared by 
intramuscular inoculation with 100 µg of recombinant LipL32 in Freund’s complete 
adjuvant (first vaccination) followed by 100 µg intramuscularly in Freund’s incomplete 
adjuvant (booster) three weeks later. Three weeks after the second booster, the rabbit 
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was sacrificed and serum was collected. Anti-L. interrogans antibodies were prepared 
in hamsters from the challenge controls [35]. The  anti-LigBCen and LigBCtv 
antibodies were prepared in hamsters as previously described [36]. N-terminal domain 
(NTD) or gelatin-binding domain (GBD) of Fn were purchased from Sigma (St. Louis, 
MO), and Keyhole limpet haemocyanin (KLH) and biotin labeling kit were purchased 
from Pierce (Rockford, IL). Full length human plasma fibronectin was purchased from 
GIBCO (Carlsbad, CA). Heparin was purchased from MP biomedicals (Solon, OH). 
 
Plasmid construction and protein purification 
 Rat 12th-13th, 14th, or 15th type III modules were purified as MBP fusion proteins 
(Figure. 7.5A) [40]. The DNA fragments of LigBCon and BBK32 (AA 56-205) were 
inserted into pGEX4T2 (Amersham Pharmacia Biotech, Piscataway, NJ) and pQE30 
(Qiagen, Valencia, CA), respectively [35]. LigBCtv sequence was analyzed with Jpred 
to predict the secondary structure for truncation construction [49]. Constructs for the 
expression of GST-fused with LigBCtv1 (AA 1418-1632), LigBCtv2 (AA 1633-1889), 
LigBCtv3 (AA 1633-1723) and LigBCtv4 (AA 1724-1889) were generated using the 
vector pGEX-4T-2 (Figure. 7.1A). Relevant fragments of DNA were amplified by PCR 
using primers (Table 7.1) based on the ligB sequence [19]. Primers were engineered to 
introduce a BamHI site at the 5’ end of each fragment and a stop codon followed by a 
SalI site at the 3’ end of each fragment, except LigBCtv1. For LigBCtv1, primers were 
engineered to introduce a SalI site at the 5’ end of each fragment and a stop codon 
followed by a NotI site at the 3’ end. PCR products were digested sequentially with 
BamHI /SalI or SalI /NotI for the indicated fragment and then ligated into pGEX-4T-2 
cut with BamHI/SalI or SalI/NotI, respectively. In this study, we purified the soluble 
form of the four GST fusion peptides from E. coli as described earlier [19; 20].   
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Table 7.1  Primers.   
Primer Sequence 
LigBCtv1fp GTCGACTCAAGCAGCTCGATTC 
LigBCtv1rp GCGGCCGCTTATATTCCCACA 
LigBCtv2fp GGATCCGATTCTCTATTCGTT 
LigBCtv2rp GTCGACTTATTGATTCTGTTG 
LigBCtv3fp GGATCCGATTCTCTATTCGTTTTT 
LigBCtv3rp GTCGACTTATCCGTTAAATTCTGC 
LigBCtv4fp GGATCCAGATTGTATGTAACAAGA 
LigBCtv4rp GTCGACTTATTGATTCTGTTGTCT 
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Binding assays by ELISA 
To determine the binding of truncated LigB (LigBCtv1, LigBCtv2, LigBCtv3, or 
LigBCtv4) or LigB peptides to Fn, 1 μg of Fn or BSA (negative control) was coated 
onto microtiter plate wells as previously described [16; 24]. The plates were incubated 
at 4oC for 16 h and subsequently blocked with blocking buffer (50 μl/well) containing 
3% BSA in PBS at room temperature (RT) for 2 h. Then, various concentrations (0.625, 
1.25, 2.5, 5, 10, 20, 40 μM) of biotinylated LigB truncated protein, LigB peptide, (as 
indicated in Figure. 7.1B, C, E, F and 7.5), scrambled peptide (negative control, as 
indicated in Table 7.2), BBK32 (56-205) or LigBCon was added to each microtiter plate 
wells for 1 hour at 37oC. BBK32 (56-205) or LigBCon serve as positive and negative 
control due to the strong or no Fn-binding activities reported previously [15; 14; 50]. To 
measure the binding of biotinylated LigB protein, HRP-conjugated streptavidin was 
added into microtiter plate wells (1:1,000). 
To identify the binding site of LigB1706-1716 on Fn, 1 μg of each of full length Fn, NTD, 
GBD, CBD, 40 kDa domain of Fn, or MBP fused with 12th- 13th type III modules 
(MBP-12-13F3), 14th type III modules (MBP-14F3), or 15th type III modules (MBP-15F3) 
of Fn were coated onto microtiter plate wells. 1 μg of BSA or maltose binding protein 
(MBP) was coated as a negative control. Then, various concentrations (as indicated in 
Figure. 7.6B and C) of biotin conjugated LigB1706-1716 (biotin-LigB1706-1716) or biotin 
(negative control, data not shown) were added to microtiter plate wells. To measure the 
binding of LigB1706-1716 to MDCK cells, MDCK cells (105) were incubated with various 
concentrations (as indicated in Figure. 7.3 A.) of biotin-LigB1706-1716 or biotin (negative 
control) in 100 μl PBS for 1 hour at 37oC. To measure the binding inhibition of 
Leptospira to MDCK cells treated with LigB1706-1716, MDCK cells (105) were pretreated 
with various concentrations (as indicated in Figure. 7.3 B.) of biotin-LigB1706-1716 or 
biotin (negative control) in 100 μl PBS for 1 hour at 37oC. Then, Leptospira (107) were 
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added to each well and incubated for 6 hours at 37oC. Following incubation, the plates 
were washed three times with phosphate-buffered saline (PBS) containing 0.05% 
Tween-20 (PBST). To measure the binding of Leptospira, hamster anti-Leptospira 
(1:200) and HRP-conjugated goat anti-hamster IgG (1:1,000) were used as primary and 
secondary antibodies, respectively. To detect the binding of biotin-LigB1706-1716 or 
biotin to Fn or MDCK cells, HRP conjugated streptavidin (1:1,000) was added and 
incubated for 30 min at 25oC. After washing the plates thrice with PBST, 100μL of 
TMB (KPL, Gaithersburg, MD) was added to each well and incubated for 5 min. The 
reaction was stopped by adding 100 μl of 0.5% hydrofluoric acid in each well. Each 
plate was read at 630 nm using an ELISA plate reader (Bioteck EL-312, Winoski, VT). 
Each value represented the mean ± SEM of three trials in triplicate samples. Statistically 
significant (P<0.05) differences are indicated by asterisks. In order to determine the 
dissociation constant (KD), the data were fitted by the following equation using 
KaleidaGraph software (Version 2.1.3 Abelbeck software). The KD value represents the 
mean ± SEM of three trials in triplicate samples. 
 
 
Binding assays by confocal laser-scanning microscopy (CLSM) 
To determine the binding inhibition of Leptospira to MDCK cells by LigB1706-1716 
by CLSM, MDCK cells (106) were preincubated with 10 μM of biotin-LigB1706-1716 or 
biotin (negative control) as previously described [24]. Untreated MDCK cells served 
as negative control as well (data not shown). To quantify the attachment of Leptospira 
(Figure. 7.3C), hamster anti-Leptospira antibodies (1:250) served as the primary 
antibody, and Alexa 594-conjugated goat anti-hamster IgG (1:250) was used as the 
secondary antibody. To reveal the binding of biotin-LigB1706-1716 or biotin, 150μl of 
FITC-conjugated streptavidin was added (1:250). Fixation and immunofluorescence 
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staining were followed as previously described [24]. For measuring the reduced 
attachment of Leptospira to biotin-LigB1706-1716 treated MDCK cells, three fields were 
selected to count the number of binding organisms. All studies were repeated three 
times and the number of Leptospira attached to the MDCK cells were counted by an 
investigator blinded to the treatment group. The value of reduced leptospiral 
attachment represents the mean ± SEM of three trials performed in triplicate samples.  
 
Generation of polyclonal antibodies against LIPAD-containing peptides 
  Keyhole limpet haemocyanin (KLH) conjugated LigB-derived peptides LigB 
AA 1698-1712 (LigB1698-1712), LigB AA 1703-1717 (LigB1703-1717), and LigB AA 
1708-1722 (LigB1708-1722) were ordered from Genemed Synthesis (San Antonio, TX). 
Ten female BALB/c mice were immunized intramuscularly once with a cocktail (10 μg 
of each peptide) of three conjugated peptides (LigB1698-1712, LigB1703-1717, and 
LigB1708-1722) in Freud’s complete adjuvant and twice with these three conjugated 
peptides in Freud’s incomplete adjuvant. After that, the mice were immunized one 
more time with a single conjugated peptide (LigB1703-1717) in Freud’s incomplete 
adjuvant.  
Two weeks after the second booster, all mice were sacrificed and the sera were 
collected. All  the experimental work was conducted in compliance with the 
regulations, policies, and principles of the Animal Welfare Act, the Public Health 
Service Policy on Humane Care and Use of Laboratory Animals used in Testing, 
Research, and Training, the NIH Guide for the Care and Use of Laboratory Animals 
and the New York State Department of Public Health. 
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Determining whether LIPAD-containing peptide was surface-exposed by CLSM  
  Both low passage and high passage L. interrogans serovar Pomona were 
harvested from EMJH medium, pelleted by centrifugation and washed once with PBS. 
108 bacteria were suspended in 100 μL of 0.3% BSA in PBS and placed on glass culture 
slides. Bacteria were fixed in 2% paraformaldehyde for 60 min at room temperature 
(RT). For antibody labeling, fixed bacteria were incubated in PBS containing 0.3% 
BSA for 10 min at RT. Rabbit anti-LipL32 antibody (1:250), mouse anti-LigB1703-1717 
antibody (LigB peptide pAb; 1:250), and hamster anti-LigBCen and LigBCtv antibody 
(1:250) served as primary antibodies. Alexa 647-conjugated goat anti-rabbit IgG, Texas 
Red-conjugated goat anti-mouse IgG, and Alexa 488-conjugated goat anti-hamster IgG 
were used as secondary antibodies (1:250). The glass slides were mounted with 
coverslips using Prolong Antifade (Molecular Probe, Eugene, OR) and viewed with a 
60x objective by CLSM (Olympus, America, Inc., Melville, NY). The settings were 
identical for all captured images. Images were processed using Adobe Photoshop CS2. 
 
Fluorescence Spectrometry 
Fluorescence emission spectra were measured on a Hitachi F4500 
spectrofluorometer (Hitachi. San Jose, CA). All spectra were recorded in correct 
spectrum mode of the instrument using excitation and emission band passes of 5 nm. 
The intrinsic Trp fluorescence of protein was recorded by exciting the solution at 295 
nm and measuring the emission in the 305-400 nm regions. For LigB1706-1716 titration, 
0.625, 1.25, 2.5, 5, 10, 20, 40 μM of LigB1706-1716 was mixed with 1 μM of 15th type III 
module of Fn and spectra were recorded after 5 minutes. In order to determine the 
dissociation constant (KD), the fluorescence intensities at 350 nm were recorded and 
fitted in following equation using KaleidaGraph software (Version 2.1.3 Abelbeck 
software).  
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where Fmax is the fluorescence intensity of 15F3 in the absence of LigB1706-1716 and Fmin 
is the fluorescence intensity in the presence of 40 μM of LigB1706-1716. In addition, F is 
the fluorescence intensity in the presence of various concentrations of LigB1706-1716. All 
of the measurements were corrected for dilution and for inner filter effect.  
 
Stopped-flow Measurements 
Stopped-flow measurements were performed using a KinTek stopped flow system 
(Austin, TX) with 1-ms dead time. Protein Trp fluorescence emission above 320 nm 
was monitored using an excitation wavelength of 295 nm. A cut-off filter was used to 
prevent the detection of fluorescence signal below 320 nm. The observation cell was 
maintained at 25 °C during the stopped-flow measurements. The stopped-flow 
experiments were performed by mixing Fn 15th type III modules (15F3) in a PBS buffer 
after rapidly mixing with 25, 50, 100, 200, or 400 μM of LigB1706-1716; the time course of 
fluorescence intensity change was recorded by computer data acquisition. In each 
experiment 1000 pairs of data were recorded, and sets of data from three experiments 
were averaged. The apparent observed rate (kobs) was obtained by fitting the 
stopped-flow trace (average of five repeated runs) with a single exponential equation as 
shown follows. 
  
 
where Ft is the fluorescence observed at any time, t, and A is the signal amplitude. F∞ is 
the final value of fluorescence, and kobs is the observed first order rate constant. In  
 
 Table 7.2. Peptides used in this study 
Peptide name Amino acid no. Source of sequence Residues 
LigB1633-1662 AA 1633-1662 LigB / L. interrogans serovar Pomona DSLFVFKEKLYAANGGFPNSLHNGSIIHST 
LigB1658-1687 AA 1658-1687 LigB / L. interrogans serovar Pomona IIHSTSANPSPCEGINRCSSWKDTAPRSNP 
LigB1683-1712 AA 1683-1712 LigB / L. interrogans serovar Pomona PRSNPKWHNSPHNNWFSLELTKYRNLIPAD 
LigB1708-1723 AA 1708-1723 LigB / L. interrogans serovar Pomona LIPADKAFSQFAEFNG 
LigB1688-1698 AA 1688-1698 LigB / L. interrogans serovar Pomona KWHNSPHNNWF 
LigB1694-1704 AA 1694-1704 LigB / L. interrogans serovar Pomona HNNWFSLELTK 
LigB1698-1707 AA 1698-1707 LigB / L. interrogans serovar Pomona FSLELTKYRN 
LigB1700-1710 AA 1700-1710 LigB / L. interrogans serovar Pomona LELTKYRNLIP 
LigB1706-1716 AA 1706-1716 LigB / L. interrogans serovar Pomona RNLIPADKAFS 
LigB1711-1720 AA 1711-1720 LigB / L. interrogans serovar Pomona ADKAFSQFAE 
LigB1713-1722 AA 1713-1722 LigB / L. interrogans serovar Pomona KAFSQFAEFN 
LigB1714-1723 AA 1714-1723 LigB / L. interrogans serovar Pomona AFSQFAEFNG 
LigB1698-1712 AA 1698-1712 LigB / L. interrogans serovar Pomona FSLELTKYRNLIPAD 
LigB1703-1717 AA 1703-1717 LigB / L. interrogans serovar Pomona TKYRNLIPADKAFSQ 
LigB1708-1722 AA 1708-1722 LigB / L. interrogans serovar Pomona LIPADKAFSQFAEFN 
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Table 7.2 (Continued) 
Peptide name Amino acid no. Source of sequence Residues 
LigBharjo1713 AA 1713-1723 LigB / L. borgpetersenii serovar Hardjo-bovis RDLIPADKAFS 
LigC1773-1783 AA 1773-1783 LigC / L. interrogans serovar Pomona YNLIPGDKAFA 
LigBL1708A   RNAIPADKAFS 
LigBI1709A   RNLAPADKAFS 
LigBP1710A   RNLIAADKAFS 
LigBD1712A   RNLIPAAKAFS 
LigB1708-1723 
scrambled 
  LASEGIDFANAKQPFF 
LigB1706-1716 
scrambled 
  ASDLARIKFNP 
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Table 7.3. Thermodynamic parameters for the interaction of Fn and LigB1706-1716 
[LigB1706-1716] [Fn] ΔH TΔS Kd ΔG 
μM μM kcal mol-1 kcal mol-1 μM kcal mol-1 
8 40 -3.31±0.32 3.61±0.29 8.06±0.11 -6.92 
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Figure. 7.7D, each value represents the mean ± SEM of three trials in triplicate samples. 
The residuals were measured by the differences between the calculated fit and the 
exponential data. In order to calculate kon and koff of the binding reaction, the 
concentrations of LigB1706-1716 used in this experiment were at least 25 fold higher than 
that of 15F3 to fulfill the requirement of pseudo-first order so kobs obtained from 
different concentrations of LigB1706-1716 could fit the following equation to determine 
the value of kon and koff. 
 
 
Isothermal Titration Calorimetry   
 Calorimetric experiments were carried out with CSC 5300 microcalorimeter 
(Calorimetry Science Corp. Lindon, UT, USA) at 25  as previously described ℃ [23; 24]. 
The cell contained 1 ml of a solution containing LigB1706-1716 ; the syringe contained 250 
μl of a solution of full length Fn at a concentration indicated in Table 7.3. Both solutions 
were in phosphate based saline, pH 7.5. The titration was performed as follows: 25 
injections of 10 μl (Table 7.3) with a stirring speed of 250 rpm, with delay time between 
the injections at 5 min. Data were analyzed using Titration Binding Work 3.1 software 
(Calorimetry Science Corp. Lindon, UT, USA) fitting them to an independent binding 
model. The concentration of Fn and LigB1706-1716 used in this study was based on our 
preliminary dose titration experiment (data not shown). 
 
Statistical analysis 
Significance between samples was determined using the Student’s t-test following 
logarithmic transformation of the data. Two-tailed P-values were determined for each 
sample and a P-value <0.05 was considered significant. Each data point represents the 
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mean + standard error of the mean (SEM) of sample tested in triplicate. An (*) indicates 
the result was statistically significant. 
 
NMR Sample Preparation and Experiments 
Cysteine conjugated LigB1703-1717 used to immunize mice was prepared by 
dissolving lyophilized powder in a solution of PBS (pH 6.0) in either H2O or D2O to 
apply to NMR. The pH was adjusted by phosphoric acid or sodium hydroxide to a final 
concentration of 2.51 mM. 
NMR spectra were recorded at 25oC on a Varian Inova 600 MHz spectrometer 
using the States-Haberkorn hypercomplex method of frequency discrimination [51]. 
Two-dimensional homonuclear total correlation spectroscopy (TOCSY) [52] and 
nuclear Overhauser enhancement spectroscopy (NOESY) [53] spectra were recorded 
with spectral widths of 6 kHz in t1 (1024 real + imaginary data points in the TOCSY and 
H2O NOESY experiments, 800 real + imaginary in the D2O NOESY experiment) and 8 
kHz in t2 (2048 real + imaginary data points). Two-dimensional TOCSY spectra were 
acquired with a DIPSI-2 [54] isotropic mixing period (tmix) of 55 ms, and NOESY 
spectra were acquired with a tmix of 200 ms. For both experiments, the spectra were 
processed to a final data size of 1024 by 2048 real points.  
NMR data were processed and analyzed using the software tools nmrPipe and 
nmrDraw [55]. Solvent subtraction was obtained by subtraction of a fourth-order 
polynomial fit in the time domain. The free induction decay (FID) was generally 
multiplied by a 72o shifted squared sine-bell function before zero-fitting and Fourier 
transformation. Linear baseline correction was applied in the acquisition dimension of 
all spectra. Analysis of the resulting TOCSY and NOESY spectra yielded proton 
resonance assignments for all 16 LigB-derived residues (Table 7.4). Cys1 and Thr2 lack 
δHN assignments because of fast proton exchange of the N-terminal amino group.  
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Figure 7.2  Binding affinity determined by the ITC profile of LigB1706-1716 with Fn. 
Data of heat change obtained with Fn titration is shown in the upper panel. In the lower 
panel, the solid lines represent the best fits to a single-site binding model data after peak 
(◆) integration, subtraction of blank titration data (not shown), and concentration 
normalization. Molar heats of binding are plotted vs. the molar ratio of Fn to 
LigB1706-1716. Binding potency of protein with ligand KD is 8.06μM. The thermodynamic 
data that were obtained from ITC are shown in Table 7.3. 
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Construction of a Ribbon model of the 15th type III module of Fn 
 A Ribbon model was made with the program CPHmodels 2.0 
(http://www.cbs.dtu.dk/services/CPHmodels) for residues 2116-2189 (corresponding to 
the 15F3) of rat fibronectin using data previously published, coordinated, and retrieved 
from the Protein Data Bank (PDB http://www.rcsb.org) [56].  
 
Results 
LigB Residues from 1708-1712 (LIPAD) possess Fn-binding activity 
 To identify the Fn-binding region, truncated forms of LigBCtv including 
LigBCtv1, LigBCtv2, LigBCtv3, and LigBCtv4 (Figure. 7.1A) were purified and 
assayed for Fn-binding capability using ELISA. Only LigBCtv2 and LigBCtv3 bind 
to Fn (Figure. 7.1B). The Fn-binding region was more finely mapped to LigB residues 
1688-1723 using synthesized peptides corresponding to the LigBCtv sequence 
(Figure. 7.1C, Table 7.2). To identify the specific residues required for Fn-binding 
activity, peptides corresponding to AA 1688-1723 were synthesized with overlapping 
regions of 5 amino acids (Figure. 7.1D and Table 7.2). As presented in Figure. 7.1D, 
LigB1706-1716 displayed the highest Fn-binding activity, while both LigB1700-1710 and 
LigB1711-1720 had moderate Fn-binding affinities. Based on the alignment of these 
three peptides, the residues LIPAD (LigB1708-1712) of LigBCtv were found to be 
essential for Fn binding (Figure. 7.1E).  
In order to investigate the importance of each residue of LigB1708-1712, LIPAD, to 
Fn-binding, peptide variants of LigB1706-1716 with individual residues substituted with 
alanine were synthesized. These peptides, designated LigBL1708A, LigBI1709A, LigBP1710A, 
and LigBD1712A, were screened for Fn-binding activity with ELISA (Table 7.2). The 
binding activities of each of these peptides was significantly decreased (Figure. 7.1F), 
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suggesting that polar or charge-charge interactions involving D1712 and hydrophobic 
interactions involving L1708 and I1709 may serve important roles in binding.  
The binding of LigB1706-1716 to Fn was also confirmed using isothermal titration 
calorimetry (ITC), which yielded a KD of 8.06 ± 0.11 μM (Figure. 7.2 and Table 7.3). As 
seen in Table 7.3, the ΔH of binding is negative while the ΔS is positive, consistent with 
the release of water molecules upon binding. This indicates that the binding of 
LigB1706-1716 to Fn is driven by favorable changes in both entropy and enthalpy, in 
agreement with our finding that both polar and hydrophobic residues are critical for the 
binding event (Figure. 7.1F).  
To further explore the role of the LIPAD residues in Fn-binding activity, a 
competitive ELISA assay was performed where the LigBCtv-Fn interaction was 
inhibited by treating Fn-coated microtiter plate wells with various concentrations of 
LigB1706-1716, LigBCtv, and BSA. We found that LigB1706-1716 as well as LigBCtv could 
block the binding of LigBCtv to Fn (data not shown). 
 
LigB1708-1712 LIPAD residues mediate the attachment of Leptospira to MDCK cells 
 To investigate the role of the LIPAD residues in cell binding, 100 μl of various 
concentrations (0, 1.25, 2.5, 5, or 10 μM) of biotin-conjugated LigB1706-1716 or biotin 
were added to MDCK cells; binding levels were detected using ELISA and 
immunofluorescence staining. Our results clearly show that biotin-LigB1706-1716, but not 
biotin alone, binds to MDCK cells in a dose-dependent manner (KD = 2.23 μM, Figure. 
7.3A, 7.3C). Pretreatment of MDCK cells with 10 μM biotin-LigB1706-1716 for 1 hour 
reduced the attachment of Leptospira by approximately 39% compared to either 
untreated (data not shown) or biotin-treated MDCK cells, also in a dose-dependent 
manner (Figure. 7.3B).  
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Figure. 7.3  The binding of LigB1706-1716 to MDCK cells reduces leptospiral adhesion. 
(A) Binding of LigB1706-1716 to MDCK cells. Various concentrations (0, 2, 4, 6, 8, or 10 
μM) of biotin-LigB1706-1716, or biotin (negative control) were added to MDCK cells 
(105), and binding was measured by ELISA. (B) LigB1706-1716 inhibits the binding of 
Leptospira to MDCK cells. MDCK cells were incubated with various concentrations (0, 
2, 4, 6, or 8, 10 μM) of biotin-LigB1706-1716, or biotin (negative control) prior to the 
addition of Leptospira (107). The adhesion of Leptospira to MDCK cells (105) was 
detected by ELISA. The reduced percentage of attachment was determined relative to 
the attachment of Leptospira on untreated MDCK cells. (C). LigB1706-1716 inhibits the 
binding of Leptospira to MDCK cells. MDCK cells (106) were pre-treated with 10 μM 
of biotin-LigB1706-1716, and biotin (negative control) prior to the addition of Leptossira 
(108). The adhesion of Leptospira or the binding of these proteins to MDCK cells was 
detected by CLSM. In (A) and (B), each value represents the mean± SEM of three trials 
in triplicate samples. Statistically significant values (P<0.05) are indicted by *. In (C), 
the CLSM settings were identical for all the captured images. Images were processed 
using Adobe Photoshop CS2. 
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Figure 7.4  LigBCtv residues encompassing the LIPAD domain are surface-exposed. 
(A) To test for binding of the polyclonal antibody against peptides containing the 
LIPAD residues, ELISAs were performed with various overlapping LigB peptides or 
BSA (negative control, data not shown). The polyclonal serum was only reacted to those 
peptides containing all or part of the sequence used for immunization. (B) Alignment of 
peptide sequences used in the ELISA revealed that the LigB peptide pAb recognized a 
region of LigB protein that was no greater than 16 amino acids. The three peptides 
marked with the asterisks were used to generate the LigB peptide pAb. The residues 
indicated in bold were the five residues in LigB peptides that are essential for 
Fn-binding activity. (C) 108 of low passage L. interrogans were cultured in EMJH with 
150mM of NaCl overnight and were sequentially fixed and incubated with rabbit 
anti-LipL32, mouse anti-LIPAD containing peptide (LigB peptide pAb), and hamster 
anti-LigBCen plus LigBCtv polycolonal serum as primary antibodies and Alexa647 
conjugated goat anti-rabbit IgG, Texas red conjugated goat anti-mouse IgG, and Alexa 
488 conjugated goat anti-hamster IgG as secondary antibodies. The CLSM settings 
were identical for all the captured images. Images were processed using Adobe 
Photoshop CS2. 
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LigB1708-1712 LIPAD residues are surface-exposed in vivo 
 To determine whether the LigB1708-1712 LIPAD residues are surface-exposed in the 
pathogen, mouse anti-LigB peptide polyclonal antibodies (LigB peptide pAb) were 
generated using three peptides spanning residues 1698-1722 of LigB, which include the 
LIPAD sequence. To determine the binding specificity of these LigB peptide pAbs, 
ELISA was performed with a variety of LigB-derived peptides (Figure. 7.4B). As 
shown in Figure. 7.4A, the LigB peptide pAb recognize a stretch of about 16 amino 
acids within LigBCtv which contain the LIPAD sequence. To determine if the 
LigB1708-1712 LIPAD residues are surface-exposed, immunofluorescence staining was 
performed and visualized using confocal laser-scanning microscopy. High- and low- 
passage Leptospira were incubated with LigB peptide pAb as well as polyclonal 
antibodies against LigBCtv, LigBCen, and LipL32. The high passage Leptospira was 
used as negative reference (data not shown). Leptospira were cultured in EMJH 
medium with 150 mM sodium chloride to enhance expression levels of LigB [21; 22]. 
We have observed that LigB is expressed in low passage Leptospira cultured in EMJH 
medium supplemented with sodium chloride (data not shown), and is recognized by 
anti-LigB peptide pAb and polyclonal antibodies against LigBCtv and LigBCen 
(Figure. 7.4C) [18; 20]. The constitutively-expressed LipL32 served as a positive 
control (Figure. 7.4C and data not shown) [26].  These results indicate that the 
LigB1708-1712 LIPAD residues are surface-exposed. 
 
The LigB LIPAD Fn-binding motif is conserved in various serovars of pathogenic 
Leptospira and also present in LigC 
 Sequence analysis reveals that the LIPAD motif is conserved in LigB proteins from 
several serovars of pathogenic Leptospira, including Pomona, Copenhageni, Lai, and 
Hardjo (Figure. 7.5A). Surprisingly, LIPAD sequence is also present  in LigC proteins  
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Figure 7.5  LIPAD Fn-binding motif distributed in LigB and LigC from different 
Leptospira serovars show similar Fn-binding activity. (A) Sequence alignment of LigB 
from L. interrogans serovar Pomona type kennewicki (GenBankTM AAP74956) 
(LigB_Pomona), L. interrogans serovar Copenhageni (GenBankTM AAS69085) 
(LigB_Copenhageni), L. interrogans serovar Lai (GenBankTM AAN50976) (LigB_Lai), 
L. borgpetersenii serovar Hardjo-bovis JB197 (GenBankTM ABJ75289) 
(LigB_Hardjo-bovis), L. kirschneri serovar Grippotyphosa (GenBankTM AAP04736) 
(LigB_Grippotyphosa), and LigC from L. interrogans serovar Lai (GenBankTM 
AAN50273) (LigC_Lai), L. interrogans serovar Pomona type kennewicki (GenBankTM 
AAP92092) (LigC_Pomona) were aligned along the of LIPAD Fn-binding motif. 
Sequence alignments were performed using the programs ClustalW [57] and BioEdit 
[58]. Black and gray outlines indicate identical and similar amino acid residues, 
respectively, and the sequence number is presented on the side. (B) Various 
concentrations (40μM, 20μM, 10μM, 5μM, 2.5μM, 1.25μM, 0.625μM) of biotinylated 
LigB1706-1716, LigBhardjo1713, LigC1773-1783, scrambled LigB peptide (negative control), or 
BBK32 (56-205) (positive control) (10nM in 100μL PBS) was added to wells coated 
with one μg of Fn. The binding of each of these proteins or peptides to Fn was 
determined by ELISA. Each value represents the mean ± SEM of three trials in triplicate 
samples. Statistically significant (P<0.05) binding of peptides compared to BSA by Fn 
is indicted by *. 
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Figure 7.6  Mapping the LIPAD binding site in Fn. (A) A chart presenting the location 
of Fn and truncated Fn used in this study. (B and C) Binding of LigB LIPAD motif to 
various concentration of immobilized Fn and 40kDa domain. Various concentration of 
biotin-LigB1706-1716 and biotin (negative control and data not shown) (0.625, 1.25, 2.5, 5, 
10, 20, 40μM) were added to 1μg of (B) full length Fn, NTD, GBD, CBD, 40kD domain 
(40kDa), or BSA (negative control) (C) 40kDa domain, MBP-12-13F3, MBP-14F3, 
MBP-15F3, MBP(negative control), or BSA (negative control) in 100μL PBS coated 
microtiter plate wells. Bound proteins were measured by ELISA.  
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of serovars Pomona type kennewicki and Lai (Figure. 7.5A). As shown in Figure. 7.5B, 
LIPAD peptide analogs corresponding to the sequences from these serovars  exhibit 
similar Fn-binding activity.  
 
The LigB LIPAD motif binds to the 15th type III module of Fn and exhibits slow 
binding kinetics 
In order to identify the specific region of Fn recognized by the LigB LIPAD motif, 
ELISA was performed with biotin-LigB1706-1716 and full-length Fn or different truncated 
domains of Fn including NTD, GBD, CBD, and a 40 kDa domain containing the last 
four type III module repeats (Figure. 7.6A). The results (Figure. 7.6B) show that 
LigB1706-1716 binds exclusively to intact Fn (KD = 5.45 ± 0.64 μM) and the 40 kDa 
domain (KD = 5.31 ± 0.96 μM). To further locate the binding site on the 40 kDa domain,  
the assay was repeated with biotin-LigB1706-1716 and MBP-12-13F3, MBP-14F3, 
MBP-15F3, BSA, MBP (negative control), and the 40 kDa domain (positive control) 
(Figure. 7.6A). Only the 40 kDa domain and MBP-15F3 (KD = 14.31 ± 0.76 μM) were 
observed to immobilize LigB1706-1716, though the binding of MBP-15F3 was slightly 
weaker than that of the 40 kDa domain (Figure. 7.6C). Quenching of the intrinsic Trp 
fluorescence intensity of 15F3 in the presence of LigB1706-1716 is in agreement with the 
results (KD = 11.70 ± 2.23 μM), indicating that the LigB LIPAD motif binds to 15F3 
(Figure. 7.7A, 7.7B). Furthermore, stopped flow techniques were used to obtain kinetic 
rates for the LigB1706-1716:15F3 interaction. As shown in Figure. 7.7C and D, the 
concentrations of all the reactant species fulfilled the requirement for a pseudo-first 
order rate equation. The kinetic rates of LigB1706-1716-15F3 (kon = 600 ± 12 M-1 Sec-1 and 
koff = 0.0129 ± 0.0003 Sec-1), are very slow relative to typical rates for protein-protein 
interactions [27]. These results indicate that the LIPAD motif binds to the 15th type III 
module (15F3) with unusually slow binding kinetics.  
  
 
 
 
 
 
Figure 7.7  Kinetic analysis of the binding of LIPAD Fn-binding motif and 15th type III modules of Fn. (A) Intrinsic fluorescence 
spectrum of 15F3 in the presence and absence of LigB LIPAD motif. 1 μM of 15F3 in PBS was excited at 295 nm. Aliquots of 
LigB1706-1716 were added. The figure shows Trp fluorescence in the presence of 0, 0.625, 1.25, 2.5, 5, 10, 20 and 40 μM of LigB1706-1716. 
(B) The determination of KD of 15F3 and LigB LIPAD motif by monitoring quenching fluorescence intensities. The emission 
wavelength recorded in this figure was 350nm, and KD was obtained by fitting the data to Eq. 2. (KD= 10.70±2.23μM). Each value 
represents the mean ± SEM of three trials in triplicate samples. (C) Time course of the intrinsic fluorescence intensity caused by 
binding of 15F3 to LigB1706-1716. Single-exponential fit to the fluorescence data. Excitation wavelength was 295nm. The signal 
represents the total fluorescence emission above 320nm. The residuals were measured by the differences between the calculated fit 
and the exponential data. (D) The kinetic plot of kobs versus concentration of 1μM 15F3 under different LigB1706-1716 concentrations 
(25, 50, 100, 200, 400μM). kon and koff were obtained as the intercept (kon = 600±12M-1Sec-1) and the y intercept (koff = 
0.0129±0.0003Sec-1). (E) A ribbon model showing the surface-exposed tryptophan, W2122, in 15th type III module of rat Fn. 
 
 
 
 
235 
  
 
 
236 
 237
 
 
Figure 7.8 (A) HN-HN region of the homonuclear NOESY spectrum (tmix = 200 ms, pH 
= 6.0) of LigB1703-1717 in PBS in H2O. The dNN cross-peaks are labeled with residue 
numbers, and arrows indicate sequential connectivities. The NOEs between sequential 
residues in residues A1711 through F1715 indicate nascent helical character. (B) Plot of the 
difference in Hα chemical shifts, or ΔδHα, between observed and random coil values for 
LigB1703-1717. C indicated the first cysteine conjugated on LigB1703-1717. A stretch of ΔδHα 
values below -0.1 indicates nascent α-helical structure, and a stretch of values above 0.1 
indicates preference for β-strand conformation.
 Table 7.4. Proton chemical shift assignments for LigB1703-1717 (error ± 0.01 ppm) 
residue δHN δHα δHβ δHγ δHδ δHε 
Cys -- 4.32 3.35, 3.11       
Thr1703 -- 4.36 4.11 1.14     
Lys1704 8.41 4.28 1.68 1.27 1.34 2.97 
Tyr1705 8.18 4.58 3.04, 2.89 2,6H: 7.12 3,5H: 6.84   
Arg1706 8.24 4.28 1.79, 1.71 1.55 3.17   
Asn1707 8.38 4.68 2.85, 2.73       
Leu1708 8.17 4.36 1.57 1.63 0.84, 0.91   
Ile1709 8.15 4.49 1.89 1.48, 1.17, 0.94 0.86   
Pro1710 -- 4.34 2.29 1.95, 2.06 3.66, 3.88   
Ala1711 8.34 4.26 1.40       
Asp1712 8.26 4.56 2.70       
Lys1713 8.11 4.28 1.74, 1.85 1.44 1.69 3.01 
Ala1714 8.18 4.24 1.29       
Phe1715 8.08 4.67 3.07, 3.21 2,6H: 7.30 3,5H: 7.38 4H: 7.33 
Ser1716 8.10 4.45 3.83       
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Table 7.4 (Continued) 
residue δHN δHα δHβ δHγ δHδ δHε 
Gln1717 7.92 4.18 1.95 2.14, 2.31   
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β-Strand and nascent helical characters are present in a peptide containing the 
LIPAD motif 
The structure of LigB1703-1717 was investigated with solution NMR. The nuclear 
Overhauser effect, or NOE, is a useful structural probe for identifying spatially close 
residues. A NOE cross-peak between two atoms indicates that they are separated by a 
distance of less than 5 Å. Sequential through-space NOE cross-peaks between 
successive amide protons, or dNN(i,i+1) NOEs, were observed for residues 
A1711D1712K1713A1714F1715 in the NOESY spectra of LigB1703-1717, shown in Figure 8A. 
An additional cross-peak between the amide protons of D1712 and A1714, or dNN(i,i+2) 
NOE, was also observed. This pattern of local NOEs is indicative of nascent helical 
structure, which is defined as an equilibrium between a series of turn-like structures and 
unfolded states [28]. No other dNN NOEs were observed, and other dNα NOEs did not 
reveal any additional structure, although more peaks may be present but unresolved due 
to overlap. 
An additional probe of backbone structure is provided by the resonance 
frequency of alpha protons (δHα). Because of the distance between an alpha proton and 
the side chains of its preceding and following residues, its electronic environment is 
dominated by its own side chain identity and φ and ψ torsion angles but not the identities 
of neighboring residues. The difference between an observed Hα chemical shift and the 
corresponding random coil value for a given type of amino acid residue, or ΔδHα, gives 
an accurate measure of the secondary structure of proteins and peptides[29]. Three or 
more sequential ΔδHα values greater than +0.1 indicate 　-strand conformation, whereas 
four or more sequential ΔδHα values less than -0.1 indicate helical conformation. Values 
of ΔδHα were determined for LigB1703-1717 and the results are depicted  in Figure 8B. 
The low value for cysteine, the first amino acid in the peptide (conjugated for mouse 
immunization) is most likely due to its position near the positive N terminus. The plot 
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reveals ΔδHα values greater than +0.1 for sequential residues L1708 and I1709 (+0.19 and 
+0.54, respectively), indicating that this segment of the peptide may transiently adopt a 
β-strand conformation. Although minor corrections to ΔδHα have been rationalized in 
the interpretation of ΔδHα for residues directly preceding a proline, the large positive 
value for I1709 observed here far exceeds the typical correction (+.11 ppm) [30]. This 
region is followed by a nascent helical region for residues A1711D1712K1713A1714. 
Although not all below -0.1 ppm, the sequential negative values of ΔδHα are consistent 
with the nascent helical character deduced from the observed NOEs involving these 
residues as described above. 
 
Discussion 
Various bacterial MSCRAMMs possess Fn-binding activity [31; 32] which is 
often pivotal for host cell colonization and bacterial infection. Molecular interactions of 
bacterial pathogens and Fn have been extensively studied in recent years, especially 
with S. aureus and Streptococcus spp. These studies have made progress towards a 
greater understanding of how these interactions lead to host cell signaling and 
physiological changes and can result in bacterial uptake [5]. Leptospiral LigB has 
emerged as an important Fn binding protein that can serve as a protective antigen 
against Leptospira infection [33-36] and its Fn-binding regions have been found to be 
localized to two regions, LigBCen and LigBCtv [15; 16; 24]. This study sought to  
finely map the Fn binding site of LigBCtv. 
Based on the results from this study, the sequence LIPAD (LigB1708-1712) on 
LigBCtv is required for Fn-binding. The Fn-binding capabilities of LIPAD 
alanine-substituted peptides including LigBL1708A, LigBI1709A, LigBP1710A, and 
LigBD1712A were greatly reduced compared to the wild-type LigB1706-1716, indicating that 
the LIPAD residues are important for LigBCtv’s interaction with Fn. These results are 
 242
consistent with the reduced binding of LigBCtv to Fn that was observed upon 
pretreatment of Fn with LigB1706-1716 (data not shown). The binding affinity of 
LigB1706-1716 and Fn measured by ITC also confirms these results (KD = 8.06 μM, Figure. 
7.2 and Table 7.3). It should be noted that this is within the error of the KD of the 
interaction between whole LigBCtv and Fn (KD = 8.55 ± 0.75 μM) as measured by ITC 
[24]. This strongly suggests that the residues of LigB1706-1716 are predominantly 
responsible for the interaction between LigBCtv and Fn and that long-range 
structure-dependent interactions were not overlooked as a result of the truncation-based 
screening process.  
LigBCtv mediates Leptospira adhesion to MDCK cells, as evidenced by the 
reduced attachment of Letpospira to LigBCtv-treated cells [24]. In this study, the 
adhesion of Leptospira to MDCK cells pretreated with a LIPAD-containing peptide 
(LigB1706-1716) was also decreased (Figure. 7.3C). We hypothesized that AA 1708-1712 
of LigBCtv are responsible for Leptospira adhesion. Adhesion inhibition caused by 
LigB1706-1716 was 39 ± 5% (Figure. 7.3B), slightly less than 47% ± 5% for cells 
pretreated with LigBCtv [24] though the errors of these measurements overlap. This 
may be due to other regions of LigBCtv, in addition to LigB1706-1716, mediating the 
interaction between LigBCtv and ECM components or cell-surface elements. This study 
also demonstrates that the LIPAD residues of LigB are highly immunogenic (Figure. 
7.4) and surface-exposed. The LIPAD Fn-binding motif is present in LigB and LigC of 
various pathogenic serovars of Leptospira, and peptides corresponding to these serovars 
all display similar Fn-binding affinities (Figure. 7.5).  
Most bacterial Fn-binding proteins have been found to bind to the NTD or GBD 
of Fn [37]. Recently, it was shown that the Staphylococcus dysgalactiae 
fibronectin-binding protein B3 binds to the first two F1 modules in the N-terminal 
domain of Fn by contributing an additional antiparallel strand to a β-sheet in each 
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module [38]. A few bacterial Fn-binding proteins have also been shown to bind to the 40 
kDa domain. For example, ShdA of Salmonella enterica binds the cationic cradle of the 
13th type III module of Fn [39]. Here, we show that the LIPAD motif of LigB binds to 
the 15th type III module (Figure. 7.6B and C). Our study describes for the first time a 
bacterial MSCRAMM binding to this module. A previous report indicated that 
dipeptidyl peptidase IV (DPPIV), a transmembrane sialoglycoprotein from various 
epithelial tissues, binds to a consensus motif, T(I/L)TGLX(P/R)G(T/V)X in the 13th, 
14th, and 15th type III modules of Fn [40]. Since the LIPAD motif binds to the 15th and 
not the 13th or 14th type III modules (Figure. 7.6C), it can be inferred that the binding site 
of LIPAD should involve sequence(s) unique to the 15th type III module. Therefore, the 
LigB LIPAD motif is not expected to interact with the DPPIV binding site. The long 
wavelength (350 nm) of the maximum intensity of the fluorescence spectrum (Figure. 
7.7A), and a homology model of 15F3 based on residues 1431 to 1505 of the 10th type III 
module (Figure. 7.7E) suggest that the sole tryptophan in the 15th type III module, W2122, 
is in a polar and surface-exposed environment. The observed sensitivity of Trp 
fluorescence to the binding event suggests that the binding site may be near W2122. These 
results suggest that LigB1706-1716 may exploit a novel mechanism to bind a region of Fn 
distinct from the previously identified DPPIV binding sites. 
The immunoglobulin-like repeat regions of LigA and LigB, including LigBCen2, 
strongly bind to the N-terminal (NTD) and gelatin binding domains (GBD) of Fn, as 
well as to other ECM components [15; 16; 24]. This study identifies a Fn-binding 
LIPAD motif located in the C-terminal non-repeat region of LigB that binds, in 
comparison to interactions between LigB and other ECM components, with moderate 
affinity (KD = 10.70 μM), to the 15th type III module of Fn (Figure. 7.6C, 7.7B and data 
not shown). This binding event has unusually slow association and dissociation rates 
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(kon = 600 M-1Sec-1, koff = 0.0129 Sec-1), in agreement with the retarded equilibrium of 
each interaction obtained from ITC (Figure. 7.2).  
The modest affinity of LigBCtv for fibronectin in vitro appears to be at odds with 
the appreciable ability of LigB1706-1716 to block leptospiral cell binding. It is possible that 
environmental factors in vivo such as pH, ionic strength, cofactors, or other binding 
partners may play an important role in the binding event. As measured by ELISA 
(Figure 3A), the ex vivo binding affinity of LigB1706-1716 for MDCK cells (KD = 2.23 μM) 
is higher, albeit only modestly, than its affinity for Fn in vitro (KD = 8.06 μM). Such 
factors assisting ex vivo binding may not be crucial to rectify the cell-binding inhibition 
data and the in vitro KD measurements. Micromolar affinities are by no means unusual 
in biologically relevant protein-protein interactions. For example, the SH3 domain, a 
highly-characterized and widespread protein-interaction module important in signal 
transduction pathways, has KD values in the low µM range for optimized synthetic 
peptide ligands. This low binding affinity is frequently compensated for by additional 
binding domains, such as SH2 or other SH3 domains, that act in synergy to promote 
biding [41]. Likewise, LigB has multiple regions that bind to different parts of 
fibronectin and to other components of the extracellular matrix [15; 16; 24]. It has been 
indicated a ligB mutant with an insertion containing a Spcr cassette into the 3’ end of the 
ligB gene is still virulent in a hamster model [42]. The reasons are unknown. However, 
there are several possibilities: 1). The truncated LigB is expressed, but at a lower level 
since the insertion is only in the far 3’ end of ligB  2). Since the first 630 amino acids of 
LigA and LigB are identical, LigA may compensate for LigB in this mutant even with a 
similar LigA expression level. 3). LigB is not required for virulence in a hamster or rat 
model. 4). LigB is only needed for initial adhesion and invasion of Leptospira spp. 
moving from the environment through mucous membranes and injured skin.  5). The 
presence of several other putative adhesins with potentially redundant functions in the 
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pathogen. In order to answer these questions, it is essential to knockout the complete 
ligA and ligB genes (in frame deletion of the complete ligA and ligB genes) and perform 
a virulence test using different animal models, such as in dogs or monkeys or any other 
suitable animals. 
The kinetic rates of LigB1706-1716 binding to the 15th type III module of Fn are at 
least 100 fold slower than rates seen with any other bacterial Fn-binding proteins 
(Figure. 7.6C and D) [37; 43-45]. The slow dissociation rate, koff, may be an important 
factor in retention of the bound state in the biological system. In an in vivo system where 
the concentration of ligand is not constant, but rather influenced by factors such as 
absorption, distribution, metabolism, and excretion (ADME), the residence time of a 
receptor-ligand complex is not necessarily appropriately described by the equilibrium 
dissociation constant KD [46]. Current experimental evidence has pointed to the 
dissociation rate constant koff as a more relevant parameter in some cases. For example, 
recent kinetic studies [47] of peptide inhibitors of HER2, a member of the epidermal 
growth factor receptor family, showed that the koff of the peptide-receptor complex was 
a better predictor of the in vivo efficacy of the peptides than the KD. This has led to 
arguments that the dissociation rate constant may be an important parameter to be 
considered in drug design and screening. In light of this, it is tempting to interpret the 
slow dissociation rate of the LigB1706-1716:Fn complex as an example of an 
evolutionarily optimized koff for a bacterial adhesin/target complex, which is challenged 
by many of the same limitations to overall ligand concentration as drug/target 
complexes are. 
In light of our findings that the LIPAD motif of LigB binds the 15th type III 
module of Fn and that LigBCen2 binds the NTD of Fn, we speculate that LigB may 
interact with fibronectin via different binding mechanisms during different stages of 
infection, or possibly via both simultaneously. It is possible that LigB might bind the 
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NTD and 15th type III module of the same Fn molecule simultaneously, but this would 
require substantial bending of Fn. Alternatively, each LigBCen2 and the LIPAD motif 
might bind a separate Fn molecule. Binding to two different Fn molecules together  
might allow LigB to cluster the cell-binding regions of Fn, which in turn can cluster 
integrins on the surface of a host cell. This is thought to be important for the entry of 
invasive bacteria such as S. pyogenes and S. aureus into host cells [48]. However, unlike 
the multiple Fn binding sites on SfbI from S. pyogenes and FnBPA from S. aureus, the 
two binding sites on LigB attach to different regions of Fn, which would not seem to be 
ideal for such clustering.  
We have demonstrated that the sequence LIPAD located on the C-terminus of 
LigB is a Fn-binding motif that interacts with the 15th type III module of Fn with slow 
binding kinetics. Furthermore, this Fn-binding motif is surface-exposed, and a peptide 
corresponding to this region displays β-strand and nascent helix character when free in 
solution. The specificity of the motif for the 15th type III module of Fn suggests a novel 
mode of bacterial Fn binding. The slow dissociation rate of the complex may be 
important for evading clearance in vivo, analogous to the importance of koff in drug 
efficacy. Further studies should include the identification of the binding site within the 
type III module, using NMR, X-ray crystallography and/or mutagenesis studies. Work 
to further elucidate this interaction is in progress in our lab. 
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CHAPTER 8 
THE REPEATED DOMAINS OF LEPTOSPIRA IMMUNOGLOBULIN-LIKE 
PROTEINS INTERACT WITH ELASTIN AND TROPOEALSTIN 
 
Introduction 
Pathogenic Leptospira spp. are spirochetes that cause leptospirosis, a serious 
infectious disease of people and animals (1,2). Weil’s syndrome, the severe form of 
leptospiral infection, leads to multi-organ damage including liver failure (jaundice), 
renal failure (nephritis), pulmonary hemorrhage, meningitis, abortion and uveitis (3,4). 
Furthermore, this disease is not only prevalent in many developing countries, it is 
reemerging in the United States (3). Although leptospirosis is a serious world-wide 
zoonotic disease, the pathogenic mechanisms of Leptospira infection remain enigmatic.  
Recent breakthroughs in applying genetic tools to Leptospira promise to speed studies 
into the molecular pathogenesis of leptospirosis (5-8).  
The attachment of pathogenic Leptospira spp. to host tissues is critical in the early 
phase of Leptospira infection. Leptospira spp. adhere to host tissues to overcome 
mechanical defense systems at tissue surfaces and to initiate colonization of specific 
tissues, such as the lung, kidney, and liver.  Leptospira invade hosts tissues through 
mucous membranes or injured epidermis, coming in contact with subepithelial tissues.  
Here, certain bacterial outer surface proteins serve as microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs) to mediate the binding of 
bacteria to different extracellular matrices (ECMs) of host cells (9).  Several leptospiral 
MSCRAMMs have been identified (10-18) and we speculate that more will be 
identified in the near future.  
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Lig proteins are distributed on the outer surface of pathogenic Leptospira and the 
expression of Lig protein is only found in low passage strains (14,16,17), probably 
induced by environmental cues such as osmotic or temperature changes (19).  Lig 
proteins can bind to fibrinogen and a variety of ECMs including fibronectin (Fn), 
laminin, and collagen, thereby mediating adhesion to host cells (20-23).  Lig proteins 
also constitute good vaccine candidates (24-26). 
Elastin is a component of ECM critical to tissue elasticity and resilience and is 
abundant in skin, lung, blood vessels, placenta, uterus and other tissues (27-29). 
Tropoelastin is the soluble precursor of elastin (28).  During the major phase of 
elastogenesis, multiple tropoelastin molecules associate through coacervation (30-32).  
Due to the abundance of elastin or tropoelastin on the surface of host cells, several 
bacterial MSCRAMMs use elastin and/or tropoelastin to mediate adhesion during the 
infection process (33-35).  
Since leptospiral infection is known to cause severe pulmonary hemorrhage (36,37) 
and abortion (38), we hypothesize that some leptospiral MSCRAMMs may interact 
with elastin and/or tropoelastin in these elastin-rich tissues. This is the first report that 
Lig proteins of Leptospira interact with elastin and tropoelastin, and the interactions are 
mediated by several specific immunoglobulin-like domains of Lig proteins including 
LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 which bind to the 17th to 27th exons of 
human tropoelastin (HTE). 
 
Materials and Methods 
Bacterial strains 
L. interrogans serovar Pomona (NVSL1427-35-093002) was used in this study (18). All 
experiments were performed with virulent, low-passage strains obtained by infecting 
golden Syrian hamsters as previously described (24). Leptospires were grown in EMJH 
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medium at 30  for less than 5 passages; growth was monitored by dark℃ -field 
microscopy. 
 
 
Reagents and antibodies 
rabbit anti-GST antibody and Alexa488-conjugated goat anti-hamster antibody were 
ordered from Molecular Probes (Eugene, OR). Horseradish peroxidase 
(HRP)-conjugated goat anti-hamster antibody, HRP-conjugated goat anti-horse 
antibody, HRP-conjugated goat anti-rabbit antibody, and HRP-conjugated streptavidin 
were ordered from KPL (Gaithersburg, MD). Human lung, aortic and skin elastins, and 
bovine serum albumin (BSA) were ordered from Sigma-Aldrich (St. Louis, MO). The 
Quickchange mutagenesis kit was purchased from Stratagene (La Jolla, CA). Elastin 
peptide was ordered from Elastin Products Company (Owensville, MO). Hamster anti-L. 
interrogans antibodies were previously prepared in hamsters from the challenge 
controls (24).  
 
Plasmid construction and Protein purification 
N2-N3 domain of FnBPA (rFnBPA194-511) gene from Staphylococcus aureus (34,39) 
and full length human tropoelastin (HTE) gene (40) were cloned into pQE30 and 
pTrcHis-TOPO vectors, respectively, and purified as histidine-tag fusion proteins. 
Construction for expression as histidine-tag, GST or MBP fused with truncated HTE 
including 1-18 HTE (1st to 18th exons of HTE), 17-27 HTE (17th to 27th exons of HTE), 
and 27-36 HTE (27th to 36th exons of HTE) is schematized in Figure. 8.5A. Truncated 
LigB constructs including LigBCon (amino acids 47-630 in LigB), LigAVar (amino 
acids 631-1225 in LigA), LigBCen (amino acids 631-1417 in LigB), LigBCtv (amino 
acids 1418-1889 in LigB), LigBCen1 (amino acids 631-1013 in LigB), 
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LigBCen2(amino acids 1014-1165 in LigB), LigBCen3(amino acids 1166-1417 in 
LigB), LigBCon1-3 (amino acids 47-316 in LigB), LigBCon4-7’(amino acids 307-630 
in LigB), LigBCon4 (amino acids 307-403 in LigB), LigBCon5 (amino acids 397-492 
in LigB), LigBCon6-7’(amino acids 486-630 in LigB), LigB7’-8 (amino acids 
631-756 in LigB), LigB9 (amino acids 755-850 in LigB), LigB10(amino acids 
846-941 in LigB), LigB11(amino acids 942-1028 in LigB), LigB12 (amino acids 
1047-1119 in LigB), and LigBCen2NR (amino acids 1120-1165 in LigB) is 
schematized in Figure. 8.2. Each PCR amplified fragment was inserted into vectors 
pET-THGT, pET-THMT, pQE30 (Qiagen, Alencia, CA) and/or pGEX-4T-2 (GE 
Healthcare, Piscataway, NJ) as previously described (21,22,26). Constructs for the 
expression of histidine-tag or GST fused LigBCon, LigAVar, LigBCen, LigBCtv, 
 LigBCen1, LigBCen2, LigBCen3, LigBCen2NR and GST were obtained from 
previous studies (21, 22, 26, 41;Figure. 8.1). Other constructs including 1-18HTE, 
17-27HTE, 27-36HTE, LigBCon1-3, LigBCon4-7, LigBCon4, LigBCon5, 
LigBCon6-7’, LigB7’-8, LigB9, LigB10, LigB11, and LigB12 were amplified by PCR 
using primers described in Table 8.1 and are based on the DNA sequences derived 
from Genbank (L. interrogan serovar Pomona: FJ030916) 
and human tropoelastin (42).  For constructing LigBCon1-3 and LigBCon4-7’, primers 
were engineered to introduce a SalI site at the 5’ end and a stop codon followed by a 
NotI site at the 3’ end of each fragment.  For LigBCon4, LigBCon5, LigBCon6, 
LigBCen7’-8, LigB9, LigB10, LigB11, and LigB12 fragments, primers were 
engineered to introduce a SphlI site at the 5’ end and a stop codon followed by a SalI site 
at the 3’ end of each fragment (Table 8.1).  PCR products were sequentially digested 
with either SalI and NotI or SphI and SalI, and inserted into pQE30 or pGEX-4T-2 cut 
with appropriate matching restriction enzyme sets. Sets of primers were engineered to 
introduce an EcoRI site at the 5’ end and a stop codon followed by a NotI site at the 3’  
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Table 8.1. Primers. 
Primer/Vector Sequence* 
LigBCon1-3fp/pGEX4T2** CGGTCGACTGGTAACTCTAATCCG 
LigBCon1-3rp CGGCGGCCGCAATAGAAACTAAGGC 
LigBCon4-7’fp/pGEX4T2 CGGTCGACTATCGTTACTCCAGCA 
LigBCon4-7’rp CGGCGGCCGCAATATCCGTATTAGA 
LigBCon4fp/pQE30*** CGGCATGCATCGTTACTCCAGCA 
LigBCon4rp CGGTCGACTAATACCTCTTGTGT 
LigBCon5fp/pQE30 CGGCATGCAAAGTTACACAAGAG 
LigBCon5rp CGGTCGACGAGAACCGCAGGAAC 
LigBCon6-7’fp/pQE30 CGGCATGCACTGTAGTTCCTGCG 
LigBCon6-7’rp CGGTCGACAATATCCGTATTAGA 
LigBCen7’-8fp/pQE30 CGCGGATCCATTGCTGAAATT 
LigBCen7’-8rp CGCCCTGCAGGACATTCAAAAC 
LigBCen9fp/pQE30 CGGCATGCAATGTCACTCCTGCA 
LigBCen9rp CGGTCGACTAAGTCAGTGACTGT 
LigBCen10fp/pQE30 CGGCATGCACAGTCACTGACTTA 
LigBCen10rp CGGTCGACGGCAGCACTTACATT 
LigBCen11fp/pQE30 CGGGATCCACGTTAGATTCCATT 
LigBCen11rp CGAAGCTTTTAGACCGTTATGTC 
LigBCen12fp/pQE30 CGGGATCCACCCTTTCTTCGATT 
LigBCen12rp CGAAGCTTTTATACTGTGAGAATTGT 
LigBCon4D341Nf**** GGGATCTTTACAAATAATTCAAACTCG 
LigBCon4D341Nr**** CGAGTTTGAATTATTTGTAAAGATCCC 
1-18HTEfp/pET-THGT# CGGAATTCATGGCGGGTCTGACGGCG 
1-18HTErp/ CGGCGGCCGCTGGAACCGCAGCACC 
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Table 8.1 (Continued) 
 
Primer/Vector Sequence* 
17-27HTEfp/pET-THGT CGGAATTCGGCGTTGGGACTCCA 
17-27HTErp/ CGGCGGCCGCTCCATATTTGGCTGC 
27-36HTEfp/pET-THMT$ CGGAATTCGTACCTGGAGCCCTG 
27-36HTErp CGGCGGCCGCTTTTCTCTTCCGGCC 
* The restriction enzyme cutting sites were underlined. ** GE Healthcare, Piscataway, 
NJ,  ***Qiagen Inc., Volencia,CA,**** Primers used for site directed mutagenesis. # 
and $: Obtained from the Cornell protein production and characterization core facility, 
Cornell University). 
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end of each fragment in constructing 1-18HTE, 17-27HTE, and 27-36HTE clones. 
(Table 8.1).  PCR products were sequentially digested with EcoRI and NotI then 
ligated into pET-THMT or pET-THGT (obtained from the Cornell protein production 
and characterization core facility, Cornell University) cut with EcoRI and NotI, 
respectively. For LigBCon4D35N mutant construction, the pQE30 expression plasmid 
containing the DNA sequence encoding LigBCon4 was subjected to site-directed 
mutagenesis using the Quickchange mutagenesis kit following the manufacturer’s 
instructions (Strategene, La Jolla, CA). Resulting PCR products were digested with 
DpnI to remove contaminating wild-type plasmid and then transformed into E.coli 
XL-1 Blue (Strategene, La Jolla, CA). Transformants were screened and subjected to 
DNA sequencing. In this study, we purified the soluble form of the histidine-tag, GST, 
or MBP fusion proteins from E. coli as previously described (21,23,41).   
 
Bacterial Adhesion to Immobilized Elastin or Tropoelastin measured by ELISA 
and Epifluorescence Microscope (EPM) 
To measure the binding of Leptospira to elastin or tropoelastin, 100μL of 10 μg/mL of 
human lung elastin, chicken tropoelastin, or BSA (negative control) were coated onto 
microtiter plate wells. For dose dependent binding experiments, 100μL of different 
concentrations of each human lung, aortic and skin elastins, chicken tropoelastin, or 
BSA were coated onto microtiter plate wells. In order to immobilize elastin, all of the 
elastins were dissolved in coating buffer (0.1M sodium bicarbonate, pH 9.4), and then 
air-dried under UV light (355nm) at room temperature (RT) for 18 hours as previously 
described (35). To immobilize tropoelastin or BSA, tropoelastin or BSA was dissolved 
in Tris buffer (25mM Tris and 150mM sodium chloride at pH7.5), added to microtiter 
plate wells and incubated at 4oC overnight (21,22,43). After the plates were 
subsequently blocked with blocking buffer (100μL/well) containing 3% BSA in Tris 
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buffer at RT for 2 hours, Leptospira (107) were added to each well and further incubated 
at 37oC for 6 hours. Following incubation, the plates were washed three times with Tris 
buffer containing 0.05% Tween-20 (TBST). To measure the binding of Leptospira, 
hamster anti-Leptospira (1:200) and HRP-conjugated goat anti-hamster IgG (1:1000) 
were used as primary and secondary antibodies, respectively. After washing the plates 
thrice with TBST, 100μL of TMB (KPL, Gaithersburg, MD) was added to each well and 
incubated for 5 min. The reaction was stopped by adding 100μl of 0.5% hydrofluoric 
acid to each well. Each plate was read at 630nm by an ELISA plate reader (Bioteck 
EL-312, Winoski, VT).  Each value represents the mean ± SEM of three trials in 
triplicate samples. Statistically significant (P<0.05) differences are indicated by *. 
To measure the binding of Leptospira to elastin or tropoelastin by Epifluorescene 
microscopy (EPM), Leptospira (108) were added to each well (eight well culture slides) 
coated with 1μg of human lung elastin, chicken tropoelastin, or BSA (negative control) 
in 100μL of Tris buffer and incubated at 37oC for 6 hour. For the detection of Leptospira 
binding in Figure. 8.2B, hamster anti-Leptospira antibodies (1:100) and Alexa 
488-conjugated goat anti-hamster IgG (1:250) were used as primary and secondary 
antibodies, respectively. Fixation and immunofluorescence staining were performed as 
previously described (22) with slight modifications. Briefly, Leptospira were fixed in 
2% paraformaldehyde for 60min at RT. For antibody labeling, fixed bacteria were 
incubated in Tris buffer containing 0.3% BSA for 10min at RT. The primary and 
secondary antibodies, diluted in Tris buffer containing 0.3% BSA, were incubated 
sequentially for 60min at RT. After incubation with the primary and secondary 
antibodies, the glass slides were mounted with coverslips using Prolong Antifade 
(Molecular Probe, USA) and viewed with a 60 × objective by EPM (Nikon, Japan). The 
settings were identical for all captured images. Images were processed using Adobe 
Photoshop CS2. 
 Table 8.2. The dissociation constant (KD) obtained from the Elastin and HTE binding by Lig proteins determined by ELISA. 
Truncated Lig KD 
 Elastin HTE 1-18HTE 17-27HTE 27-36HTE 
LigBCon 166 ± 38 nM n/db n/db n/db n/db 
LigBCon1-3 n/ba n/db n/db n/db n/db 
LigBCon4-7 181 ± 33 nM n/db n/db n/db n/db 
LigBCon4 179 ± 29 nM 475 ± 80 nM n/ba 501 ± 51 nM n/ba 
LigBCon5 n/ba n/db n/db n/db n/db 
LigBCon6-7’ n/ba n/db n/db n/db n/db 
LigAVar n/ba n/db n/db n/db n/db 
LigBCen 101 ± 11 nM n/db n/db n/db n/db 
LigBCen1 189 ± 21 nM n/db n/db n/db n/db 
LigBCen7’-8 750 ± 56 nM 824 ± 17 nM n/ba 833 ± 13 nM n/ba 
LigBCen9 1230 ± 15 nM 1390 ± 11 nM n/ba 1540 ± 351 nM n/ba 
LigBCen10 n/ba n/db n/db n/db n/db 
LigBCen11 n/ba n/db n/db n/db n/db 
LigBCen12 208 ± 25 nM 726 ± 20 nM n/ba 742 ± 31 nM n/ba 
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Table 8.2 (Continued) 
Truncated Lig KD 
 Elastin HTE 1-18HTE 17-27HTE 27-36HTE 
LigBCen2 212 ± 34 nM n/db n/db n/db n/db 
LigBCen2NR n/ba n/db n/db n/db n/db 
LigBCen3 n/ba n/db n/db n/db n/db 
LigBCtv n/ba n/db n/db n/db n/db 
rFnBPA194-511 42 ± 1.5 nM 133 ± 22 nM n/db n/db n/db 
n/ba , no binding. 
n/db , not determined. 
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Elastin and Tropoelastin binding assays 
100 μL of 10μg/mL human lung elastin, HTE, or BSA (negative control and data not 
shown) were coated onto microtiter plate wells as described above. 100μL of different 
concentrations of biotinylated LigBCon, LigAVar, LigBCen, LigBCtv, LigBCon1-3, 
LigBCon4-7’, LigBCen1, LigBCen2, LigBCen3, LigBCon4, LigBCon5, LigBCon6-7’, 
LigBCen7’-8, LigBCen9, LigBCen10, LigBCen11, LigBCen12, LigBCen2NR, or 
rFnBPA194-511 (positive control), or biotin (negative control) were added subsequently 
(Figure. 8.3). To reveal the HTE binding sites of Lig protein, 100μL of 1μM full length 
HTE and truncated HTE including 1-18HTE, 17-27HTE, 27-36HTE or BSA (negative 
control) were coated onto microtiter plate wells, and 100μL of different concentrations 
of biotinylated LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 or biotin (negative 
control) were added subsequently (Figure. 8.5). To detect binding of biotinylated 
proteins, HRP-conjugated streptavidin (1:1000) was added to each well at RT for 1 hour 
prior to washing the wells thrice with TBST. The measurement of binding by ELISA 
was as described above.  To determine the dissociation constant (KD), the data were 
fitted by the following equation using KaleidaGraph software (Version 2.1.3 Abelbeck 
software, Reading, PA), and the calculated KD are listed in Table 8.2. 
  
 
Inhibition of LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12, and 
rAFnBPA194-511 Binding to Immobilized Elastin or Tropoelastin with Soluble 
Elastin peptides or Tropoelastin 
The wells of a microtiter plate were coated with 100μL of 10μg/mL of human lung 
elastin, HTE, or BSA (negative control) as described previously. 100μL of 1μM of 
biotinylated LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12, rAFnBPA194-511 
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(positive control), or biotin (negative control) were mixed with different concentrations 
of soluble lung elastin peptides or HTE at RT for 1 hour prior to be added to elastin or 
HTE coated wells (Figure. 8.4). The binding of biotinylated proteins was measured by 
ELISA described above. 
 
Steady State Fluorescence Measurement 
Steady state fluorescence emissions were measured on a Hitachi F4500 
spectrofluorometer (Hitachi. San Jose, CA). All spectra were recorded in correct 
spectrum mode of the instrument using excitation and emission band passes of 2 nm. 
The intrinsic tryptophan fluorescence of 1μM wild type LigBCon4 or LigBCon4D35N 
was recorded by exciting the solution at 295 nm and measuring the emission in the 
305-400 nm regions. For truncated tropoelastin titration, 0.4, 0.8, 1.6, 3.2, 6.4, or 12.8 
μM of 1-18HTE, 17-27HTE, 27-36HTE in Tris buffer (25mM Tris-150 mM sodium 
chloride, pH 7.5) was mixed with 1μM of LigBCon4 or LigBCon4D35N. For 
measuring the pH effect on LigBCon4 (1μM) binding to 17-27 HTE, the same serial 
dilution of 17-27HTE mentioned above using Tris buffer with pH ranging from 4.5 to 
9.5 as described in Figure. 8.7C were used.  All spectra were recorded at 25oC after 5 
minutes. Furthermore, the spectra of the various concentrations of HTE indicated above 
were also recorded and used to subtract the spectra of each Lig protein in the addition of 
certain concentrations of HTE. To determine the dissociation constant (KD), the 
fluorescence intensities at 320nm were recorded and fitted by the following equation 
using KaleidaGraph software (Version 2.1.3 Abelbeck sotware):  
  
Where Fmax is the fluorescence intensity of Lig proteins in absence of HTE, Fmin 
indicates the fluorescence intensities of Lig proteins saturated with HTE.  In addition, 
  
 
 
 
 
Table 8.3. Thermodynamic parameters for the interaction of 17-27 HTE and LigBCon4 or LigBCon4D341N 
 [Proteins] [HTE] ΔH TΔS KD ΔG n 
 μM μM kcal mol-1 kcal mol-1 K-1 μM kcal mol-1  
LigBCon4 20 1 -46.39 -37.88 0.54±0.02 -8.51 1.01 
LigBCon4D341N 20 1 -56.68 -49.05 2.51±0.48 -7.63 0.99 
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F is the fluorescence intensities of Lig proteins in presence of various concentration of 
HTE. All of the measurements were corrected for dilution and for inner filter effect.   
 
Calculation of Charges on LigBCon4 and 17-27HTE at different pH  
The charges on LigBCon4 at different pHs and 17-27HTE was determined using ABIM, 
a Web Service for remote and automatic data processing,. The analyses were performed 
using default values. 
 
Isothermal Titration Calorimetry (ITC) 
The experiments were carried out with a CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25oC as previously described (21,22). In a typical 
experiment, the cell contained 1 ml of a solution of LigBCon4 or LigBCon4D35N and 
the syringe contained 250 μl of a solution of 17-27HTE.  The concentration of Lig 
proteins and 17-27HTE are detailed in Table 8.3. Both solutions were in Tris buffer (pH 
7.5). The titration was performed as follows: 25 injections of 10 μl with a stirring speed 
of 250 rpm with a delay time between injections of 5min. Data were analyzed using 
Titration Binding Work 3.1 software (Calorimetry Science Corp. Lindon, UT, USA) 
fitting them to an independent binding model.  
 
Circular dichroism (CD) spectroscopy 
CD analysis was performed on an Aviv 215 spectropolarimeter (Lakewood, NJ) under 
N2 atmosphere. CD spectra were measured at RT (25oC) in a 1-cm path length quartz 
cell. Spectra of LigBCon4 and LigBCon4D35N were recorded in Tris buffer, pH7.5, at 
a protein concentration of 10 μM. Three spectra were recorded for each condition from 
190 to 250 nm for far-UV CD in 1 nm increments. To reveal the effect of pH, 10 μM of 
LigBCon4 or 17-27HTE in Tris buffer ranging from pH 4.5 to 9.5 were used in all CD  
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Figure 8.1  Binding of L. interrogans serovar Pomona (NVSL 1427-35-093002) to 
elastin and tropoelastin. (A) Binding of Leptospira to BSA, elastin, or tropoelastin.  
Leptospira (107) were added to wells coated with BSA, human lung elastin, or HTE 
(1μg in 100μL Tris buffer). (B) Binding of Leptospira to immobilized elastin or HTE.  
Leptospira (108) cultured in human lung elastin, HTE, or BSA (negative control) coated 
(1μg in 100 Tris buffer) or un-coated wells (negative control). Leptospiral 
immobilization was assayed by immunofluorescence microscopy. (C) Binding of 
Leptospira (107) to various concentrations of human lung elastin, human aortic elastin, 
human skin elastin, HTE, or BSA (0 , 0.25, 0.5, 1, 2, 4, 8, 16μg/mL in 100μL Tris 
buffer). BSA serves as negative control. In (A) and (C), the binding Leptospira was 
estimated by ELISA, and each value represents the mean± SEM of three trials 
performed in triplicate samples. Statistically significant (p＜0.05) differences compared 
to the negative reference are indicated by an asterisk. 
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experiments.  The background spectrum of buffer without protein was subtracted from 
the protein spectra. CD spectra were initially analyzed by the software accompanying 
the spectrophotometer. Analysis of spectra to extrapolate secondary structures was 
performed by Dichroweb (44) (http://www.cryst.bbk.ac.uk/cdweb/html/home.html) 
using the K2D and Selcon 3 analysis programs (45,46). 
 
Statistical analysis 
Significant differences between samples were determined using the Student’s t-test 
following logarithmic transformation of the data. Two-tailed P-values were determined 
for each sample and a P-value <0.05 was considered significant. Each data point 
represents the mean + standard error of the mean (SEM) for each sample tested in 
triplicate.  An (*) indicates the result was statistically significant. 
 
Results 
Leptospira can be immobilized by elastin and tropoelastin 
To determine if leptospiral adherence is mediated by elastin, ELISA-based and 
immunofluorescence assays were performed. As shown on Figure. 8.1A and B, both 
elastin and its precursor, tropoelastin, can immobilize Leptospira on microtiter plate 
wells or culture slides. 
To reveal whether elastin derived from different tissues affect the immobilization 
of Leptospira, Leptospira were incubated over various concentrations of human lung, 
aortic or skin elastin coated onto microtiter plate wells. Based on the results of Figure. 
8.1C, Leptospira can bind to elastin from all different sources including lung, skin, and 
blood vessels. 
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Figure 8.2  A schematic diagram showing the structure of Lig proteins and the 
truncated Lig proteins used in this study. 
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Figure. 8.3  Localization of the elastin or HTE-binding domains on Lig proteins. 
Various concentrations (0.0156, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1μM) of biotin 
(negative control), biotinylated rAFnBPA194-511, (A) LigBCon, LigAVar, LigBCen, 
LigBCtv, (B) LigBCon, LigBCon1-3, LigBCon4-7’, (C) LigBCen, LigBCen1, 
LigBCen2, LigBCen3, (D) LigBCon4’-7, LigBCon4, LigBCon5, LigBCon6-7’, (E) 
LigBCen1, LigBCen7’-8, LigBCen9, LigBCen10, LigBCen11, (F) LigBCen2, 
LigBCen12, or LigBCen2NR, (G) LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 
were added to wells coated with 1μg of BSA (negative control and data not shown), 
(A-F) human lung elastin or (G) HTE in Tris buffer. The binding of biotinylated 
proteins to elastin or HTE was measured by ELISA. For all experiments, each value 
represents the mean± SEM of three trials in triplicate samples. Statistically significant 
(p＜0.05) differences compared to negative control are indicated by an asterisk. 
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Figure 8.4  Soluble elastin peptide or HTE inhibited LigBCon4, LigBCen7’-8, 
LigBCen9, LigBCen12 binding to immobilized elastin or HTE. One μM of LigBCon1-3 
(negative control), biotinylated rAFnBPA194-511 (positive control) LigBCon4, 
LigBCen7’-8, LigBCen9, LigBCen12 treated with various concentrations (3.90, 7.81, 
15.62, 31.25, 62.5, 125, 250μg/mL in 100μL of Tris buffer) of soluble elastin peptide or 
HTE were added to each well coated with 1 μg of BSA (negative control and data not 
shown), (A) human lung elastin or (B) HTE in Tris buffer. The binding of biotinylated 
proteins to wells was measured by ELISA. The percentage of binding was determined 
relative to the binding of biotinylated proteins in the untreated well. For all experiments, 
each value represents the mean± SEM of three trials in triplicate samples.  
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LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 mediate the binding of 
Leptospira to elastin and tropoelastin 
To examine LigA and LigB mediated leptospiral adhesion to elastin, Lig proteins were 
truncated and expressed as shown in Figure. 8.2. First, biotinylated LigBCon, LigAVar, 
LigBCen, LigBCtv, or biotin (negative control) was added to elastin coated microtiter 
plate wells. In addition, rFnBPA194-511 was used as a positive control (33,35). As 
indicated in Figure. 8.3A, only LigBCon and LigBCen can bind to elastin (LigBCon; 
KD= 166 ± 38 nM, LigBCen; KD= 101 ± 11 nM).  In order to further localize the elastin 
binding sites on LigBCon or LigBCen, truncated significant (p＜0.05) differences 
compared to the negative reference are indicated by an asterisk. elastin peptide blocked 
the interaction of LigBCon4, LigBCen7’-8, LigBCen9, and LigBCen12 with elastin.    
Pretreatment of these four fragments with HTE also inhibited binding (Figure. 8.4B), 
suggesting that these fragments contain both HTE and elastin binding sites. LigBCon 
and LigBCen were constructed, expressed, purified, biotinylated (Figure. 8.2), and 
ELISA assays were performed to map the elastin binding sites. As shown in Figure. 
8.3B and D, the elastin binding site on LigBCon was determined as LigBCon4, the 
fourth immunoglobulin repeated region of LigBCon (LigBCon4; KD= 179 ± 29 nM). 
On the other hand, unlike LigBCon, there were three elastin binding sites on LigBCen 
including LigBCen7’-8, LigBCen9, and LigBCen12 (LigBCen7’-8; KD= 750 ± 56 nM, 
LigBCen9; KD= 1230 ± 15 nM, LigBCen12; KD= 208 ± 25 nM) (Figure. 8.3C, E, and 
F).  
To investigate whether tropoelastin also binds to similar Lig protein binding sites 
as elastin, biotinylated LigBCon4, LigBCen7’-8, LigBCen9, or LigBCen12 was added 
to human tropoelastin (HTE) coated microtiter plate wells in a binding assay. As 
presented in Figure. 8.3G, all four of these regions can also bind to HTE (LigBCon4; 
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KD= 475 ± 80 nM, LigBCen7’-8; KD= 824 ± 17 nM, LigBCen9; KD= 1390 ± 11 nM, 
LigBCen12; KD= 726 ± 20 nM). 
 
Soluble elastin or HTE block LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 
binding to elastin or HTE 
To further confirm the association of specific lig domains with elastin or HTE, biotin 
(negative control) and biotinylated LigBCon4, LigBCen7’-8, LigBCen9, or LigBCen12 
were incubated in the presence of soluble elastin or HTE prior to be added to elastin or 
HTE coated microtiter plate wells. As shown in Figure. 8.4A, soluble 
 
LigBCon4, LigBCen7’-8, LigBCen9, LigBCen12 bind to 17th to 27th exons of HTE 
To locate the binding domain on HTE,  biotin (negative control), biotinylated 
LigBCon4, LigBCen7’-8, LigBCen9, or LigBCen12 was incubated with either full 
length HTE or different truncated fragments of HTE including 1-18HTE( 1st to 18th 
exons of HTE), 17-27HTE( 17th to 27th exons of HTE), and 27-36HTE(27th to 36th exons 
of HTE) (Figure. 8.5A) and assayed for their binding activity using ELISA. As 
indicated in Figure. 8.5, all four Lig protein fragments only bind to 17-27HTE 
(LigBCon4; KD= 0.50±0.051μM, LigBCen7’-8; KD= 0.83±0.13μM, LigBCen9; KD= 
1.54±0.35μM, LigBCen12; KD= 0.74±0.031μM).  
Since the binding affinity of LigBCon4 to 17-27HTE is highest, further studies 
using steady state fluorescence spectrometry and ITC were used; the results confirm 
those from the ELISA tests. We found that the tryptophan fluorescence intensity of 
LigBCon4 in the presence of 17-27HTE (compared with 1-17HTE or 27-36HTE) was 
quenched; this is in agreement with our ELISA results, indicating that LigBCon4 binds 
to 17-27HTE (Figure. 8.6A and B). The KD obtained from the quenched fluorescence 
spectra (KD= 0.49 ± 0.07μM) matched the data obtained with ELISA very closely  
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Figure 8.5  Mapping the binding site of LigBCon4, LigBCen7’-8, LigBCen9, 
LigBCen12 on HTE. (A) A chart presenting the location of HTE and truncated HTE 
used in this study. (B-E) Binding of LigBCon4, LigBCen7’-8, LigBCen9, and 
LigBCen12 to various concentrations of immobilized truncated HTE. Various 
concentrations (0.03125, 0.0625, 0.125, 0.25, 0.5, 1, 2μM) of biotin (negative control 
and data not shown), biotinylated (B) LigBCon4, (C) LigBCen7’-8, (D) LigBCen9, or 
(E) LigBCen12 were added to 1μM of full length HTE, 1-18HTE, 17-27HTE, 
27-36HTE, or BSA (negative control) in 100μL PBS coated microtiter plate wells. 
Bound proteins were measured by ELISA. For all experiments, each value represents 
the mean± SEM of three trials in triplicate samples. Statistically significant (p＜0.05) 
differences compared to the negative control are indicated by an asterisk. 
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Figure 8.6 Interaction of 17-27HTE and LigBCon4 by steady state fluorescence 
spectroscopy and isothermal titration calorimetry (ITC).  (A) Intrinsic fluorescence 
spectrum of LigBCon4 in the presence and absence of 17-27HTE.  One μM of 
LigBCon4 in Tris buffer was excited at 295 nm. Aliquots of 17-27HTE from respective 
stock solutions were added. The figure shows Trp fluorescence in the presence of 0, 0.4, 
0.8, 1.6, 3.2, 6.4, 12.8μM of 17-27HTE. (B) The determination of KD of LigBCon4 and 
truncated HTE by monitoring the quenching fluorescence intensities of LigBCon4 
titrated by 1-18HTE, 27-36HTE (data not shown), or 17-27HTE shown in (A). The 
emission wavelength recorded in this figure was 327nm, only the titration of 17-27HTE 
can quench the spectrum of LigBCon4. KD was determined by fitting the data point into 
the equation described in materials and methods (KD= 0.49±0.07μM). (C) ITC profile of 
LigBCon4 with 17-27HTE as a typical ITC profile in this study.  (Upper panel) Heat 
difference obtained from 25 injections. (Lower panel) Integrated curve with 
experimental point (◇) and the best fit (—). The thermodynamic parameters are shown 
in Table 8.3. 
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(Figure. 8.6B). Furthermore, KD values from ITC measurements confirmed the binding 
nature of LigBCon4 to 17-27HTE (KD= 0.54 ± 0.02μM) (Figure. 8.6C and Table 8.3).  
On the other hand, the negative values of both enthalpy and entropy shown on table 8.2 
indicated that the binding of LigBCon4 to 17-27HTE was a enthalpy favorable and 
entropy unfavorable interaction. The binding was only driven by enthalpy through 
charge-charge interactions or by Van der Waal forces. That is, the surface charges of 
interface of LigBCon4-17-27HTE might contribute to the binding. 
 
Effect of pH on the LigBCon4-17-27HTE interaction 
Due to the possibility of surface charges for the binding of LigBCon4 to 17-27HTE 
(Table 8.3), we further investigated the influence of pH on the interaction of both 
proteins. An ABIM software program was used to analyze the titration curve of 
LigBCon4 and 17-27HTE 
(http:\\www.iut-arles.up.univ-mrs.fr/w3bb/d_abim/compo-p.html). As shown in Figure. 
8.7A, 17-27HTE undergoes a sharp isoelectric transition at pH 9.5, and maintains a 
positive charge up to pH 9.5. However, there are two step of transitions from the 
titration curve of LigBCon4 located around pH4 and pH11, and the surface charge of 
LigBCon4 is kept slightly negative from pH 4 to pH10 (Figure. 8.7A). The effect of pH 
on the LigBCon4-17-27HTE interaction was also measured by the quenching of 
fluorescence intensity of LigBCon4 in the presence of various concentrations of 
17-27HTE. As presented in Figure. 8.7B and C, the highest affinity was found in the 
range of pH 6.5 to 7.5 (pH6.5; KD= 0.60±0.08μM, pH7.5; KD= 0.49±0.07μM). When 
pH was lower than 6.5 or higher than 7.5, the binding affinity of LigBCon4-17-27HTE 
was considerably lower (pH4.5; KD= 4.84±0.20μM, pH5.5; KD= 2.53±0.27μM, pH8.5; 
KD= 2.30±0.20μM) (Figure. 8.7B); interaction was found to be negligible at pH9.5 or 
higher (data not shown).  
 279
 
 
 
 
Figure 8.7  The effect of different pH values on the binding of LigBCon4 to 17-27HTE. 
(A) Titration curve for LigBCon4 and 17-27HTE. LigBCon4 (broken line) undergoes 
two step charge transition at pH 4 and 11. 17-27 HTE (solid line) undergoes a charge 
transition at pH 9.5. (B) The determination of KD of LigBCon4 and 17-27HTE by 
monitoring the quenching fluorescence intensities of LigBCon4 at various 
concentrations (0, 0.4, 0.8, 1.6, 3.2, 6.4, and 12.8μM) of 17-27HTE in Tris buffer at 
different pH (4.5, 5.5, 6.5, 7.5, and 8.5). One μM of LigBCon4 in Tris buffer was 
excited at 295 nm, and the emission wavelength recorded in this figure was 327nm. The 
KD was determined by fitting the data point into the equation described in materials and 
methods (C) LigBCon4 binding to 17-27HTE from pH 4.5 to 8.5. A plot of KD against 
pH indicates that the interaction is strongly dependent on pH. 
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To determine if the observed reduced affinity was due to conformational changes by 
LigBCon4 and 17-27HTE when the pH was outside the 6.5 -7.5 range, we performed a 
CD analysis. Results from our undifferentiated CD spectra recorded from pH4.5 to 9.5 
indicate that the reduced affinity was not the result of disruption of the structure of 
LigBCon4 and 17-27HTE (Figure. 8.9). Furthermore, the secondary structures of 
LigBCon4 and 17-27HTE were shown to be unaffected by various pH environments 
(Figure. 8.9). This indicates that the interaction of LigBCon4 and 17-27HTE is largely 
influenced by charge-charge interaction via the environmental pH. 
 
Asp341 is critical for the association of LigBCon4 and 17-27HTE 
The results of surface charge prediction showed that the negatively charged amino acids 
of LigBCon4 at physiological pH might contribute to the interaction of Lig/HTE by 
charge-charge interaction (Figure. 8.7A).  The sequence alignment was performed on 
LigBCon4, LigBCen7’-8, LigBCen9, and LigBCen12 to identify potential conserved 
acidic amino acids that may contribute to the binding of Lig proteins to HTE. 
Surprisingly, Asp341 in LigBCon4 was the only acidic amino acid conserved in all four 
elastin binding immunoglobulin-like domains (Asp341 in LigBCon4, Asp703 in 
LigBCen7’-8, Asp789 in LigBCen9, and Asp1061 in LigBCen12) (Figure. 8.8A)  To 
determine whether this aspartate plays a role in binding to 17-27HTE, a mutant, 
LigBCon4D341N was constructed. The intrinsic fluorescence spectra of 
LigBCon4D341N in the absence or presence of various concentrations of 17-27HTE 
were recorded and our results showed the binding affinity of LigBCon4D341N and 
17-27HTE was fitted by the quenching of fluorescence intensities with a KD of 
2.44±0.21μM (Figure. 8.8B). ITC was performed to measure the binding affinity of 
LigBCon4D341N to 17-27HTE (KD = 2.51±0.48μM) (Figure. 8.8C and Table 8.3). 
Interestingly, the binding affinity of LigBCon4D341N to 17-27HTE was 4.6-fold lower  
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Figure 8.8  Asp341 is one of the important residues contributing to the 
LigBCon4-17-27HTE interaction. (A) Sequence alignment of LigBCon4 (Asp341), 
LigBCen7’-8(Asp703), LigBCen9(Asp789), and LigBCen12(Asp1061)shows that an 
arspartate is conserved in these four doamins as indicated by an asterisk. The gaps were 
introduced to maximize the alignment. Black and gray colored residues indicate the 
conserved residues, and the homology analysis was performed with EMBL-EBI 
ClustalW (http://www.ebi.ac.uk/clustalw/). (B) Intrinsic fluorescence spectrum of 
LigBCon4D341N in the presence and absence of 17-27HTE.  One μM of 
LigBCon4D341N in Tris buffer was excited at 295 nm. Aliquots of 17-27HTE from 
respective stock solutions were added. The figure shows Trp fluorescence in the 
presence of 0, 0.4, 0.8, 1.6, 3.2, 6.4, 12.8μM of 17-27HTE (Inner plot). The 
determination of KD of LigBCon4D35N and 17-27HTE by monitoring the quenching 
fluorescence intensities of LigBCon4D35N titrated by 17-27HTE. The emission 
wavelength recorded in this figure was 327nm, and KD was revealed by fitting the data 
point into the equation described in materials and methods (KD= 2.44±0.21μM). (C) 
ITC profile of LigBCon4D35N with 17-27HTE as a typical ITC profile in this study.  
(Upper panel) Heat difference obtained from 25 injections. (Lower panel) Integrated 
curve with experimental point (◇) and the best fit (—). The thermodynamic parameters 
are shown in Table 8.3. 
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Figure 8.9    Environmental pH cannot affect the secondary structures of 17-27HTE 
and LigBCon4. Far-UV CD analysis of (A) 17-27HTE and (B) LigBCon4 at different 
pH (4.5, 5.5, 6.5, 7.5, and 8.5). The molar ellipticity, Φ, was measured from 190 to 250 
nm for 10 μM of each protein in Tris buffer. 
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Figure 8.10  D341N mutation cannot affect the structure of LigBCon4. Far-UV CD 
analysis of LigBCon4 and LigBCon4D341. The molar ellipticity, Φ, was measured 
from 190 to 250 nm for 10μM of each protein in Tris buffer. 
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compared to wild type LigBCon4 (KD = 0.50μM from ELISA, KD = 0.49μM from 
fluorescence spectroscopy, KD = 0.54μM from ITC) (Figure. 8.5A, 6 and Table 8.3). 
Moreover, the far-UV CD data of LigBCon4D341N to17-27HTE was similar to that of 
wild-type LigBCon4.  This result rules out the possibility that the reduction of binding 
activity of LigBCon4D341N is due to a conformation change (Figure. 8.10).  This data 
indicates that Asp341 is a pivotal residue in LigBCon4 -17-27HTE binding. 
 
Discussion 
The colonization of host tissues by pathogenic Leptospira spp. is a pivotal factor 
in leptospiral pathogenesis. Leptospira spp. express a number of MSCRAMMs on their 
surfaces that promote binding to host ECMs, and likely play an important role in 
leptospiral pathogensis (10-13,18,20-23). Leptospira spp. causes severe pulmonary 
hemorrhage with significant mortality rates in several countries, (36,37,47,48) and 
abortion with placentitis (38,49,50). The lung and placenta are elastin-rich tissues; this 
led us to examine the interaction of L. interrogans with elastin. Our results clearly show 
that L. interrogans can adhere to both immobilized elastin peptides and tropoelastin, the 
precursor of elastin (Figure. 8.1A, B), and that elastin peptides extracted from tissues 
including lung, skin, and blood vessels can immobilize Leptospira as well (Figure. 
8.1C). This data indicates that L. interrogans can bind to immobilized elastin peptides 
and tropoelastin.     
We and others have shown that Lig proteins bind to Fn, laminin, collagen, and 
fibrinogen (20,21). We, therefore, wanted to know if Lig proteins can bind to elastin. 
Our ELISA data show that coated elastin peptides can bind to the Lig protein 
fragements LigBCon and LigBCen, but not LigAVar or LigBCtv (Figure. 8.3A).  
Additionally, LigBCon and LigBCen can only partially block leptospiral binding to 
elastin, raising the possibility that L. interrogans may possess other elastin binding 
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proteins on its surface (Figure. 8.3B).  Further studies confirming this are needed. To 
our surprise, LigBCon was recently shown to have no binding capacity for Fn, laminin, 
fibrinogen or collagen (20,21), but it proved capable of  binding to elastin. This may 
explain why LigBCon is a protective antigen against L. interrogans serovar Pomona 
challenge (41). This study clearly demonstrated that Lig proteins bind to elastin, thus 
proving our hypothesis that one or more leptospiral MSCRAMMs bind to elastin.  A 
recent study indicated a ligB mutant with an insertion containing a Spcr cassette into the 
3’ end of the ligB gene is still virulent in a hamster model(5). Although The reasons are 
unknown, there are several possibilities: 1). The truncated LigB is expressed, but at a 
lower level since the insertion is only in the far 3’ end of ligB  2). Since the first 630 
amino acids of LigA and LigB are identical, LigA may compensate for LigB in this 
mutant even with a similar LigA expression level. 3). LigB is not required for virulence 
in a hamster or rat model. 4). LigB is only needed for initial adhesion and invasion of 
Leptospira spp. moving from the environment through mucous membranes and injured 
skin.  In order to answer these questions, it is essential to knockout the complete ligA 
and ligB genes (in frame deletion of the complete ligA and ligB genes) and perform a 
virulence test using different animal models, such as dogs or monkeys.       
To map the potential binding sites of Lig proteins to elastin, LigBCon and 
LigBCen were further truncated into several fragments and the recombinant proteins 
were purified for use in an ELISA assay to identify the potential elastin binding domains. 
From our truncated constructs, we found that only LigBCon4, LigBCen7’-8, LigBCen9, 
and LigBCen12 can bind to elastin (Figure. 8.3D-F). Furthermore, soluble elastin 
peptides can block the binding of these four truncated proteins to elastin.  This data 
clearly indicates that there are four elastin binding sites located on the LigB 
moiety(Figure. 8.4A).  Although LigA and LigB contain twelve and thirteen 
immunoglobulin-like domains, respectively, only LigBCon4, LigBCen7’-8, LigBCen9, 
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and LigBCen12 are able to bind to elastin.  This is not surprising, given that the amino 
acids of each immunoglobulin-like domain of LigA and LigB are so divergent 
(14,16,17).     
      Apart from elastin, the binding regions of LigB to human tropoelastin (HTE), the 
precursor of elastin, were examined by ELISA and competition binding assays, and our 
results indicated that the elastin binding domains of LigB, LigBCon4, LigBCen7’-8, 
LigBCen9, and LigBCen12, can also bind to HTE (Figure. 8.3G and 8.4B). Moreover, 
we demonstrated that the HTE binding region for LigBCon4, LigBCen7’-8, LigBCen9, 
LigBCen12 resides in 17-27HTE, the central region of HTE (Figure. 8.5B, C, D, and E).  
Interestingly, FnBPA, the elastin binding protein of Staphylococcus aureus, was found 
to bind to 1-18HTE and 17-27HTE, N-termini and central region of HTE (33). It 
suggests that binding to elastin or tropoelastin is a common mechanism for pathogen 
adhesion (33). However, HTE is also involved in elastogenesis, the process of elastin 
formation, which is pivotal for tissue repair and the regeneration of host cells. Basically, 
monomer HTE is expressed and excreted into the extracellular area, undergoing a rapid 
ordered assembly to form tropoelastin packages, a self-association process called 
coacervation.  Lysine oxidation by lysyl oxidase facilitates cross-linking and then 
incorporation into microfibrils to generate elastic fibers (28,32). HTE is tethered to the 
cell surface and probably binds to ligands, including glycosaminoglycans, integrins and 
other non-ECM molecules, by its C-terminal region, 27-36HTE (43,51). Thus, Lig 
protein binding to 17-27HTE may not only mediate leptospiral adhesion but may also 
inhibit tissue regeneration by blocking the network formation (from HTE) of elastin 
fibers. Moreover, failed tissue repair may further facilitate the invasion of L. 
interrogans during infection. 
In order to gain more insight into the interaction of Lig proteins with HTE, 
LigBCon4 was chosen for further characterization using steady state fluorescence 
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spectroscopy and ITC techniques (Figure. 8.6). The KD obtained from both experiments 
are close to each other and to our ELISA results (ELISA; KD= 0.50±0.05μM, ITC; KD= 
0.49±0.07μM , Fluroescence spectroscopy; KD= 0.54±0.02μM ). The spectrum of 
LigBCon4 possesses a doublet maximum in 315nm and 326nm similar to that of 
LigBCen2.  LigBCen2 contains a tryptophan in an immunoglobulin-like domain; 
indications are that this tryptophan is buried in a highly hydrophobic core (23), but the 
quenching of the spectra in the presence of 17-27HTE suggest the binding site of 
LigBCon4 may be close to this hydrophobic core containing a tryptophan. Also, the 
interaction of 17-27HTE and LigBCon4 is driven by enthalpy as determined by ITC 
(Table 8.3).  Since enthalpy-driven reactions are generally due to charge-charge 
interactions or Van der Waal forces, the examination of the influences of surface 
charges on LigBCon4 and 17-27HTE were conducted by adjusting the environmental 
pH. Interestingly, the optimal binding of LigBCon4 to 17-27HTE corresponds to pH 6.5 
to 7.5, where the charge of LigBCon4 and 17-27HTE are opposite to each other and 
implies that binding between the two is governed by charge-charge interaction (Figure. 
8.7). Furthermore, the structure of LigBCon4 or 17-27HTE and the binding activities of 
LigBCon4-17-27HTE are properly maintained from pH4.5 to pH8.5 when detected by 
CD and fluorescence spectroscopy; this indicates that the interaction can occur in 
slightly basic and/or acidic environments (Figure. 8.7B and C and supplemental Figure. 
8.9).  Leptospira spp. usually invade the host through mucous membranes or 
injured skin and then are distributed to different organs such as the lung, liver, kidney or 
placenta through spirochetemia (1).  The normal range of pH in plasma is 7.38-7.42 
and that of urine ranges from 4.5 to 8.5 (52) . We conclude that the pH range from 4.5 to 
8.5 allows the optimal environment for LigBCon4-17-27HTE binding, facilitating 
adhesion of Leptospira spp. to tissues in these organs. 
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In this study, it was inferred that the interaction of LigBCon4/17-27HTE can 
partly be attributed to charge-charge interaction due to the enthalpy driven interaction 
found by ITC (Table 8.3), and the acidic amino acids of LigBCon4, LigBCen7’-8, 
LigBCen9, and LigBCen12  participate in the binding because of the negative charge 
on the surface of LigBCon4 as predicted in Figure. 8.7A. The results obtained from 
alignment of LigBCon4, LigBCen7’-8, LigBCen9, and LigBCen12 indicate that D341 
of LigBCon4 is conserved in all four elastin binding immunoglobulin-like domains 
(Figure. 8.8A). A mutant, LigBCon4D341N, was constructed and the binding activity 
of the mutated protein to 17-27HTE was analyzed by ITC and fluorescence 
spectroscopy to determine if an aspartate residue is involved in the binding of 
LigBCon4 to 17-27HTE.  The ITC and fluorescence spectroscopy results show a 
4.6-fold reduction of binding activity when LigBCon4D341N was used instead of the 
wild type LigBCon4 (LigBCon4; KD= 0.54±0.02μM, LigBCon4D341N; KD= 
2.51±0.48μM) (Figure. 8.8C, Table 8.3). This result further supports that the 
charge-charge interaction of LigBCon4 to 17-27 HTE is due to the negative charge of 
aspartate at physiological pH (Asp; pKa = 3.9). However, the binding of 17-27HTE to 
LigBCon4D341N is not completely eliminated.  This strongly indicates that other 
residues of LigBCon4 also contribute to the binding of HTE, but to a lesser degree. It is 
not surprising that Lig proteins interact with HTE mainly through charge-charge 
interactions because of the biochemical nature of HTE. There are two major types of 
domains found in tropoelastin including hydrophobic domains rich in nonpolar amino 
acids as well as hydrophilic domains rich in basic amino acids like lysine, so HTE can 
inherently bind to many partners via charge-charge interaction; examples include 
FnBPA binding to 17-27HTE and glycosaminoglycans binding to HTE (32,53,54).  
In conclusion, we have identified that Lig proteins contribute leptospiral adhesion to 
elastin and HTE. Elastin and HTE binding regions on the immunoglobulin-like domains 
 290
of LigBCon4, LigBCen7’-8, LigBCen9, and LigBCen12 were mapped.  Among these 
binding regions, LigBCon4 was found to bind to elastin and HTE with the highest 
affinity and the residue Asp341 of LigBCen4 was determined to be involved in HTE 
binding through charge-charge interactions. This is the first report that elastin and 
tropoelastin can bind to LigBCon, the conserved region of Lig from Leptospira spp. 
Further study of the interaction of Lig protein with elastin and tropoelastin is in progress 
in our laboratory.  
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CHAPTER 9  
LEPTOSPIRA IMMUNOGOBULIN-LIKE PROTEINS BIND TO THE 
C-TERMINAL FIBRINOGEN ΑC DOMAIN INHIBITING FIBRIN CLOT 
FORMATION, PLATELET ADHESION AND AGGREGATION  
 
Introduction 
Leptospira spp are pathogenic spirochetes that can cause acute or chronic 
infections in both humans and animals. The disease is widespread in developing 
countries and is reemerging in the United States (1, 2). Patients with Weil’s syndrome, a 
severe form of leptospirosis, may develop liver failure (jaundice), renal failure 
(nephritis), pulmonary hemorrhage, meningitis, abortion and uveitis (3). Several 
potential virulence factors from Leptospira spp. have been identified including LipL32 
(4, 5), Lsa21 (6), Lsa27 (7), HlyC (8), Lp95 (9), Leptospira endostatin-like proteins 
(Len) (10,11), and Leptospira immunoglobulin-like (Lig) proteins  (12-16). Among 
these molecules, only Lig proteins possess fibrinogen (Fg) binding activity (12,13). Lig 
proteins, including LigA, LigB, and LigC, contain 13, 12, and 13 Ig-like domains 
(17-19). The N-terminal 630 amino acids of LigA and LigB are highly conserved 
(LigBCon), but the C-terminals are variable (18,19). In addition, a non-Ig-like region is 
located in the C-terminals of LigB and LigC (18,19). Lig proteins bind calcium, which 
aids their binding to fibronectin (Fn) (20,21). LigBCen2NR, a disordered region of 
LigBCen2 binds to the N-terminal of Fn (21). Apart from Fn, LigBCen2 also binds to 
elastin, laminin, collagen, and Fg (13-16). A recent study indicated that knockout of the 
C-terminal of the LigB gene does not affect the virulence of this organism (22). 
Therefore, the role of LigB in the pathogenesis of leptospirosis is still unclear.   
 Fibrinogen (Fg) is a 340 kDa plasma glycoprotein composed of α, β, and γ chains 
crosslinked by 29 disulfide bonds (1-3). Fg interacts with activated αIIbβ3 integrin on the 
 299
surface of platelets thereby inducing platelet aggregation, which is intimately associated 
with blood coagulation (23-25).  Activation of prothrombin to thrombin by the 
coagulation cascade converts soluble Fg into a three-dimensional network of insoluble 
fibrin to form a clot (23,25). The fibrinolytic cascade limits the extent of the resulting 
thrombus. Plasminogen (PLG) is converted to plasmin by tissue-type plasminogen 
activator (tPA) and decomposes the fibrin clot by breaking down fibrin and interfering 
with fibrinogen polymerization (25). Several microbial adhesins classified as either 
Microbial Surface Components Recognizing Adhesive Matrix Molecules 
(MSCRAMMs) or secreted adhesins termed Secretable Expanded Repertoire Adhesive 
Molecules (SERAMs) are able to interfere with blood coagulation and thrombosis by 
binding to Fg (26,27).  We hypothesized that Lig proteins could play a similar role in 
the pathogenesis of leptospirosis. 
     In this study, we demonstrate that LigBCen2R, the partial 11th and entire 12th 
Ig-like domain of LigB, is able to bind to the C-terminus of Fg α (FgαCC) and fibrin, 
and the binding is expanded to other Ig-like domains of Lig proteins. The 
LigBCen2R-FgαCC interaction may prevent Fg binding to integrin αIIbβ3 on platelets 
and platelet aggregation. Furthermore, LigBCen2R could disrupt fibrin clot formation 
but did not affect the binding of PLG and tPA to FgαCC.   
 
Materials and Methods 
Reagents and antibodies 
rabbit anti-GST antibody, mouse anti-integrin αIIbβ3, Texas Red conjugated 
streptavidin, and FITC-conjugated goat anti-mouse antibody were ordered from 
Invitrogen (Eugene, OR). HRP-conjugated goat anti-rabbit antibody and 
HRP-conjugated streptavidin were ordered from KPL (Gaithersburg, MD). Integrin 
αIIbβ3 was purchased from Millipore (Billerica, MA). Thrombin and protein A HP 
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spintrap column were ordered from GE healthcare (Piscataway, NJ). Human plasma 
fibrinogen, human fibrin, plasminogen from human plasma, and human tissue 
plasminogen activator, bovine serum albumin (BSA), Tris-HCl, sodium phosphate 
dehydrate, and sodium chloride were obtained from Sigma-Aldrich (St. Louis, MO).  
 
 
Plasmid construction and protein purification 
ClfAN2N3 , N2-N3 domain of ClfA (amino acids 1131-1225 in ClfA) were from 
Staphylococcus aureus (28). All constructs used in this study were cloned into 
pGEX-4T-2 (GE healthcare) or pQE-30 (Qiagen, Alencia, CA) described in Table 9.1 
and schematized in Figure. 9.1 and overexpressed proteins  purified as 
Glutathione-S-Transferase (GST) or histidine tagged fusion proteins, respectively 
(16,20,29). To clone all above constructs, PCR reactions were performed by using the 
primers listed in Table 9.2 and is based on the DNA sequence in L. interrogans 
serovar Pomona (Genbank number: FJ030916) for all subconstructs of LigA. FgαC, 
FgαD, FgαE, FgαCC, and FgαCN were amplified from the α chain of human Fg (gifts 
from Dr. Timothy J. Foster) using primers as indicated in Table 9.1 and 9.2. For 
constructing all clones described above, primers were engineered to introduce a 
BamHI site at the 5’ end and a SalI site at the 3’ end of each fragment. PCR products 
were sequentially digested with BamHI and SalI and then ligated into pQE30 or 
pGEX-4T-2 digested with same restriction enzymes. For LigBCen2RW1073C and 
FgαCCY570W mutant constructions, a Quickchange mutagenesis kit (Strategene, La 
Jolla, CA) was used and followed the manufacturer’s instructions as previously 
described (16). In this study, the soluble form of the histidine-tag and GST fusion 
proteins were purified from E. coli as previously described (29).   
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Table 9.1. The sources of clones used in this study 
Clone Source Tag 
LigAVar7’-8 Residues 631-765 of LigA from L. interrogans GST tag 
LigAVar9 Residues 756-856 of LigA from L. interrogans Histidine tag 
LigAVar10 Residues 847-946of LigA from L. interrogans Histidine tag 
LigAVar11 Residues 938-1038 of LigA from L. interrogans Histidine tag 
LigAVar12 Residues 1029-1140 of LigA from L. interrogans Histidine tag 
LigAVar13 Residues 1131-1225 of LigA from L. interrogans Histidine tag 
FgαC Residues 198-644 of Fgα chain from human Histidine tag 
FgαD Residues 111-197 of Fgα chain from human Histidine tag 
FgαE Residues 1-110 of Fgα chain from human Histidine tag 
FgαCN Residues 198-391 of Fgα chain from human GST-tag 
FgαCC Residues 392-644 of Fgα chain from human GST-tag 
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Table 9.2. Primer Table 
Primer/Vector Sequence 
LigAVar7’-8fp/pGEX4T2 GCGGATCCCTTACCGTTTCCAAC 
LigAVar7’-8rp GCGTCGACATTGAAGTAAGAATT 
LigAVar9fp/pQE30 GCGGATCCTACCGTTACTCCCGC 
LigAVar9rp GCGTCGACCTCAATAAGTTCCGC 
LigAVar10fp/pQE30 GCGGATCCTTATCCGTTACCGCA 
LigAVar10rp GCGTCGACCGAAACTACTTTAGC 
LigAVar11fp/pQE30 GCGGATCCTTCCAAGTTACTCCG 
LigAVar11rp GCGTCGACGTAACGAAGAAGCGC 
LigAVar12fp/pQE30 GCGGATCCTTGAATGTCACTCCA 
LigAVar12rp GCGTCGACATTTACTATACCACT 
LigAVar13fp/pQE30 GCGGATCCGTTACGGTTACGGAA 
LigAVar13rp GCGTCGACTTATGGCTCCGTTTT 
LigBCen2RW1073Cf TCTTCGGTTACATGTTCCAGCTCAAAT 
LigBCen2RW1073Cr ATTTGAGCTGGAACATGTAACCGAAGA 
FgαCfp/pQE30 CGGGATCCGAAGATCAGCAGAAG 
FgαCrp CGGTCGACCTAGGGGGACAGGGA 
FgαDfp/pQE30 CGGGATCCGAAATTTTGAGAGGC 
FgαDrp CGGTCGACATAGTCCTTCAGATC 
FgαEfp/pQE30 CGGGATCCATGTTTTCCATGAG 
FgαErp CGGTCGACCATTATATTAGTGGT 
FgαCCfp/pGEX4T2 CGGGATCCGGCACATTTGAAGAG 
FgαCCrp CGGTCGACCTAGGGGGACAGGGA 
FgαCNfp/pGEX4T2 CGGGATCCGAAGATCAGCAGAAG 
FgαCNrp CGGTCGACCCAGTCTGGGTTGTT 
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Fig. 9.2 (Continued) 
 
Primer/Vector Sequence 
FgαCCY570Wf AGCACGAGTTGGAACAGAGGA 
FgαCCY570Wr TCCTCTGTTCCAACTCGTGCT 
  
Figure 9.1  A schematic diagram showing the structure of truncated (A) LigA, (B) LigB , and (C) Fg used in this study. 
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Platelet preparation 
All studies were performed in healthy blood donors without anti-platelet medication for 
at least four weeks. The preparation of platelets was performed using published methods 
(30). Briefly, 5 mL of blood was collected into citrated vacuum tubes, centrifuged at 140 
x g for 10 minutes and platelet rich plasma (PRP) was aspirated from the upper layer. 
Platelet poor plasma (PPP) was obtained after centrifuging the lower phase at 200 x g 
for 20 min. The number of platelets used in this study was adjusted by mixing different 
volumes of PRP and PPP and counted using a hemocytometer. In order to remove Fg on 
the surface of platelets, the platelets were spun down at 1,000 x g for 1 min and then 
treated with 1µM of PGE1 and 1.0 U/ml of apyrase. After removing the upernatant, the 
platelet pellets were gently resuspended in 10 mL of wash buffer (134mM NaCl, 5 mM 
Glucose, 1 mM EDTA, 15 mM Tris, pH 6.3) containing 1.0 U/mL apyrase and 
subsequently centrifuged at 800 x g for 15 min. The Fg depleted platelets were 
resuspended in buffer (145 mM NaCl, 5 mM KCl, 0.5 mM EGTA, 1 mM MgSO4, 10 
mM Glucose, 25 mM HEPES, pH 7.3) containing 1.0 U/mL of apyrase. 
 
Binding assays by ELISA 
To identify the Fg binding site on Lig proteins, 1 μM of Fg (Figure. 9.2A, 9.3A and B) 
or BSA (negative control and data not shown) in Tris buffer (25 mM of Tris and 150 
mM of sodium chloride at pH 7.0) were coated onto microtiter plate wells as previously 
described (21). Subsequently 100 μL of a serial dilution of biotinylated LigBCon 
(negative control), ClfAN2N3 (positive control in Figure. 9.2A) (28), LigBCen2 
(positive control in Figure. 9.2A) (13), LigBCen2NR, or LigBCen2R (Figure. 9.2A and 
positive control in Figure. 9.3A and B), LigAVar7’-8, LigAVar9, LigAVar10, 
LigAVar11, LigAVar12, LigAVar13, LigBCen7’-8, LigBCen9, LigBCen10, or 
LigBCen11 was added (Figure. 9.3A and B). To analyze the fibrin binding site of 
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LigBCen2R, 1μM of biotinylated LigBCon (negative control), ClfAN2N3 (positive 
control) (31), LigBCen2, LigBCen2R, or LigBCen2NR was added to a serial dilution of 
fibrin coated onto microtiter plate wells (Figure. 9.2B). To map the binding site of Lig 
proteins to Fg, 1 μM of Fg (positive control), BSA (negative control), Fgα, Fgβ, Fgγ 
(Figure. 9.4A), FgαC, FgαD, FgαE (Figure. 9.4B), FgαCC, or FgαCN (Figure. 9.4C) in 
Tris buffer were coated onto microtiter plate wells. A 100 μL aliquot of a serial dilution 
of GST fused LigBCon (negative control and data not shown) or LigBCen2R in Tris 
buffer was added subsequently (Figure. 9.4A, B, and C). To study the effect of 
LigBCen2R-Fg interaction on the binding of PLG and tPA on FgαCF, 100 μL of a serial 
dilution of GST fused LigBCon (negative control and data not shown) or LigBCen2R 
was mixed with 200 nM of PLG, tPA, LigBCen2R (positive control), or LigBCon 
(negative control) immediately before being added to microtiter plate wells coated with 
1 μM of FgαCC (Figure. 9.8B). To measure the interaction of Fg or fibrin with Lig 
proteins by ELISA, rabbit anti-GST (1:200) and horseradish peroxidase-conjugated 
goat anti-rabbit IgG (1:1000) were used as primary and secondary antibodies. To detect 
the binding of the biotinylated proteins, HRP-conjugated streptavidin (1:1000) was 
added to each well at RT for 1 hour prior to washing the wells three times with TBST. 
The measurement of binding by ELISA was performed as previously described (21).  
To determine the dissociation constant (KD), the data were fitted by the following 
equation using KaleidaGraph software (Version 2.1.3 Abelbeck software, Reading, PA), 
and the calculated KD are listed in Table 9.3.  
 
 
 
 
  
 
Table 9.3. The dissociation constant (KD) obtained from the Fibrinogen binding by Lig proteins determined by ELISA. 
KD Truncated Lig 
Fg Fgα Fgβ Fgγ FgαC FgαD FgαE FgαCC FgαCN
LigBCen2 116 ± 15 nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigBCen2R 110 ± 12 nM 165 ± 33 
nM 
n/ba n/ba 200 ± 43 nM n/ba n/ba 355 ± 43 nM n/ba 
LigBCen2NR n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar7’-8 n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar9 n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar10 207 ± 9 nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar11 n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar12 303 ± 44 nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigAVar13 755 ± 12 nM  n/db n/db n/db n/db n/db n/db n/db n/db 
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Table 9.3 (Continued) 
KD Truncated Lig 
Fg Fgα Fgβ Fgγ FgαC FgαD FgαE Fgα
CC 
FgαCN 
LigBCen7’-8 3170 ±15nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigBCen9 758 ± 26 nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigBCen10 295 ± 78 nM n/db n/db n/db n/db n/db n/db n/db n/db 
LigBCen11 n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
LigBCon n/ba n/db n/db n/db n/db n/db n/db n/db n/db 
n/ba , no binding. 
n/db , not determined. 
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Inhibition assays by ELISA 
To confirm that Fg- or fibrin-Lig protein interactions reflected specific binding, the 
microtiter plate wells were coated with 100 μL of 1 μM of Fg (Figure. 9.2C, 3C and D), 
fibrin (Figure. 9.2D) or BSA (negative control) as previously described (21). 100 μL of 
1 μM of biotinylated LigA10, LigA12, LigA13 (Figure. 9.3C), LigB7’-8, LigB9, 
LigB10 (Figure. 9.3D), LigBCen2R (Figure. 9.2C and D and positive control in 3C and 
D), ClfAN2N3 (positive control in Figure. 9.2C and D) (28) or LigBCon, LigBCen2R, 
LigBCon (negative control), or integrin αIIbβ3 (positive control) prior to being added to 
microtiter plate wells coated with 200 nM of integrin αIIbβ3 or containing 105 human 
platelets treated with 1 μM ADP (Figure. 9.5C and D). To elucidate if PLG or tPA 
binding to FgαCC affects the LigBCen2R-Fg interaction, 1 μM of FgαCC was coated on 
microtiter plate wells and treated with a serial dilution of PLG, tPA, LigBCen2R 
(positive control), or LigBCon (negative control) before incubation with 1 μM of GST 
fused LigBCen2R (Figure. 9.8A). The binding of GST fused or biotinylated proteins 
was measured by ELISA as described above. 
 
Isothermal Titration Calorimetry (ITC) 
The experiments were carried out with a CSC 5300 microcalorimeter (Calorimetry 
Science Corp. Lindon, UT, USA) at 25oC as previously described (21). In a typical 
experiment, the cell contained 1 ml of a solution of LigBCen2R and the syringe 
contained 250 μl of a solution of FgαCC. The concentration of LigBCen2R and FgαCC 
are 2.4 μM and 40 μM in Tris buffer. The titration was performed as follows: 25 
injections of 10 μl with a stirring speed of 250 rpm with a delay time between injections 
of 5 min. Data were analyzed using Titration Binding Work 3.1 software (Calorimetry 
Science Corp. Lindon, UT, USA) fitting them to an independent binding model. 
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Steady State Fluorescence Measurement 
Steady state fluorescence emissions were measured on a Hitachi F4500 
spectrofluorometer (Hitachi. San Jose, CA). All spectra were recorded in correct 
spectrum mode of the instrument using excitation and emission band passes of 2 nm. 
For titration experiments of LigBCen2R, 0.15, 0.3125, 0.625, 1.25, 2.5, or 5 μM of 
FgαCC were incubated with 1 μM LigBCen2R for 5 min. For the titration experiments 
of FgαCCY570W, 1 μM was mixed with 0.15, 0.3125, 0.625, 1.25, 2.5, or 5 μM of 
LigBCen2RW1073C for 5 minutes. The emission spectra were taken as the excitation 
wavelength at 295 nm and the emission wavelength recorded from 310 nm to 400 nm in 
Tris buffer (Figure. 9.5A). All spectra were recorded at 25oC after 5 min. To determine 
the dissociation constant (KD), the fluorescence intensities at 330 nm were recorded and 
fitted by the following equation using KaleidaGraph software (Version 2.1.3 Abelbeck 
software):  
  
Where Fmax is the fluorescence intensity of LigBCen2R or FgαCCY570W proteins in 
the absence of FgαCC or LigBCen2RW1073C, Fmin indicates the fluorescence 
intensities of FgαCCY570W saturated with LigBCen2RW1073C or LigBCen2R 
saturated with FgαCC. In addition, F is the fluorescence intensities of LigBCen2R or 
FgαCCY570W in the presence of various concentrations of FgαCC or 
LigBCen2RW1073C. All of the measurements were corrected for dilution and for inner 
filter effect.   
 
Circular dichroism (CD) spectroscopy 
CD analysis was performed on an Aviv 215 spectropolarimeter (Lakewood, NJ) under 
N2 atmosphere. CD spectra were measured at RT (25℃) in a 1-mm path length quartz 
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cell. Spectra of LigBCen2R, LigBCen2RW1073C, FgαCC (10 μM), and 
FgαCCY570W (10 μM) were recorded in Tris buffer at 25oC, and three far-UV CD 
spectra were recorded from 190 to 250 nm for far-UV CD in 1 nm increments. The 
background spectrum of buffer without protein was subtracted from the protein spectra. 
CD spectra were initially analyzed by the software accompanying the 
spectrophotometer. Analysis of spectra to extrapolate secondary structures was 
performed by Dichroweb  (http://www.cryst.bbk.ac.uk/cdweb/html/home.html) using 
the K2D and Selcon 3 analysis programs (20). 
 
 
Binding assays by Confocal Laser Scanning Microscopy (CLSM) 
To determine the binding inhibition of FgαC to platelets by LigBCen2R, 1 μM of 
GST-FgαCC was treated by 50 μM of LigBCen2R or LigBCon (negative control) in 
100 μl of Tris buffer for 1 hour at 37℃ prior to being added to wells containing 106 
platelets treated with 1 μM ADP and incubated at 37℃ for 1 hour. Fixation and 
immunofluorescence staining were performed as described previously with slight 
modification (21). Briefly, platelets were fixed in 2% paraformaldehyde for 60 min at 
room temperature (RT) and then incubated in PBS containing 0.3% BSA for 10 min at 
RT. The primary and secondary antibodies in PBS containing 0.3% BSA were 
incubated sequentially for 60 min at RT. To detect the expression of integrin αIIbβ3 and 
its binding to GST- FgαC, mouse anti-integrin αIIbβ3 (1:250x) and rabbit anti-GST 
antibodies (1:250x) served as primary antibodies, and FITC conjugated goat anti-mouse 
IgG (1:250x) and Texas Red-conjugated goat anti-rabbit IgG (1:250x) were used as 
secondary antibodies. To measure the binding by CLSM, the glass slides were mounted 
with coverslips using Prolong Antifade (Molecular Probe, Eugene, OR) and viewed 
with an Olympus Fluoview 500 confocal laser-scanning imaging system equipped with 
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krypton, argon, and He-Ne lasers on an Olympus IX70 inverted microscope with a 
PLAPO 60X objective (Olympus, America, Inc., Melville, NY). Confocal images were 
processed using Adobe Photoshop CS2 (San Jose, CA). The settings were identical for 
all captured images.All studies were repeated three times.  
 
Platelet aggregation  
IgG depleted human serum was produced from the flowthrough of the human serum 
passed through protein A HP spin trap column. and ELISA and SDS-PAGE were used 
to test that IgG has been depleted from IgG as previously described (32). To inactivate 
complement proteins, human serum was incubated at 56℃ for 30 min (32,33). To 
measure platelet aggregation in serum, PRP (106) was treated with various 
concentration (1.5 μM, 3.125 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, 100 μM) of 
LigBCen2R, LigBCon (negative control), or ClfAN2N3 (positive control) (34) for 1 
hour, and treated PRP was mixed with 1 μM ADP and incubated for 1 hour 
subsequently. All the procedures were performed in 37℃. To measure the platelet 
aggregation in IgG depleted or complement protein inactivated serum, platelets were 
washed by spinning down and washing through washed buffer prior to be suspended in 
IgG depleted or complement inactivated human serum. The number of platelets can be 
adjusted by the added volume of certain serum. Light microscopy was used to measure 
the platelet aggregation (35). Basically, the platelet aggregation was immediately 
analyzed using 60× objective by epifluorescence microscope (Nikon, Japan). This 
setting was identical for all captured image. The aggregation size was measured by 
counting the area of each aggregate in one field (1,024×1,024 μm). The total area 
covered by all aggregates was calculated and normalized to the total surface measured, 
and the percentage of reduced aggregation surface coverage is relative to the area 
covered by the aggregates of untreated platelets. 
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Fibrin clot formation assay 
The fibrin clot formation assay was performed as previously described (34). For the 
time course study  of fibrin clot formation, each reaction contained 10 μL of Fg (10 
U/mL) mixed with 90 μL of thrombin (1 mg/mL) with 30 μM of LigBCen2R, ClfAN2N3 
(positive control) (34), or LigBCon (negative control) in the presence of 2 mM calcium 
chloride on microtiter plates wells (Figure. 9.7A). The OD600 values were recorded 
every 1 min by an ELISA plate reader (Bioteck EL-312; BioTeck, USA). To determine 
the effect of LigBCen2R binding to Fg on  clot formation, 10 μL of thrombin (10 U/mL) 
mixed with 90 μL of Fg (1 mg/mL) that was pre-treated with a serial dilution of 
LigBCen2R, ClfAN2N3 (positive control), or LigBCon (negative control) in the 
presence of 2 mM calcium chloride at 25℃ was incubated for 1 hour in microtiter plate 
wells (Figure. 9.7B). The OD600 values were recorded described above. 
 
Statistical analysis 
Significance between samples was determined using the Student’s t-test following 
logarithmic transformation of the data. Two-tailed P-values were determined for each 
sample and a P-value <0.05 was considered significant. Each data point represents the 
mean + standard error of the mean (SEM) of samples tested in triplicate. An (*) 
indicates the result was statistically significant.  
 
Results 
The Ig-like domains of Lig proteins interact with Fg  
LigBCen2 includes a well-folded region, LigBCen2R, which contains part of the 11th 
and all of the 12th Ig-like domains, and a disordered region, LigBCen2NR (Figure. 9.1B) 
(20). To further map the Fg binding site on LigBCen2, LigBCen2R and LigBCen2NR  
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Figure 9.2  Determination the binding sites of Fg and fibrin on LigBCen2. (A and B) 
Binding of serial concentrations of LigBCen2R to immobilized Fg or fibrin by ELISA. 
0.015, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1μM of biotinylated LigBCen2R, 
LigBCen2NR, LigBCen2 (positive reference), LigCon (negative reference), or 
ClfAN2N3 (positive reference) was added to 1μM of Fg or BSA (negative control, data 
not shown) coated wells in Tris buffer. (B) 1μM of biotinylated LigBCen2R, 
LigBCen2NR, LigBCen2, ClfAN2N3 (positive reference), or LigCon (negative 
reference) was added to the microtiter plate wells coated with 0.062, 0.125, 0.25, 0.5, 1, 
2, 4μg/mL of Fibrin or BSA (negative control, data not shown) coated wells in Tris 
buffer. (C and D) Fg or fibrin inhibited LigBCen2R binding to immobilized Fg or fibrin. 
One μM of biotinylated ClfAN2N3 (positive control), LigBCon (negative control), or 
LigBCen2R was incubated with various concentrations of (C) Fg (0.031, 0.0625, 0.125, 
0.25, 0.5, 1, 2μM in Tris buffer), (D) fibrin (0.062, 0.125, 0.25, 0.5, 1, 2, 4μg/mL in Tris 
buffer), or GST (negative control and data not shown) at RT for 1 hour prior to be added 
to wells coated with (C) 1μM of Fg, (D) 4μg/mL of fibrin, or BSA (negative control and 
data not shown). The percentage of binding was determined relative to the binding of 
biotinylated proteins in the LigBCon treated wells. The binding of biotinylated proteins 
to Fg or fibrin was measured by ELISA. For all experiments, each value represents the 
mean± SEM of three trials in triplicate samples. Statistically significant (p＜0.05) 
differences compared to negative control are indicated by an asterisk.  
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Figure 9.3  Localization of the Fg-binding domains on Lig proteins. (A and B) Various 
concentrations (0, 0.015, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1μM) of biotinylated 
LigCon (negative control), LigBCen2R (positive control), and (A) LigAVar7’-8, 
LigAVar9, LigAVar10, LigAVar11, LigAVar12, LigAVar13, (B) LigBCen7’-8, 
LigBCen9, LigBCen10, LigBCen11 were added to wells coated with 1μM of Fg or BSA 
(negative control and data not shown) in Tris buffer. The binding of biotinylated 
proteins to Fg was measured by ELISA. For all experiments, each value represents the 
mean± SEM of three trials in triplicate samples. Statistically significant (p＜0.05) 
differences compared to negative control are indicated by an asterisk. (C and D) Soluble 
Fg inhibited Fg-binding Ig-like domains of Lig proteins to immobilized Fg. One μM of 
biotinylated LigBCen2R (positive control), LigBCon (negative control), (A) LigA10, 
LigA12, LigA13, (B) LigB7’-8, LigB9, LigB10 was incubated with various 
concentrations (0.031, 0.0625, 0.125, 0.25, 0.5, 1, 2μM in Tris buffer) of Fg or GST 
(negative control and data not shown) at RT for 1 hour prior to be added to 1μM of Fg or 
BSA coated wells (negative control and data not shown) The percentage of binding was 
determined relative to the binding of biotinylated proteins in the LigBCon wells. The 
binding of biotinylated proteins to Fg was measured by ELISA. For all experiments, 
each value represents the mean± SEM of three trials in triplicate samples. Statistically 
significant (p＜0.05) differences compared to negative control are indicated by an 
asterisk.  
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were examined for their Fg binding activities by ELISA, which shows that the Fg 
binding site on LigBCen2 is located on LigBCen2R (KD = 0.11±0.012 μM) (Figure. 
9.2A). The binding of LigBCen2R and fibrin was also analyzed and as shown in Figure. 
9.2B, LigBCen2 and LigBCen2R can also interact with fibrin. This indicates that the Fg 
binding site is preserved when fibrinogen is converted to fibrin. In addition, the 
interaction of LigBCen2R with Fg or fibrin is specific since pretreatment of Fg or fibrin 
with LigBCen2R abrogates binding (Figure. 9.2C and D).  
Since Fg binds to LigBCen2R, the Ig-like domain containing fragment of LigBCen2, it 
is rational to speculate that Fg may also bind to other Ig-like domains. To test this 
hypothesis, each Ig-like domain of LigA and LigB was purified and their ability to bind 
to Fg was assayed by ELISA. LigA10, LigA12, LigA13, LigB7’-8, LigB9, and LigB10 
can bind Fg with different binding affinities (LigA10, KD = 0.207±0.009 μM; LigA12, 
KD = 0.303±0.044 μM; LigA13, KD = 0.755±0.012 μM; LigB7’-8, KD = 3.17±0.015 μM; 
LigB9, KD = 0.758±0.026 μM; LigB10, KD = 0.295±0.078 μM; Figure. 9.3A and B). 
Moreover, the treatment of Fg with LigA10, LigA12, LigA13, LigB7’-8, LigB9, or 
LigB10 reduced their binding to Fg in a dose dependent manner, thus confirming that 
Fg binds to certain Ig-like domains of LigA and LigB (Figure. 9.3C and D). 
 
The Fg binding site for Lig proteins is located on the C-terminal tail of Fg αC 
domain (FgαCC)  
To elucidate the Fg binding site for Lig proteins, the binding of various truncated 
forms of Fg, including α (Fgα), β (Fgβ), and γ (Fgγ) chains, with LigBCen2R were 
examined by ELISA (Figure. 9.1C). The results showed that only Fgα could bind to 
LigBCen2R (KD = 0.165±0.033 μM; Figure. 9.4A). To map the LigBCen2R binding 
region, Fgα was further truncated into C (FgαC), D (FgαD), and E (FgαE) domains  
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Figure 9.4  Characterization the LigBCen2R binding site on Fg exhibited by ELISA, 
ITC, and steady state fluorescence spectroscopy. (A-D) Various concentrations (0.0156, 
0.03125, 0.0625, 0.125, 0.25, 0.5, 1μM) of GST-LigCon (negative control and data not 
shown) or GST-LigBCen2R was added to wells coated with 1μM of BSA (negative 
control), (A) Fg (positive control), Fgα, Fgβ, Fgγ, (B) Fgα (positive control), FgαC, 
FgαD, FgαE, (C) FgαC (positive control), FgαCC, FgαCN in Tris buffer. (D) FgαCC 
inhibited LigBCen2R binding to immobilized Fg. One μM of GST-LigBCon (negative 
control and data not shown), or GST-LigBCen2R was incubated with various 
concentrations (0.031, 0.0625, 0.125, 0.25, 0.5, 1, 2μM in Tris buffer) of GST (negative 
control), Fg (positive control) or FgαCC at RT for 1 hour prior to be added to wells 
coated with 1μM of Fg or BSA (negative control and data not shown). The percentage 
of binding was determined relative to the binding of GST fused proteins in the GST 
treated wells. The binding of GST fused proteins to Fg was measured by ELISA. For all 
experiments, each value represents the mean± SEM of three trials in triplicate samples. 
Statistically significant (p ＜ 0.05) differences compared to negative control are 
indicated by an asterisk. (E) Determination of the binding affinity by ITC. The cell 
contained 1 ml of 2.5μM of LigBCen2R and the syringe contained 250 μl of 40μM of 
FgαCC (upper panel) Heat differences obtained from 25 injections of FgαCC; (lower 
panel) Integrated curve with experimental data (◇) and the best fit (—). The 
thermodynamic parameters are shown by the average of duplicate experiments (Kd = 
0.382 ± 0.045μM, ΔH = -5.57 ± 0.57 kcal mol-1, TΔS = 3.14 ± 0.5 kcal mol-1 K-1), and 
the molar ratio of FgαCC to LigBCen2R is 1.02. (F) and (G) Intrinsic fluorescence 
spectrum of LigBCen2R in the presence and absence of FgαCC.  One μM of 
LigBCen2R in Tris buffer was excited at 295 nm. Aliquots of FgαCC from respective 
stock solutions were added. The figure shows Trp fluorescence in different 
concentration of FgαCC.  
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(Figure. 9.1C) and it was found that LigBCen2R binds only FgαC  (KD = 0.20±0.043 
μM; Figure. 9.4B). FgαC was truncated into 2 fragments, including an N-terminal 
disordered connecting region (FgαCN) and a C-terminal folded region with a 
hydrophobic collapsed region formed by two pairs of anti-parallel β-sheets (FgαCC) 
(Figure. 9.1C) (44-46). The results showed that LigBCen2 could bind only to FgαCC 
(KD = 0.355±0.043 μM; Figure. 9.4C). Also, the treatment of LigBCen2R with FgαCC 
reduced its binding to Fg, indicating that the Fg binding site for LigBCen2R is on the 
FgαCC domain (Figure. 9.4D). 
To gain more insight into the binding nature between LigBCen2R and FgαCC, 
ITC was performed to measure the binding affinity. As presented in Figure. 9.4E, the 
LigBCen2R- FgαCC interaction is driven by both enthalpy and entropy because of the 
negative values obtained, and the dissociation constant is in agreement with that 
obtained from ELISA (ITC, KD = 0.382±0.045 μM; ELISA, KD = 0.355±0.043 μM). On 
the other hand, the intrinsic fluorescence of LigBCen2R was also measured by the 
titration of FgαCC due to its absence of tryptophan. As shown in Figure. 9.4F and G, the 
KD of LigBCen2R- FgαCC interaction was obtained from the quenched tryptophan 
fluorescence of LigBCen2R upon the increased binding of FgαCC (KD = 0.364±0.037 
μM). A red shift of the wavelength in the maximum fluorescence intensity from 321 nm 
to 325 nm observed in FgαCC- -LigBCen2R inferred a conformational change led by 
FgαCC binding. This conformational change offers a solvent-exposed environment 
close to the tryptophan on LigBCen2R (Figure. 9.4F).  
 
LigBCen2R- FgαCC interaction prevents the binding of Fg to integrin on platelets 
due to a conformation change 
It is known that Fg can bind to activated integrin αIIbβ3 on the surface of platelets 
by its RGD motif located on FgαD and FgαCC to activate the functions of platelets (3).   
 Figure 9.5 LigBCen2R prevents the binding of FgαCC to integrin on platelets by altering the conformation close to RGD motif on 
FgαCC. The conformational change close to RGD motif of FgαCC induced by the binding of LigBCen2R observed in intrinsic 
fluorescence spectra. (A) A blue shift and quenching of the maximum wavelength of the spectra (339 to 330nm) of FgαCCY570W in 
the addition of LigBCen2RW1073C. One μM of FgαCCY570W in Tris buffer was excited at 295 nm. Aliquots of LigBCen2W1073C 
from respective stock solutions were added. The figure shows Trp fluorescence in the presence of 0.15, 0.3125, 0.625, 1.25, 2.5, 5μM 
of FgαCF. (B) The determination of KD of LigBCen2RW1073C and FgαCCY570W by monitoring the quenching fluorescence 
intensities of FgαCCY570W titrated by LigBCen2RW1073C or GST (data not shown) shown in (A). The emission wavelength 
recorded in this figure was 330nm. KD was determined by fitting the data point into the equation described in materials and methods 
(KD= 0.349±0.011μM). (C and D) LigBCen2R binding to FgαCC inhibits its interacting with integrin or platelets measured by ELISA. 
One μM of GST-FgαCC was mixed with various concentrations (0.015, 0.031, 0.0625, 0.125, 0.25, 0.5, 1μM in Tris buffer) of 
LigBCon (negative control), integrin (positive control) or LigBCen2R at RT for 1 hour prior to be added to wells (C) coated with 1μM 
of integrin or BSA (negative control and data not shown) or (D) containing 105 human platelets (negative control and data not shown). 
(E) LigBCen2R binding to FgαCC blocks its adhesion to platelets detected by immunoflourescence microscopy. 1μM of GST-FgαCC 
was treated with 50μM of LigBCen2R or LigBCon (negative control) prior to be incubated with 106 human platelets. The expression 
of integrin and the binding of FgαCC was examined by CLSM. In (C) and (D), the percentage of binding was determined relative to 
the binding of GST fused proteins in the LigBCon treated wells. The binding of GST fused proteins to integrin or platelets were 
measured by ELISA. For all experiments, each value represents the mean± SEM of three trials in triplicate samples.  
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Due to the presence of an RGD motif in FgαCC (RGDS within α572-574), the 
possibility ofinhibiting binding to integrin by LigBCen2R- FgαCC interaction was 
tested. To test whether blocking the FgαCC RGD binding site inhibited binding to 
integrin, FgαCCY570W, a FgαCC mutant with tryptophan close to the RGD motif, and 
LigBCen2RW1073C, a LigBCen2R mutant without tryptophan, were constructed. The 
undistinguishable secondary structures of the LigBCen2RW1073 and FgαCCY570W 
mutants were measured by CD spectroscopy and compared to wild type LigBCen2 and 
FgαCC to eliminate the possibility that the mutations changed their structure (data not 
shown). As indicated in Figure. 9.5A and B, the intrinsic fluorescence spectrum of 
FgαCCY570W was quenched after the addition of LigBCen2RW1073C in a dose 
dependent manner with a KD (KD = 0.349±0.011 μM) consistent with the value reported 
above, which suggested that the mutations did not affect the nature of the binding (ITC, 
KD = 0.382±0.045 μM; ELISA, KD = 0.355±0.043 μM; Fluorescence spectrometry of 
LigBCen2R and FgαCC, KD = 0.364±0.037 μM). Furthermore, the wavelength of the 
maximum fluorescence intensity in the spectrum of FgαCCY179W recorded in the 
absence of LigBCen2RW1073C was located at 339 nm indicating that the environment 
close to this sole tryptophan (RGD motif) is polar and exposed, which is in agreement 
with previous studies (Figure. 9.5A) (36). However, a significant blue shift of the 
wavelength in the maximum fluorescence intensity from 339nm to 330nm was found in 
the spectrum of FgαCCY179W upon the addition of 5μM LigBCen2RW1073C, which 
indicates that the environment close to the tryptophan (RGD motif) on FgαCCY179W 
was buried and became hydrophobic upon the binding of LigBCen2RW1073C (Figure. 
9.5A). 
To determine whether the buried RGD motif of FgαCC after saturation with 
LigBCen2R blocks the interaction of FgαCC and integrin, the binding of FgαCC treated 
with a serial dilution of LigBCen2R was measured by ELISA. As revealed in  
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Figure 9.6  Platelet aggregation inhibited by LigBCen2R- FgαCC interaction.  
Platelets (106) in (A to D) PRP or in (E to G) IgG depleted and complement inactivated 
serum was treated with 100μM of (A and E) LigBCen2R, (B and F) ClfAN2N3, or (C 
and G) LigBCon, or (D and H) various concentration (1.56 μM, 3.125 μM, 6.25 μM, 
12.5 μM, 25 μM, 50 μM, 100 μM) of LigBCon, LigBCen2R, or ClfAN2N3. Aggregation 
was observed by light microscopy. For all experiments, each value represents the 
mean± SEM of three trials in triplicate samples. The light microscopic settings were 
identical for all the captured images. In (D) and (H), the area covered by the aggregates 
in one field normalized to the total surface measured, and the percentage of reduced 
aggregation surface coverage corresponds to the area covered by the aggregates of 
untreated platelets. Statistically significant (p＜0.05) differences compared to negative 
control are indicated by an asterisk. 
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Figure 9.7 Effect of LigBCen2R on thrombin-induced fibrin clot. (A) Dose dependent reduced fibrin clot formation by premixing 
with LigBCen2R. 90μL of fibrinogen (0.9 mg/mL) was mixed with various concentrations (0.23, 0.46, 0.93, 1.875, 3.75, 7.5, 15, 
30μM in Tris buffer with 2mM of CaCl2) of ClfAN2N3 (positive control), LigBCon (negative control), or LigBCen2R at RT for 5min. 
Then, the mixture was incubated with 10μL of thrombin (1unit/mL) for 1 hour. The fibrin clot was measured by the optical density of 
the reaction at 600nm.  (B) Time course of fibrin formation affected by LigBCen2R. 90μL of fibrinogen (0.9 mg/mL) was mixed 
with 30μM of ClfAN2N3 (positive control), LigBCon (negative control), or LigBCen2R in Tris buffer with 2mM of CaCl2 at RT for 
5min. Then, the mixture was incubated with 10μL of thrombin (1unit/mL). The optical density of the reaction at 600nm was recorded 
at 1 min intervals over 30 min. All above experiments was performed thrice, and each value represents the mean± SEM of three trials 
in triplicate samples. Statistically significant (p＜0.05) differences compared to negative control are indicated by an asterisk. 
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Figure. 9.5C, the binding of LigBCen2R to FgαCC prevented the interaction of FgαCC 
with integrin. Furthermore, LigBCen2R interfered with the binding of FgαCC to 
platelets as shown by both ELISA and immunofluorescence microscopy (Figure. 9.5D 
and E). 
 
LigBCen2R- FgαCC interaction blocks platelet aggregation 
To gain more insight into the influence of LigBCen2R- FgαCC binding on platelet 
aggregation, PRP was treated with LigBCon, LigBCen2R, or ClfAN2N3. Platelet 
aggregation was significantly decreased in a dose-dependent manner in PRP treated 
with LigBCen2R but not LigBCon, which indicates LigBCen2R inhibits platelet 
aggregation (Figure. 9.6A-D). Furthermore, platelet aggregation in IgG depleted and 
complement inactivated serum was also evaluated in order to elucidate the role of Lig 
protein binding to Fg in platelet aggregation. As shown in Figure. 9.6 E-H, the addition 
of LigBCen2R could block the aggregation ADP induced platelet aggregation in IgG 
depleted and complement inactivated serum and is dose dependent. Therefore, 
LigBCen2R- FgαCC interaction inhibits platelet aggregation. 
 
LigBCen2R- FgαCC interaction inhibits clot formation 
To determine if LigBCen2R could interfere with Fg function, a thrombin-induced 
clot formation experiment was performed (Figure. 9.7). Pretreatment of LigBCen2R 
with fibrinogen before the addition of thrombin reduced the turbidity of the fibrin 
forming reaction in a dose dependent manner (Figure. 9.7 A). Furthermore, fibrin clot 
formation upon the addition of LigBCen2R was time dependent. As shown in Figure. 
9.7B, clot formation in response to the addition of LigBCon was slow initially but was 
followed by a rapid increase in the reaction. Similarly, pretreatment of LigBCen2R or  
  
 
 
 
Figure 9.8 Competition experiments on the binding of LigBCen2 and PLG or tPA to the immunoblized FgαCC performed by ELISA. 
(A) PLG or tPA cannot compete with LigBCen2R for the binding of FgαCC. The microtiter plate wells coated with 1μM of FgαCC or 
BSA (negative control and data not shown) were treated by various concentrations (0.031, 0.0625, 0.125, 0.25, 0.5, 1, 2μM in Tris 
buffer) of PLG, tPA, LigBCen2R (positive control) Fg or LigBCon (negative control) at RT for 1 hour prior to be incubated with 1 
μM of GST fused LigBCen2R, LigBCon (negative control and data not shown). The percentage of binding was determined relative to 
the binding of GST fused proteins in the LigCon treated wells. (B) The pre-mixture of PLG or tPA to LigBCen2R doesn’t change its 
binding affinity to FgαCC. Increased concentrations (0, 0.015, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1μM) of GST-LigCon (negative 
control and data not shown), GST-LigBCen2R was treated with 200nM of PLG, tPA, LigBCen2R (positive control), or LigBCon 
(negative control) before added to wells coated with 1μM of FgαCC or BSA (negative control and data not shown) in Tris buffer. The 
binding of GST fused proteins to FgαCC was measured by ELISA. For all experiments, each value represents the mean± SEM of 
three trials in triplicate samples. Statistically significant (p＜0.05) differences compared to negative control are indicated by an 
asterisk 
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ClfAN2N3 also resulted in slow initial clot formation similar to the results seen with 
LigBCon pretreatment (negative control). However, after the initial stage, there was no 
further increase in turbidity indicating that LigBCen2R pretreatment of Fg had an 
inhibitory effect on fibrin clot formation (Figure. 9.7B).  
 
LigBCen2R cannot compete with PLG or tPA for FgαCC binding  
To determine if LigBCen2R competes with PLG or tPA for binding to FgαCC, 
competition ELISA of LigBCen2R binding to PLG or tPA saturated FgαCC was 
performed. The binding of LigBCen2R to FgαCC was not affected by the pre-treatment 
with PLG or tPA (Figure. 9.8). Moreover, the KD values of LigBCen2R interaction with 
FgαCC in the presence or absence of tPA or PLG were statistically insignificant, which 
confirmed that the binding sites of tPA, PLG, and LigBCen2R on FgαCC are distinct 
(PLG treated GST-LigBCen2R, KD = 0.358±0.062 μM; tPA treated GST-LigBCen2R, 
KD = 0.347±0.019 μM; LigBCon treated GST-LigBCen2R as negative control, KD = 
0.341±0.012 μM) (Figure. 9.8B).  
 
Discussion 
In a previous study, a high affinity fibronectin binding site on LigB was localized 
to amino acids 1014-1165 within LigBCen2. This LigBCen2 site also binds to 
fibrinogen, collagen, and laminin (13). LigBCen2 consists of two regions, LigBCen2R, 
which contains part of the 11th and the entire 12th Ig-like domains, and a disordered 
region, designated LigBCen2NR, which contains 47 non-repeated amino acids (20). In 
this study, the Fg binding site was fine-mapped to LigBCen2R, and this binding 
expanded to other Ig-like domains of LigA and LigB. Furthermore, the LigBCen2R 
binding site on Fg was mapped to the C-terminal αC domain of Fg (FgαCC). Recently, 
several bacterial Fg binding proteins were described, and the binding sites are 
 333
distributed on various regions of Fg including FgαD (31), FgαCN (37), Fgβ (38), and 
Fgγ (34,39). This is the first Fg binding protein isolated from a spirochete proven to 
interact with FgαCC. Interestingly, the major tertiary structures of Lig proteins, the 
Ig-like domains, are similar to those of ClfA, FnBPA and SdrG, the Fg binding proteins 
of S. aureus (40,41). A general model called “dock, lock, and latch” can describe the 
interaction of ClfA, FnBPA, and SdrG with Fg, although their binding sites are distinct 
(Fgγ for ClfA and FnBPA, and Fgβ for SdrG) (41-43). However, it is unclear whether 
the interaction of Lig-Fg is similar to this model due to the absence of sequence 
similarities between Lig proteins and ClfA, FnBPA and SdrG. Further structural studies 
are needed to demonstrate the binding model of LigBCen2R and FgαCC.   
Fibrinogen serves a key role in blood coagulation and thrombosis (23-25). Fg 
binding to platelets is responsible for platelet aggregation, which is essential for primary 
hemostasis (25), and integrin αIIbβ3 is the most important platelet surface protein that 
mediates the interaction of Fg with platelets (23-25). Fg contains three potential integrin 
binding sites including two RGD motifs on Fgα (RGDS Fgα572-575 and RGDF 
Fgα95-98) and a non-RGD sequence on Fg γ (HHLGGAKQAGDV Fgγ400-411) 
(23-25). The synthetic peptides RGDS Fgα572-575 and RGDF Fgα95-98 block Fg 
binding to platelets indicating that the two RGD motifs in Fgα are pivotal for the 
interaction of human Fg with human platelets (44). Previously, it was proposed that an 
extracellular Fg-binding protein, Efb, from S. aureus either blocks the RGD sequence 
on FgαD (amino acids 95-97 in Fgα) or causes a nearby conformational change when it 
binds to FgαD (31,45). In this study, LigBCen2R was found to interact with FgαCC, 
which also contains one of the RGD motifs, RGDS in Fgα572-575.  Surprisingly, the 
binding studies using mutant fragments found that LigBCen2RW1073C induces a 
transition in the environment close to the sole mutated tryptophan, W570, of 
FgαCCY570W near the RGD motif from an exposed position to one that is buried. 
 334
These results suggest that LigBCen2R either binds directly to the RGD motif or to 
amino acids at other locations and then induces a conformational change. However, the 
lack of binding activity of LigBCen2R and the peptide containing the RGD motif of 
FgαCC and LigCen2 with the cell binding domain (CBD) of Fn, which contains a RGD 
motif, suggests that LigBCen2R does not bind to the RGD domain, but binds to other 
regions of FgαCC and induces a conformational change close to the RGD motif (13 and 
data not shown) 
      Fg-integrin binding on platelets promotes platelet aggregation and induces 
primary hemostasis (23-25). To date, several bacterial Fg binding proteins are known 
and they may play a role in the pathogenesis of bacterial infection. ClfA, ClfB, FnBPA, 
and SdrG are able to bind to platelets and induce platelet aggregation and activation 
mediated by interacting with Fg (46-49). In contrast, Efb binding to Fg inhibits platelet 
aggregation and activation by interfering with Fg-integrin interaction (34,50), although 
Efb can still attach to platelets via Fg or unknown components (50). In this study, 
LigBCen2R reduced the binding of FgαCC to integrin, which led to decreased binding 
of Fg to platelets. This phenomenon can be attributed to the inability of the integrin to 
bind to the buried RGD motif on FgαCC that result from a LigBCen2R binding induced 
conformational change. Platelet adhesion is required for platelet aggregation or 
activation (25) so it is not surprising that LigBCen2R inhibited platelet aggregation by 
interacting with FgαCC. However, platelet aggregation was not completely blocked by 
treatment with LigBCen2R since other two platelet binding sites of Fg, Fgγ and FgαD, 
are still active (Figure. 9.6). Platelet aggregation was found in some cases of human 
leptospirosis associated with pulmonary hemorrhage and the authors speculated that 
leptospiral induced capillary damage led to platelet activation (51). Conversely, in 
another study the authors concluded that platelet aggregation was not important in the 
pathogenesis of leptospirosis because of the lack of platelet aggregation in organs 
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usually infected by Leptospira spp., such as kidney or lung, or only limited platelet 
aggregation observed in liver (52). Our results suggest that Lig proteins may block the 
binding of Fg to platelets, thereby inhibiting platelet aggregation, which may account 
for the pulmonary hemorrhage noted in severe, often fatal cases of leptospirosis.  
During thrombosis, soluble Fg is converted to insoluble fibrin, which contributes 
to clot formation (25). Initially, thrombin binds to and digests the E domain of Fg 
yielding fibrinopeptides A and B to form A and B knobs in the FgE domain and a and b 
holes in the C-terminals of Fgγ and Fgβ, respectively (25). Knob-hole interaction results 
in the formation of one dimensional fibrin (25). Subsequently, lateral aggregation due to 
the intermolecular interaction of FgαC domains from adjacent Fg molecules stabilizes 
the mechanical properties of the fibrin clot to form a two- and three-dimensional fibrin 
network (25). Several bacterial Fg binding proteins inhibit thrombosis by using 
different mechanisms. ClfA and FnBPA bind to the C-terminal domain of the Fgγ chain 
to block the b hole bound by the B knob (39,53), while SdrG, another Fg binding protein, 
binds to the N-terminal domain of the Fgβ chain, the thrombin targeting site, and 
prevents fibrin clot formation (38). As presented in Figure. 9.7, the initial stages of clot 
formation (0 to 3 minutes) upon the addition of LigBCen2R to Fg is similar to the results 
obtained with untreated Fg. Importantly, thrombin-induced fibrin clot formation was 
decreased at later time points, which suggests that Lig protein binding to FgαCC 
obstructs the sites needed for lateral aggregation of fibrin during the later stages of clot 
formation.  
Fibrinolysis clears the temporary hemostatic plug (25). Plasmin, a protease which 
digests fibrin, is converted from inactive plasminogen (PLG) through the action of tPA 
(25). PLG usually binds to the end-to-end junction of two fibrin molecules including 
FgαD (amino acids 148-160 in Fg α chain), and the tPA binding site on fibrin was 
identified on Fgγ (amino acids 312-324 in Fg γ chain). Interestingly, both tPA and PLG 
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also bind to the C-terminal FgαC domain (FgαCC) within fibrin, and this binding is 
physiologically relevant due to the surface exposed structure of FgαCC in firbrin 
(25,54). Since PLG and tPA do not compete with each other for their Fg binding sites on 
FgαCF, a ternary complex model for PLG-tPA-FgαCC was proposed (54). LigBCen2R 
of Lig proteins is known to interact not only with fibrin, but also with FgαCC of Fg, and 
LigBCen2R- FgαCC interaction does not affect the binding of PLG or tPA to FgαCC. 
This “dynamic equilibrium” permits fibrin clot removal as there is no inhibitory effect 
on PLG or tPA binding to FgαCC (25). The significantly reduced clot formation caused 
by LigBCen2R- FgαCC interaction suggests that leptospiral Lig proteins push this 
“dynamic equilibrium” toward fibrinolysis. This may help explain the pulmonary 
hemorrhage that is observed in most recent Leptospira spp. fatal cases, since decreased 
fibrin clot formation may lead to the severe pulmonary hemorrhage that often occurs in 
fatal cases of leptospirosis (51,55-57).  
Massive hemoptysis, either alone or in combination with acute respiratory death 
syndrome, has emerged as the leading mechanism of death among people infected with 
pathogenic leptospires. Similarly, pulmonary hemorrhage is a prominent feature in the 
hamster model of leptospirosis (58,59). We propose that Lig proteins bind to FgαCC, 
which prevents Fg from binding to αIIbβ3 on platelets thereby inhibiting platelet 
aggregation.    Furthermore, Lig proteins do not interfere with the binding of tPA and 
PLG to fibrin, which would preserve the fibrinolytic machinery. The net result of 
platelet aggregation inhibition and maintenance of fibrinolysis would be a bleeding 
diathesis. 
     In conclusion, we report a high affinity Fg binding site located on LigBCen2R and 
expanded to most of Ig-like domains of LigA and LigB.  Furthermore the binding sites 
of the Ig-like domains within Lig proteins mapped to the C-terminal tail of FgαC 
(FgαCC). The binding of LigBCen2R leads to a conformational change close to RGD 
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motifs within FgαCC, blocking the interaction of integrin and LigBCen2R and 
preventing platelet aggregation. In addition, the LigBCen2R-FgαCC interaction can 
also reduce clot formation but not influence the binding of PLG and tPA to Fg. Taken 
together, Lig proteins may modulate thrombosis and fibrinolysis by binding to Fg.  
Further work to elucidate the Lig-Fg binding structure site with high resolution should 
offer further insights into this interaction. 
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CHAPTER 10 
CONCLUSIONS 
 
Leptospirosis is a serious worldwide zoonosis and is reemerging in the United 
States.  Leptospira spp. infect humans and animals by penetrating mucous membranes 
or injured skin. Adhesion to host tissues is a crucial step in the pathogenesis of bacterial 
infection. To date, a variety of bacterial adhesins, termed MSCRAMM or SERAM, 
have been identified to interact with host extracellular matrix (ECM). Prior to these 
studies, the molecular mechanisms that mediate leptospiral adhesion were unknown. 
Previously, our laboratory discovered a group of leptospiral outer surface proteins, for 
which we coined the name “Leptopsira immunoglobulin-like protein (Lig)”, that 
includes LigA, LigB, and LigC. Due to similarities between Lig proteins and other 
bacterial adhesins, we speculated that these molecules might serve as ECM binding 
proteins. LigB was truncated into N-terminal, central and C-terminal regions and we 
demonstrated that the C-terminal LigB region, which includes LigBCen (amino acids 
631-1417) and LigBCtv (amino acids 1418-1889) can bind to fibronectin (Fn). Further 
studies confirmed that the binding of Fn-LigBCen or Fn-LigBCtv promotes the 
adhesion of Leptopsira to MDCK cells. A high affinity Fn binding region was also 
localized to LigBCen2, which consists of amino acids 1014-1165. LigBCen2 binds 
strongly to the N-terminal domain (NTD) of Fn (KD = 272nM), but binds only weakly to 
the gelatin binding domain (GBD) of Fn (KD = 1200nM).  Furthermore, we determined 
that the LigBCen2 binding sites for NTD and GBD of Fn do not overlap. In addition, 
LigBCen2 can interact with MDCK cells and binds to other ECMs including laminin, 
fibrinogen and collagens. Metal ions usually serve a pivotal role as cofactors for 
bacterial virulence factors, such as bacterial adhesins. In this study, LigBCen2 was 
found to bind calcium with a KD of 7μM.  Calcium plays an important role in 
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maintaining the stability of LigBCen2 and promoting the binding of LigBCen2 to Fn by 
altering its conformation. Since calcium concentrations are higher in vivo, calcium 
binding to LigB may aid Leptopsira infection as the organism adapts from the external 
environment to the internal environment of the host. Interestingly, LigBCen2 contains a 
well-folded region, LigBCen2R, which includes the 12th and half of 11th 
immunoglobulin-like domains (amino acids 1014-1119) and a disordered region, 
LigBCen2NR, composed of 46 amino acid residues in the C-terminal of LigBCen2 
(amino acids 1120-1165). In this study, NTD of Fn was found to bind to LigBCen2NR 
while LigBCen2R binds to GBD only. Surprisingly, the binding of NTD of Fn to 
LigBCen2NR will dramatically change this disordered region to a β-strand-rich folded 
structure.  NTD-LigBCen2NR binding may follow a β–zipper mechanism, the general 
rule of Fn binding protein binding to NTD. The disordered-ordered transition found in 
protein-protein interactions greatly increases their flexibility and receptor binding 
specificity. 
In contrast to the order to disorder transition found in LigBCen2NR upon NTD 
binding, the binding of LigBCen2R to GBD changes its folded regions to a disordered 
form. In addition to LigBCen2R, other immunoglobulin-like domains from LigA and 
LigB are able to bind GBD. Thus, the order to disorder transition observed when 
LigBCen2R binds to GBD could likely be expanded to most of the 
immunoglobulin-like domains of LigAVar and LigBCen. Furthermore, most of the 
immunoglobulin-like domains bind to GBD through a multivalent binding mechanism, 
and multivalent binding enhances the binding affinities between Fn and LigA or LigB. 
Interestingly, the terminal immunoglobulin-like domains of LigAVar, LigAVar13, and 
LigBCen, LigBCen12, serve a greater role in  Fn binding as compared to other 
immunoglobulin-like domains. The binding affinity of GBD or MDCK cells and LigA 
or LigB truncated protein containing the terminal domains is stronger than that without 
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the terminal domains. (LigAVar7’-12, KD= 2.41μM; LigAVar7’-13, KD= 0.055μM; 
LigBCen7’-11, KD= 1.39μM; LigBCen7’-12, KD= 0.056μM). This may be due to the 
compact structure contributed to by the inter-domain interactions in LigAVar7’-13 and 
LigBCen7’-12 instead of LigAVar7’-12 and LigBCen7’-11.  
There are two Fn binding sites located on LigB, namely LigBCen and LigBCtv. 
In this study, a weak Fn binding site is also localized to LigB1706-1716 containing LIPAD 
residues, and binds on 15 type III modules of Fn.  LigB1706-1716 is surface exposed and 
can also partially mediate leptopsiral adhesion to host cells. Cooperative binding led by 
conformational changes are a well recognized mechanism for protein-protein 
interaction. Although LigB1706-1716 binds to Fn weakly, the potential role of this binding 
in the pathogenesis of leptospiral infection requires further study. Thus, the multivalent 
interaction of Lig-GBD, LigBCen2NR-NTD, and LigBCtv-15 type III modules of Fn 
mentioned above may mediate leptospiral adhesion to host cells to initiate infections. 
Apart from Fn, the binding activity of LigB to elastin was also elucidated. In this 
study, elastin and its monomer, tropoelastin, were found to bind to immunoglobulin-like 
domains of Lig proteins. Four elastin binding immunoglobulin-like domains were 
identified including LigCon4, LigBCen7’-8, LigBCen9, and LigBCen12. The binding 
between elastin and Lig was found to be mediated by charge-charge interaction. Since 
Leptospira usually preferentially localize in elastin-rich organs such as lung, skin, and 
uterus, Lig-elastin interaction may enhance the attachment of Leptospira spp. to lung 
and placenta elastic fibers.  The interaction of various virulence factors of Leptospira 
spp. with lung and placenta may lead to pulmonary hemorrhage and/or abortion. 
Moreover, elastin plays a pivotal role for tissue repair and reorganization. The binding 
of Lig protein and tropoelastin may block the elastogenesis to repair the tissue injury 
caused by Leptospira spp. infection. Therefore, this may facilitate the penetration and 
migration of this organism in host tissue. 
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Fibrinogen (Fg), a plasma proteins involved in blood coagulation, was also 
proved to bind to Lig proteins in this study. Platelet aggregation, adhesion, and fibrin 
clot formation can be blocked by the buried RGD motif on FgαCC domains led by the 
binding of Lig proteins. Due to the inability of the inhibition of plasminogen or tissue 
plaminogen activator to FgαCC domains by the binding of Lig proteins, a fibrin clot 
could not be formed stably. This may explain a possible reason for pulmonary and 
mammary gland hemorrhage.. 
To date, Ig like domains of Lig proteins possess a limited size (90 amino acids 
residues) but bind to various ECM including fibronctin, laminin, collegen, elastin, 
tropoelastin, and fibrinogen.  The molecular mechanism of the interaction of Lig 
protein with multiple ECMs needs further study to understand the role of each ECM in 
the pathogenesis of Leptospira spp. infection in animals and humans. In conclusion, the 
study of the interaction of Lig protein and their ECMs has helped elucidate the 
important role of these virulence factors in the pathogenesis of leptospirosis.  
 
